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1. Schizosaccharomyces pombe 
The studies included in this thesis, aiming to achieve a better understanding of 
checkpoint response to unreplicated or damaged DNA in eukaryotes, have been 
performed using the yeast Schizosaccharomyces pombe as a model organism.  
S. pombe was first isolated in 1893 by Lindner from East African millet beer. In fact, 
the species name is derived form the Swahili word for beer (Pombe). It is a rod-
shaped unicellular eukaryote of 3-4 μm in diameter and 7-14 μm in length. S. pombe 
cells maintain their shape by growing exclusively through their cell tips. They divide by 
means of a septum formed in their medial part to give rise to two identical daughter 
cells. Therefore S. pombe is also called fission yeast.  
S. pombe genome is divided into three relatively large chromosomes. These present 
features typical of higher eukaryotes, including large diffuse DNA replication origins 
(~1 kb) and large heterochromatic centromeres (~40-100 kb). S. pombe origins 
display a wide range of efficiencies, and lack defined consensus sequences just like in 
metazoans and differing from Saccharomyces cerevisiae.  
S. pombe is the sixth model eukaryotic organism whose genome was fully sequenced, 
in 2002 (Wood et al., 2002). Characteristic of the fission yeast genome are its low 
number of genes compared to other eukaryotes and the presence of introns in 43% of 
its genes. Fifty genes were found that had significant similarity with human disease 
genes and half of these are cancer related.  
From gene-sequence comparisons, S. pombe and S. cerevisiae are estimated to have 
diverged from each other in evolution around 400 million years ago, and their 
sequences are as divergent from each other as either yeast is from higher eukaryotes. 
Thus there are around 145 genes in S. pombe that have metazoan homologues but 
are not found in S. cerevisiae and a similar number viceversa. These similarities and 
divergences among the both yeasts and larger eukaryotes turned S. pombe and S. 
cerevisiae into two complementary model organisms for the study of the organization 
and behaviour of mammalian cells. 
Fission yeast was first developed as an experimental model for cell cycle research by 
Murdoch Mitchison in the 1950s. The fission yeast researcher Paul Nurse together 
with Lee Hartwell and Tim Hunt received the Nobel Prize in Physiology or Medicine in 
2001 for their work on cell cycle regulation. S. pombe has proven to be a valuable 
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model organism for research of many other biological relevant aspects like sexual 
differentiation, chromosome dynamics and polarized cell growth and for the study of 
cellular responses to DNA damage and replication stress.  
2. CELL CYCLE 
Cell cycle in eukaryotes consists of a number of coordinated cellular events 
that must guarantee correct duplication and subsequent segregation of all cellular 
components necessary for survival and functionality of daughter cells.  
Due to the complexity of this process, yeasts as unicellular eukaryotes have proven to 
be valuable model organisms to study the regulatory and control mechanisms of cell 
cycle. S. cerevisiae and S. pombe have thus provided important contributions to the 
If nutrients are insufficient to allow for mitotic growth, S. pombe cells can enter stationary phase or initiate 
a meiotic cell cycle. In the latter, cells of different mating type can mate during G1. They fuse, mixing their 
genetic material to form a diploid zygote. The zygote immediately undergoes a meiotic cell cycle to give 
rise to four haploid spores. If favourable nutritional conditions are restored, spores germinate to form cells 
which can re-entry into mitotic cell cycle. 
 
S. pombe mitotic cell cycle is characterized by an 
extremely long G2 phase, accounting for the 70% of 
the doubling time. In addition, in exponentially 
growing S. pombe cells, cytokinesis occurs when 
cells have nearly completed S-phase. Since the S. 
pombe genome is haploid this mechanism ensures 
the availability of a reference copy to allow for repair 
in case of DNA-damage, being the time during 
which cells have only one copy of their genome 
very brief. S. pombe divides by means of 
constriction of the medial ring to give two identical 
daughter cells. On the contrary S. cerevisiae, 
diploid in the wild, presents a prolonged G1-phase 
that allows small daughter cells resulting from 
asymmetric division to grow before initiation of 
replication. 
Figure I1. Cell cycle in Fission yeast 
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discovery of basic mechanisms of cell proliferation.  
As in higher eukaryotes, cell cycle of yeasts can be divided into four periods: G1 (Gap 
phase 1), S-phase (DNA Synthesis phase), G2 (Gap phase 2) and M-phase (Mitotic 
phase). 
During G1 the proteins necessary for later progress into cell cycle are actively 
synthesized and accumulated. The START or Restriction Point in G1 is a non return 
point after which cells are determined to progress through the entire cell cycle 
(Hartwell et al., 1974; Nurse, 1990). G1 is also a preparatory phase for DNA 
synthesis, in which pre-replication complexes (pre-RCs) are formed at replication 
origins in a process known as licensing for DNA replication. This process requires the 
sequential binding to DNA replication origins of the origin recognition complex (ORC) 
and the replication licensing factors Cdt1p and Cdc6p/Cdc18p which in turn allow for 
the loading of the hexameric minichromosome maintenance complex (MCM). 
Transition through START also requires de Cdc10p transcriptional activator. Forming 
a complex with Res1p and to a lesser extent Res2p, Cdc10p activates the 
transcription of several genes required for DNA replication, including cdc22, encoding 
the enzyme ribonucleotide reductase, cdc18 and cdt1. 
During S-phase the initiation of replication takes place, a process that happens 
simultaneously in different parts of the genome. Licensed origins are activated for 
replication in a process known as origin firing by phosphorylation and binding of other 
essential replication factors including Cdc45p, Mcm10p, RPA and DNA polymerases α 
and ε. In this phase, the genetic material of the cell must be completely and accurately 
replicated once. Thus, since replication is initiated at multiple points, the activation or 
firing of each replication origin must be tightly controlled in order to guarantee genomic 
stability. Phosphorylation of pre-RC components particularly by cyclin-dependent 
kinases (CDKs) inhibit re-replication processes once origins are fired either directly by 
the inhibitory effect of phosphorylation or by leading to degradation or nuclear export 
of the target. 
During G2, after replication of genetic material, cells grow until they reach the 
adequate size to allow progression into the next phase. 
During M-phase, DNA is segregated to form two new nuclei. Mitosis comprises four 
sub-phases. During Prophase the duplicated genetic material condenses into 
chromosomes, presenting two sister chromatids bound together at the centromere. 
The mitotic spindle assembles between the two centrosomes, which have duplicated 
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and moved apart. In Metaphase chromosomes align at the equator of the spindle and 
the kinetochore microtubules attach sister chromatids to opposite poles of the spindle. 
At Anaphase, sister chromatids synchronously separate to form two daughter 
chromosomes that are pulled apart by microtubule shortening and spindle pole 
movement. During Telophase the two sets of daughter chromosomes arrive at the 
poles of the spindle and decondense forming two independent nuclei. The division of 
the cytoplasm begins with the assembly of the contractile ring. 
Finally cellular contents split during cytokinesis to give rise to two daughter cells. 
The production of two viable daughter cells depends on the execution of DNA 
synthesis, mitosis and cytokinesis in a strict sequential order. In this way, mitosis is 
initiated only upon completion of DNA synthesis and cytokinesis is initiated only after 
mitosis has been completed. In addition, checkpoint mechanisms operate to ensure 
that DNA is not damaged and completely replicated before entry into mitosis, and that 
kinetochores have attached correctly to the mitotic spindle before anaphase onset.  
2.1 Cell cycle and CDKs 
In eukaryotes, the cell cycle is controlled by the periodic activation and 
inactivation of the highly conserved cyclin dependent kinases (CDKs). Timely 
activation and inactivation of CDKs regulate most cell-cycle transitions. For example, 
entry into mitosis requires CDK activation and exit from mitosis and cytokinesis 
requires loss of CDK activity and dephosphorylation of CDK substrates. CDK activity 
is regulated in part by its binding to cyclins (proteins of oscillatory expression) to form 
kinase-cyclin complexes specific of the cell cycle stage. There are thus different types 
of cyclins depending on the cell cycle phase during which they perform their role: G1-
cyclins, S-phase-cyclins and Mitotic-cyclins. Activity of G1 CDKs promotes passage of 
cells through START. S-phase CDKs begin to accumulate at the end of G1, and are 
accumulated during G2 and mitosis. On reaching a critical level, they promote DNA 
replication. Mitotic CDKs are activated at the onset of mitosis and, among other 
processes, promote chromosome condensation, formation of the mitotic spindle and 
breakdown of the nuclear envelope. For cells to exit from mitosis, undergo cytokinesis 
and enter the following G1, mitotic CDK must be inactivated. 
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If the CDK is not bound to a cyclin, its catalytic centre is not accessible. CDKs get an 
active conformation both after binding to its regulatory subunit and by subsequent 
phosphorylation of the CDK-cyclin complex by a CDK-activating Kinase (CAK) (Fisher 
and Morgan, 1994; Espinoza et al., 1996; Kaldis et al., 1996). 
2.2 Regulation of cell cycle progression in S. pombe  
S. pombe has proven to be a highly useful model organism to study cell cycle 
functioning due to its simplicity and parallelism in behaviour to mammalian cells. S. 
 S. pombe S. cerevisiae Higher eukaryotes 
G1 CDKs Puc1 + Cdc2 
Cln1, Cln2, Cln3 + 
Cdc28 
CycD1, CycD2, CycD3 + 
Cdk4, Cdk6 
S-phase CDKs Cig2 , Cig1 + Cdc2 Clb5, Clb6 + Cdc28 
CycE + Cdk2 
CycA + Cdk2/Cdk1 
Mitotic CDKs Cdc13 + Cdc2 
Clb1, Clb2, Clb3, Clb4 + 
Cdc28 
CycB1, CycB2, CycB3 + 
Cdk1 
CycA + Cdk2/Cdk1 
 
 
Table I1. Cell cycle dependent CDK-cyclin complexes in yeasts and higher eukaryotes 
Figure I2. Schematic representation of the fluctuation in the activities of the different CDK-
cyclin complexes, responsible for adequate cell cycle progression 
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pombe relies on a single CDK, Cdc2p, four cyclins (three B type cyclins Cig1p, Cig2p, 
and Cdc13p, and Puc1p) and one CDK inhibitor (CKI), Rum1p, to drive and control all 
mitotic cell-cycle events.  
Cdc2p activity is regulated during the cell cycle by three different mechanisms: 
through its binding to different cyclins and phosphorylation by CAK in its Thr167 
residue, by the phosphorylation state of some of its residues and by the action of its 
inhibitor.  
Cdc2p protein levels remain constant throughout the cell cycle, while B type cyclins 
and Rum1p are strictly regulated in terms of protein amounts at the different stages by 
transcription and ubiquitin-mediated proteolysis.  
The Cdc2p inhibitor Rum1p accumulates in mitotic anaphase and persists through G1. 
Before onset of S-phase it targets Cdc13p for degradation and inhibits kinase activities 
of Cdc2p-Cdc13p and Cdc2p-Cig2p until the cell has reached the adequate size to 
initiate replication (Correa-Bordes et al., 1997; Benito et al., 1998).  
Puc1p levels do not vary during the cell cycle, although its role is restricted to G1, 
being implicated in transcription of genes necessary for G1/S transition and in the 
activation of Rum1p degradation and cyclin B stabilization (Caligiuri et al., 1997; 
Martin-Castellanos et al., 2000). Degradation of Rum1p at G1/S transition allows 
Cdc2p-Cig2p to induce entry into S-phase. 
Cig2p is the major S-phase cyclin (Fisher and Nurse, 1996; Martin-Castellanos et al., 
1996; Mondesert et al., 1996). It accumulates late in G1 and disappears upon exit 
from S-phase. Cdc2p-Cig2p complex is involved in pass through START and 
replication initiation. Firing of origins requires the concerted actions of Cdc2p and 
Dbf4-dependent kinase Hsk1p (DDK) which activate MCM at origins by 
phosphorylation. This allows loading of Cdc45p and the GINS complex, turning MCM 
into a replicative helicase that unwinds DNA to produce short regions of ssDNA (Sogo 
et al., 2002; Feng et al., 2006). Replication protein A (RPA) is loaded to protect ssDNA 
and moves along with the replication fork. In Δcig2 cells Cig1p and Cdc13p can trigger 
S-phase entry. 
Cig1p levels reach maximum values in G2/M and decrease at the end of Metaphase. 
Its stability is regulated by PEST sequences (Bueno et al., 1991).  
Cdc13p is the only essencial cyclin in S. pombe (Fisher and Nurse, 1996; Martin-
Castellanos et al., 1996; Mondesert et al., 1996). Cdc13p protein levels are low in G1 
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but increase in G2 and are maintained until the end of M-phase (Creanor and 
Mitchison, 1996). This periodicity is necessary to ensure adequate cell cycle 
progression and to inhibit unscheduled re-initiation of S-phase (Hayles et al., 1994). 
The Cdc13p-Cdc2p complex accumulates in the nucleus during S-phase and G2 and 
can be detected in the nucleolus, spindle pole body and spindle (Alfa et al., 1989; Alfa 
et al., 1990).  
At the end of G2, when cells reach a critical size, M-phase is induced by a large 
increase in Cdc2p-Cdc13p activity (Booher et al., 1989; Moreno et al., 1989). Cdc2p-
Cdc13p complex forms early in S-phase but its activity is kept rather low by the 
kinases Wee1p and Mik1p through inhibitory phosphorylation of Cdc2p on Tyr15 
(Russell and Nurse, 1987; Featherstone and Russell, 1991; Lundgren et al., 1991; 
Parker et al., 1992; Lee et al., 1994). This phosphorylation is reversed by Cdc25p at 
the end of G2 to induce M-phase. Activation of Cdc2p is thus promoted both by 
accumulation and activation of Cdc25p and inactivation of Wee1p and Mik1p. Cdc25p 
is cell cycle regulated displaying maximum protein levels at the end of G2  
(Ducommun et al., 1990; Moreno et al., 1990; Daga and Jimenez, 1999) and 
hyperphosphorylation and hyperactivation at the G2/M transition (Kovelman and 
Russell, 1996). Wee1p is inhibited by the kinase Nim1p/Cdr1p and the related kinase 
Cdr2p (Coleman et al., 1993; Parker et al., 1993; Wu and Russell, 1993; Breeding et 
al., 1998; Kanoh and Russell, 1998). Decrease of Cdc2p activity at the end of mitosis 
and return to G1 and S-phase is achieved by inactivation and destabilization of 
Cdc25p by the phosphatase Flp1p (Esteban et al., 2004; Wolfe and Gould, 2004).  
3. Flp1p 
3.1 Flp1p and its orthologues 
The Cdc14 family of phosphatases plays an important role in the negative 
regulation of mitotic CDKs by specifically reversing CDK-dependent phosphorylation 
events (Visintin et al., 1998; Kaiser et al., 2002; Gray et al., 2003). In S. cerevisiae the 
CDC14 gene is essential for cell viability, and thermosensitive mutants arrest cell 
cycle progression in telophase with high levels of Cdc28p-Clb associated kinase 
activity (Wan et al., 1992; Taylor et al., 1997; Visintin et al., 1998). On the basis of 
sequence similarity to the budding yeast S. cerevisiae, orthologues have been 
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identified in several eukaryotes including S. pombe (cdc-fourteen-like-protein named 
Flp1p or Clp1p), Caenorhabditis elegans (CeCDC-14), Xenopus laevis (XCdc14A and 
XCdc14B) and Homo sapiens (hCdc14A and hCdc14B) (Li et al., 1997; Cueille et al., 
2001; Trautmann et al., 2001; Gruneberg et al., 2002; Kaiser et al., 2002; Krasinska et 
al., 2007). Cdc14 proteins are dual-specificity protein phosphatases that share a core 
of approximately 300 amino acids towards the amino terminus that includes a strictly 
conserved protein-phosphatase domain motif (Gray et al., 2003). 
3.2 Cdc14 phosphatases and the control of mitotic exit 
In S. cerevisiae Cdc14p plays a role in mitotic exit by dephosphorylation and 
activation of substrates of mitotic CDK such as Hct1/Cdh1 protein, a component of the 
anaphase promoting complex/cyclosome (APC/C) responsible for ubiquitination of 
mitotic cyclins, or the CDK inhibitor Sic1p, in both cases to achieve down-regulation of 
kinase activity (Jaspersen et al., 1999; Shou et al., 1999; Visintin et al., 1999).  
In S. pombe Flp1p also regulates mitotic exit, but through a distinct mechanism. Flp1p 
does not dephosphorylate Rum1p or Ste9p, homologues of Sic1p and Hct1p of S. 
cerevisiae, respectively. Instead, it antagonizes mitotic CDK activity by 
dephosphorylating and targeting to degradation Cdc25p, which indirectly leads to 
down-regulation of Cdc2p activity by promoting its Tyr15 phosphorylated form 
(Esteban et al., 2004; Wolfe and Gould, 2004).  
CDK1 phosphorylated residues on human Cdc25A are in vitro substrates for 
hCdc14A, and this phosphatase can rescue a Δflp1 strain in S. pombe by 
dephosphorylation of Cdc25p, suggesting a parallelism in the mechanism of mitotic 
exit between fission yeast and humans (Vazquez-Novelle et al., 2005; Esteban et al., 
2006). On the other hand Hct1p has also been identified as a substrate for hCdc14A 
(Bembenek and Yu, 2001; Kaiser et al., 2002). 
3.3 Regulation of the activity of Cdc14 proteins 
The activities of the Cdc14 proteins are controlled at least in part by regulated 
sequestration and release from the nucleolus (Shou et al., 1999; Visintin et al., 1999; 
Bembenek and Yu, 2001; Cueille et al., 2001; Trautmann et al., 2001; Kaiser et al., 
2002).  
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In S. cerevisiae Cdc14p is sequestered in the nucleolus in an inactive form from G1 
until metaphase by binding the nucleolar inhibitor Net1p/Cfi1p, member of the RENT 
complex (Regulator of Nucleolar Silencing and Telophase) (Shou et al., 1999; Straight 
et al., 1999; Visintin et al., 1999; Traverso et al., 2001). In early anaphase, ScCdc14p 
is released from the nucleolus by the combined action of a set of proteins termed the 
FEAR (Cdc-fourteen early anaphase release) network (Stegmeier et al., 2002; Azzam 
et al., 2004). The FEAR promotes the phosphorylation of Net1p/Cfi1p by CDK  
(Azzam et al., 2004) and subsequently dissociation from Cdc14p, probably by down-
regulation of the protein phosphatase 2A (PP2A) (Queralt et al., 2006). Nucleolar 
release of Cdc14p is then sustained during anaphase progression by the MEN (mitotic 
exit network), a GTPase signalling cascade that becomes active upon spindle 
elongation into the daughter bud (Jaspersen et al., 1998; Bardin et al., 2000). It has 
been recently reported that Cdc14p itself is responsible for its inactivation at the end of 
mitosis, by triggering degradation of the polo kinase Cdc5p (component of the FEAR 
network and a key regulator of the MEN) through activation of APC/C-Cdh1. Cdc14p-
mediated degradation of Cdc5p leads to silencing of both the FEAR and the MEN and 
promotes the return of the phosphatase to the nucleolus (Visintin et al., 2008). 
While ScCdc14p is retained in the nucleolus until anaphase, other family members are 
 
Figure I3. Regulation of ScCdc14p localization and its role during exit from mitosis  
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not regulated in the same manner. S. pombe Flp1p, human Cdc14 isoforms A and B 
and Xenopus Cdc14A change their cellular location upon entry into mitosis (Cueille et 
al., 2001; Trautmann et al., 2001; Kaiser et al., 2002; Mailand et al., 2002; Kaiser et 
al., 2004).  
The mechanisms by which Flp1p localization and activity are regulated are reviewed 
in the following section. 
3.4 Flp1p: functions and localization 
Serine/threonine phosphatase Flp1p, unlike its S. cerevisiae counterpart, is 
not essential and Δflp1 cells survive with a phenotype of advanced mitosis (Cueille et 
al., 2001). 
Flp1p has been proven to control rapid degradation of Cdc25p at the end of mitosis 
(Esteban et al., 2004; Wolfe and Gould, 2004), which results in enhanced inhibitory 
Tyr15 phophorylation of Cdc2p and in the corresponding loss of kinase activity 
necessary for mitotic exit. Flp1p is required for the ubiquitination of Cdc25p by the 
APC/C at this cell cycle stage, and cells deleted for flp1+ present higher basal levels of 
Cdc25p. As mentioned above, this role may be conserved in higher eukaryotes. In 
fission yeast, Δflp1 cells enter mitosis at a reduced cell size, presenting a wee-
phenotype (Cueille et al., 2001; Trautmann et al., 2001). Over-expression of Flp1p 
arrests cells in G2 with dephosphorylated Cdc25p, in a process dependent on active 
Wee1p (Cueille et al., 2001; Esteban et al., 2004). Beside its role in cell cycle 
progression, Flp1p is required for an efficient cytokinesis checkpoint (Cueille et al., 
2001; Trautmann et al., 2001; Trautmann and McCollum, 2005) and for faithful 
chromosome segregation (Trautmann et al., 2004).  
In order to carry out its distinct functions, Flp1p must be correctly localized within the 
cell. In the course of a normal cell cycle Flp1p localizes in the nucleolus and to the 
SPB (spindle pole body) throughout interphase, and to the nucleus, spindle and 
medial ring during mitosis (Figure I4).  
How Flp1p is inhibited in the nucleolus during interphase is not known. Recently a 
nucleolar protein that presents sequence similarity to ScNet1/Cfi1 has been identified. 
However, this protein, Dnt1p, is not responsible for anchoring or inhibition of Flp1p  
(Jin et al., 2007). 
INTRODUCTION 
29 
Similarly to mammalian Cdc14Bp (Cho et al., 2005), and unlike ScCdc14p, Flp1p is 
released from the nucleolus upon mitotic entry. Thus, in prophase it is released from 
the nucleolus to occupy the nucleus, medial ring and mitotic spindle (Cueille et al., 
2001; Trautmann et al., 2001). Localization of Flp1p in the kinetochores and mitotic 
spindle during mitosis is necessary to prevent defects in chromosome segregation  
(Trautmann et al., 2004).  
The mechanism of Flp1p release to the nucleus remains unknown. Although the S. 
cerevisiae FEAR pathway components (separase-Esp1p, polo kinase–Cdc5p, Slk19p 
and Spo12p) are conserved in S. pombe, these do not play a role in the release of 
Flp1p to the nucleolus (Chen et al., 2006). In anaphase, much like the MEN in budding 
yeast, the SIN (Septation Initiation Network) acts to keep Flp1p out of the nucleolus 
until cytokinesis is complete. The SIN is an SPB-based regulatory network required to 
initiate cytokinesis in late anaphase (reviewed in Simanis, 2003). Although the release 
of Flp1p from the nucleolus does not depend on the SIN, its SIN dependent 
maintenance in the cytoplasmatic locations is necessary for the cytokinesis checkpoint 
(Cueille et al., 2001; Mishra et al., 2005). In fact it has been shown that Flp1p binds to 
the 14-3-3 protein Rad24p to be retained in the cytoplasm in response to cytokinesis 
defects (Mishra et al., 2005; Trautmann and McCollum, 2005). Attenuation of the SIN 
is needed for the proper relocalization of Flp1p to the nucleolus at the end of mitosis 
 
Figure I4. Flp1-GFP subcellular localization at the different stages of the cell cycle 
Image modified from Cueille et al., 2001.   
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(Cueille et al., 2001). 
Flp1p activity is inhibited at the early stages of mitosis by CDK hyperphosphorylation. 
XCdc14p is similarly hyperphosphorylated during early mitosis (Kaiser et al., 2002; 
Kaiser et al., 2004). During anaphase the phosphatase undergoes autocatalytic 
reversal of Cdk1-mediated inhibitory phosphorylation events, and its catalytic activity 
is enhanced. During this phase, Flp1p is able to dephosphorylate Cdc25p, targeting it 
to degradation, to disrupt the Cdk1 autoamplification loop, and potentiate SIN 
signaling (Esteban et al., 2004; Wolfe and Gould, 2004). 
Figure I5. Regulation of Flp1p localization and its role during exit from mitosis 
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4. GENERAL OUTLINE OF DNA CHECKPOINT RESPONSES IN 
S. pombe  
The DNA checkpoint response pathways are signalling cascades, by means 
of which in the course of cell cycle progression the presence of unreplicated DNA or 
DNA-damage is detected by sensor proteins to subsequently activate cellular 
responses in order to guarantee genomic stability. These responses include cell cycle 
retardation or block, replication fork stabilization, DNA-repair processes, alteration of 
the transcriptional program, chromatin remodelling and apoptosis. In the same way, 
there are mechanisms to allow for resumption cell cycle progression when the source 
of stress is removed or when the threat persists for a long time. These are known as 
checkpoint recovery and adaptation. 
 
Figure I6. Checkpoint responses to DNA stress through endogenous and exogenous 
agents 
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Checkpoint responses work in this way to provide the organisms with time to cope 
with endogenous or exogenous threats and to coordinate the corresponding 
mechanisms to solve or to override their cellular consequences. Failure to enforce the 
adequate checkpoint responses can lead to aneuploidy, accumulation of mutations 
and chromosomal rearrangements, commonly associated to cell death and cancer. 
DNA checkpoints respond to a general scheme in which the triggering stress is 
sensed by a set of sensor proteins and the signal is transmitted to the effector proteins 
with mediation of adaptors or scaffold proteins. In this way stress signals are traduced 
to the specific checkpoint response leading to adequate cellular behaviour to preserve 
genomic integrity.  
Table I2. Major sensors, mediators and effectors of DNA-checkpoint response in yeasts 
and mammals 
  S. pombe S. cerevisiae Mammals 
Rad17 Rad24 Rad17 
RFC  
RFC2-5 RFC2-5 RFC2-5 
Rad9 Ddc1 Rad9 
Rad1 Rad17 Rad1 
PCNA-like Hus1 Mec3 Hus1 
Rad32 Mre11 Mre11 
Rad50 Rad50 Rad50 
DSB recognition Nbs1 Xrs2 Nbs1 
Rad3 Mec1 ATR 
Tel1 Tel1 ATM 
SENSORS 
PIKK  Rad26 Ddc2 ATRIP 
 Crb2 Rad9 BRCA1 
 Mrc1 Mrc1 Claspin 
 Rad4/Cut5 Dbp11 TopBP1 
ADAPTORS 
 Rad24-25 BMH1-2 14-3-3 
 Cds1 Rad53 Chk2 
EFFECTORS 
 Chk1 Chk1 Chk1 
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S. pombe has proven to be a valuable model organism to study the functioning of 
checkpoints, due to its relative simplicity and parallelisms to human cells. DNA 
checkpoints in S. pombe include the replication checkpoint in response to unreplicated 
DNA during S-phase and the DNA-damage checkpoint in response to lesions in DNA 
during G2. In addition the intra-S-phase checkpoint has been defined as the pathway 
responsible for slowing-down of S-phase progression in response to DNA-damage 
during S-phase.  
The components of the general scheme of DNA checkpoint response in S. pombe are 
reviewed in the next sections. 
4.1 Checkpoint sensors 
Studies in fission yeast and humans have shown that Rad9p, Rad1p, Hus1p, 
Rad17p together with SpRad26p/hATRIP and phosphoinositol phosphate 3-kinase-
related kinases (hATM, hATR, SpRad3p) play central roles in checkpoint sensing and 
activation.  
Rad9p, Hus1p and Rad1p form a heterotrimeric complex (the 9-1-1 complex) which 
exhibits structural similarity with the proliferating cell nuclear antigen (PCNA), sliding 
clamp implicated in replication processivity. The 9-1-1 complex loads to DNA upon 
genotoxic stress in a Rad17p-RFC2-5 dependent manner. Rad17p-RFC2-5 binds to 
single-to-double strand transitions (Venclovas and Thelen, 2000) 
Rad17p protein is a paralogue of the largest subunit of RFC (replication factor C), and 
it forms the alterative clamp loader with RFC2-5. In this way 9-1-1 complex and 
Rad17p-RFC2-5 function as a clamp/clamp–loader pair, alternative to PCNA and RF-C. 
In fission yeast of the two phosphatidylinositol 3-kinase-related proteins Rad3p (hATR 
homolog) and Tel1p (hATM homolog), Rad3p plays a major role in both the DNA 
damage checkpoint and the DNA replication checkpoint. Rad3p constitutively forms a 
complex with the regulatory subunit Rad26p (hATRIP homologue). The Rad3p-
Rad26p complex is recruited to DNA upon genotoxic stress (Wolkow and Enoch, 
2002). A recent report has shown that Cdc18p gets stabilized during replication stress 
to ensure Rad3p association to chromatin by direct Cdc18p-Rad26p interaction 
(Hermand and Nurse, 2007).  
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Recruitment of Rad3p-Rad26p homologues and the 9-1-1 complex occur 
independently (Kondo et al., 2001; Melo et al., 2001). 
Although the checkpoint signals generated by replication stress and DNA-damage 
clearly differ one from another, this mechanism of sensor recruitment to DNA seems 
to be common to all DNA checkpoint responses.  
It has been suggested that these sensor checkpoint proteins may detect a common 
intermediate, such as single-stranded DNA coated by RPA (replication protein A), 
which is processed by various DNA repair pathways (Zou and Elledge, 2003). RPA 
has been shown to directly interact with the 9-1-1 complex (Wu et al., 2005).  
However, some events involving these sensor proteins are stress-specific. In this way, 
Rad3p phosphorylates Rad26p specifically after DNA-damage sensing (Edwards et 
al., 1999). 
Rad9p phosphorylation seems to be a key event in differentiation of checkpoint 
signals depending on the type of stress. Several Rad3-dependent phosphorylation 
events have been identified on fission yeast Rad9p. Phosphorylation of Thr412 and 
Ser423 (carboxy-terminal tail residues) is required to activate Chk1p in response to 
DNA-damage. Thr225 (within the PCNA-like domain) is required for Rad9p 
phosphorylation on replication-fork collapse (Furuya et al., 2004). Rad9p Thr225 
phosphorylation has been shown to be crucial to regulate the choice of repair 
pathways after genotoxic stress sensing (Kai et al., 2007). 
In addition, checkpoint sensor proteins have been shown to interact with a number of 
repair proteins, sometimes considered as adaptors since their interaction with 
checkpoint proteins seems to be required for damage sensing. For instance Nbs1p, 
member of the MRN (Mre11, Rad50, Nbs1) is required to recruit ATM to damage sites 
(You et al., 2005). Such adaptor proteins may be DNA damage recognition proteins 
involved in mismatch repair, nucleotide excision repair and double-strand break repair. 
In S. pombe the 9-1-1 complex has been shown to interact with base excision repair 
(BER) member MYHp  (Chang and Lu, 2005).  
4.2 Adaptor proteins and scaffolds 
Checkpoint adaptor or mediator proteins are required to transmit the 
checkpoint signal from the sensor phosphatidylinositol 3-kinase-like kinases to the 
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effector kinases Cds1p and Chk1p. In fission yeast, Crb2p, is the adaptor that 
connects the Rad3p-Rad26p complex to Chk1p (Saka et al., 1997), whereas Mrc1p 
mediates signal transduction from Rad3p-Rad26p to Cds1p (Tanaka and Russell, 
2001).  
Rad4p/Cut5p is thought to function as a scaffold in a large protein complex containing 
both checkpoint proteins and replication proteins to selectively enforce the adequate 
checkpoint effector according to the triggering stress (Taricani and Wang, 2006). 
Crb2p 
The most conserved structural feature of Crb2p is a C-terminal BRCT tandem repeat 
(protein-protein interaction domain), which resembles similar domains in budding yeast 
ScRad9p and mammalian 53BP1, BRCA1, and MDC1/NFBD1. These BRCT proteins 
are each required for the phosphorylation of certain substrates of checkpoint sensor 
kinases, and collectively have been referred to as adaptors or mediators of the DNA 
damage checkpoint (Melo and Toczyski, 2002; Wang and Elledge, 2002; Canman, 
2003). Crb2p and its homologues also present two tandem Tudor folds, which are 
protein-protein and protein-DNA interaction domains.  
The BRCT domain of Crb2p mediates the homo-oligomerization of the protein, 
necessary for Chk1p activation by Rad3p-Rad26p phosphorylation (Du et al., 2004). 
Crb2p itself is phosphorylated in a Rad3p-dependent but Chk1p-independent manner 
upon DNA damage (Saka et al., 1997). 
Crb2p is recruited to repair foci upon histone H2A phosphorylation by the Rad3p or 
Tel1p kinases and histone H4-K20 residue methylation (Nakamura et al., 2004; 
Sanders et al., 2004) 
This mediator protein also plays a role in regulation of homologous recombination in 
G2 by modulating the activity of the Rqh1p helicase (Caspari et al., 2002). 
Mrc1p 
Mrc1p (mediator of replication checkpoint) plays an essential role in checkpoint 
activation of Cds1p. Mrc1p is expressed predominantly during S phase and is 
phosphorylated by Rad3p and Tel1p on HU treatment (Tanaka and Russell, 2001; 
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Zhao et al., 2003), being Rad3p phosphorylation sufficient for its interaction with 
Cds1p (Xu et al., 2006).  
Tel2p, member of the Tel2/Rad5/Clk2 protein family has also recently been implicated 
in Mcr1p phosphorylation and Cds1p activation (Shikata et al., 2007).  
Mcr1p N-terminal region presents a typical DNA-binding helix-loop-helix motif, also 
present in its human homologue Claspin. This domain interacts preferentially with 
branched DNA structures in vitro and is essential for its checkpoint function (Zhao and 
Russell, 2004). 
Rad4p 
Fission yeast Rad4p/Cut5p, a BRCT domain protein, orthologue of mammalian 
TopBP1, is also required for Chk1p phosphorylation and Cds1p activity (Harris et al., 
2003). It has been shown to associate with the replicative DNA polymerases, 
checkpoint sensor proteins Rad3p-Rad26p, Hus1p, Rad9p and Rad17p and with 
Crb2p and the WD-repeat protein Crb3p (Saka et al., 1997; Garcia et al., 2005; 
Taricani and Wang, 2006).  
Phosphorylation of Rad9 on Thr412 and Ser423 in response to DNA-damage 
promotes its association to Rad4p via its two C-terminal BRCT domains. This 
association is necessary for activation of the Chk1p branch of the checkpoint but not 
Cds1p replication checkpoint (Furuya et al., 2004). 
14-3-3 proteins 
The 14-3-3 proteins constitute a family of conserved multifunctional adapter proteins 
involved in a multitude of cellular functions, such as cell growth, cell signaling and cell 
death (van Hemert et al., 2001). Of the two fission yeast 14-3-3 proteins, Rad24p and 
Rad25p, Rad24p appears to play the more important role in the checkpoint response 
and is involved in the proper execution of cell cycle arrest in response to DNA 
damage. However, multicopy expression of Rad25p can rescue Δrad24 defects (Ford 
et al., 1994). Simultaneous disruption of both 14-3-3 proteins is lethal. 
14-3-3 proteins mediate the checkpoint response by affecting the localization of 
signaling proteins and checkpoint-targets.  
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Thus in S. pombe both 14-3-3 proteins, Rad24p and Rad25p have been shown to 
interact with Chk1p and the association between these proteins is stimulated by DNA 
damage (Chen et al., 1999a). Rad24p is required for nuclear accumulation of Chk1p 
after replication fork collapse (Dunaway et al., 2005). Rad24p also binds to Cdc25p 
and is required for the DNA damage-induced relocation of Cdc25p to the cytoplasm, 
necessary for cell cycle arrest (Chen et al., 1999a; Lopez-Girona et al., 1999; Zeng 
and Piwnica-Worms, 1999). 
4.3 Effectors 
In response to genotoxic stress the main checkpoint event is the 
phosphorylation of the effector protein kinases Chk1p and Cds1p by Rad3p (Lopez-
Girona et al., 2001b; Tanaka et al., 2001; Capasso et al., 2002).  
Replication stress and DNA-damage inflicted during S phase leads to activation of the 
checkpoint kinase Cds1p (Murakami and Okayama, 1995; Lindsay et al., 1998; 
Brondello et al., 1999), whereas DNA-damage activates the checkpoint kinase Chk1p 
during G2 phase (Walworth et al., 1993; Brondello et al., 1999). Rad3p is necessary 
for both Chk1p and Cds1p activation but is only essential for maintenance of the 
replication checkpoint signal (Martinho et al., 1998). 
Replication stress and DNA-damage trigger by activation of either kinase a cell cycle 
block in S-phase or G2 in order to prevent progression into mitosis with damaged or 
unreplicated genetic material. Thus, activation of Cds1p and/or Chk1p leads to 
inhibition of Cdc25p and activation of Mik1p (Furnari et al., 1997; Rhind et al., 1997; 
Furnari et al., 1999; Rhind and Russell, 2001). This results in enhanced inhibitory 
phosphorylation of Tyr15 of Cdc2p and the corresponding down-regulation of kinase 
activity necessary to prevent entry into mitosis.  
Cell cycle block is not the only cellular response triggered by effector proteins upon 
checkpoint activation. As mentioned before, effector proteins also play key roles in 
coordination of cellular processes ensuring stability, repair and recovery from 
checkpoint arrest. Further information about Cds1p, Chk1p and their pathways can be 
found in sections 5 and 6. 
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5. DNA REPLICATION CHECKPOINT IN S. pombe 
The replication checkpoint is a complex signal transduction pathway that is 
activated when nucleotide pools become limiting for DNA synthesis or replication forks 
encounter lesions in template DNA (Nyberg et al., 2002; Osborn et al., 2002). Under 
these circumstances, checkpoint activation is crucial for maintenance of genomic 
integrity and cell survival. Stalled forks represent serious threats to genomic integrity 
because they are prone to collapse or rearrangement (McGlynn and Lloyd, 2002c, b, 
a). 
If replication forks are stalled, for instance as a consequence of ribonucleotide 
shortage, ssDNA accumulates as a consequence of uncoupling of DNA synthesis and 
MCM-driven DNA unwinding (Sogo et al., 2002; Byun et al., 2005; Nedelcheva et al., 
2005; Feng et al., 2006). These ssDNA regions recruit RPA, which activates the 
checkpoint signal (You et al., 2002; Zou and Elledge, 2003). The checkpoint triggers 
downstream pathways that prevent futile initiation events, stimulate the repair or 
 
Figure I7. Down-regulation of Cdc2p activity in response to DNA damage or replication 
stress 
Simplified scheme showing how upon DNA-stress, activated sensor protein Rad3p 
phosphorylates effector proteins Cds1p or Chk1p which in turn act over Mik1p and 
Cdc25p to inhibit Cdc2p activity and avoid cell cycle progression into mitosis. 
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bypass of DNA damage, delay mitosis, and stabilize the replisome, allowing 
replication to resume when normal conditions are restored. 
Cell cycle progression strongly delays at S-phase as a consequence of activation of 
the replication checkpoint. However, emerging evidence indicates that the most 
important effect of the replication checkpoint is to stabilize replication forks by 
maintaining proper assembly of replisome components and DNA structures in 
replication competent states when forks stall (Lopes et al., 2001; Tercero and Diffley, 
2001; Sogo et al., 2002; Noguchi et al., 2003; Tercero et al., 2003; Noguchi et al., 
2004; Meister et al., 2005; Ansbach et al., 2007). 
In addition, late replication origin firing is actively repressed under these conditions 
(Paulovich and Hartwell, 1995; Santocanale and Diffley, 1998; Kim and Huberman, 
2001). 
5.1 Cds1p: general features 
In S. pombe Cds1p is the main effector of the checkpoint response to 
replication stress. According to the described roles of this checkpoint, Cds1p plays 
central roles in fork protection and stabilization, regulation of transcriptional response 
and coordination of processes involved in delay of S-phase progression and recovery. 
As mentioned when reviewing the checkpoint effectors, Cds1p plays a role in 
regulating Cdc2p activity and mediating cell cycle block in response to replication 
stress. However, the fact that Δcds1 cells can experience checkpoint block because of 
Chk1p activation but rapidly loose viability after HU treatment (Boddy et al., 1998; 
Lindsay et al., 1998), underscores the importance of Cds1p role in stabilizing 
replication forks rather than in mediating cell cycle arrest.  
The cds1 gene (checking DNA synthesis) was isolated as a multicopy suppressor of a 
temperature sensitive polα mutant (Murakami and Okayama, 1995).  
Cds1p is a 460 aminoacid serine-threonine kinase. It belongs to the Chk2 family of 
checkpoint kinases, which includes S. cerevisiae Dun1p, Rad53p and Mek1p and 
human Chk2p. Like all members of this family it presents a forkhead-associated (FHA) 
domain in its N-terminal region and a protein kinase domain. Its budding yeast 
counterpart is unique within the family in presenting an additional C-terminal FHA 
domain. The FHA domain mediates protein-protein interactions, being its optimal 
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binding sequence TXXD (Sun et al., 1998; Durocher et al., 1999; Durocher et al., 
2000). 
Cds1p presents pancellular localization, being more highly concentrated in the 
nucleus during S-phase (Brondello et al., 1999; Matsuyama et al., 2006). Constitutive 
nuclear localization of the protein does not enhance its activation, indicating that its 
checkpoint role does not depend exclusively on this localization (Brondello et al., 
1999). 
5.2 Cds1p activation 
Cds1p is activated by replication stress in a two-step mechanism (Figure I8). 
In the first step, Cds1p interacts with active Rad3p-phosphorylated Mrc1p by means of 
its FHA domain. This is necessary to take Cds1p into the proximity of active Rad3p-
Rad26p complex at stalled replication forks. Rad3p then phosphorylates Cds1p in its 
 
Figure I8. Two-stage activation of Cds1p  
Adapted from Xu et al., 2006. 
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Thr11 residue, completing the priming step (Tanaka and Russell, 2004; Xu et al., 
2006). In a second step, two primed Thr11-phosphorylated Cds1p molecules interact 
in a FHA-dependent manner to form a homodimer that is activated by 
autophosphorylation. Two sites in its activation loop, Thr328 and Thr332, seem to be 
responsible for this auto-induced activation (Xu et al., 2006).  
This mechanism is similar to that leading to human Chk2p activation, which is also 
mediated by oligomerization and autophosphorylation of two activation loop residues 
(Lee and Chung, 2001; Ahn and Prives, 2002; Ahn et al., 2002; Xu et al., 2002). 
  
Other proteins implicated in Cds1p activation and fork stabilization 
Other fork associated proteins like the Swi1p-Swi3p complex, also called FPC 
(Fork Protection Complex), and Sap1p are required for full activation of Cds1p 
(Noguchi et al., 2003; Noguchi et al., 2004; Noguchi and Noguchi, 2007).  
All three proteins are involved in fork pausing at mating type switching and at 
ribosomal DNA repeats (Arcangioli et al., 1994; Dalgaard and Klar, 2000; Mejia-
Ramirez et al., 2005). The Swi1p-Swi3p complex is evolutionary conserved. It is 
homologous to the Tof1p-Csm3p complex in S. cerevisiae and to the Timeless-Tipin 
complex in humans (Gotter, 2003; Mayer et al., 2004; Noguchi et al., 2004). Both 
human and budding yeast complexes have been implicated in checkpoint signalling  
(Foss, 2001; Katou et al., 2003; Unsal-Kacmaz et al., 2005). Sap1p has been shown 
to bind to at least one origin of replication and is required to recruit Swi1p-Swi3p to 
chromatin (Noguchi and Noguchi, 2007). The FPC is thus chromatin-bound during S-
phase and travels along with the replication machinery. In this way the FPC is involved 
in the stabilization of stalled replication forks in a configuration that enables full 
checkpoint recognition and signalling.  
A putative helicase, Chl1p, has been recently proposed to work in the same pathway 
as Swi1p acting cooperatively in its fork stabilization and checkpoint functions 
(Ansbach et al., 2007). 
A replication competent state seems, thus, to be necessary to guarantee proficient 
Cds1p activation. Further supporting this, proteins implicated in replication initiation 
and progression such as Hsk1p, Ctf18p, Orc1p and Cdc45p have shown to be 
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required for full activation of the checkpoint kinase (Snaith et al., 2000; Takeda et al., 
2001; Nitani et al., 2006; Ansbach et al., 2007). 
5.3 Cds1p and co-workers: linking fork stabilization to recovery 
from checkpoint arrest 
The mechanisms of fork stabilization during replication stress, of which Cds1p 
is the main effector, are complex and further linked to a number of related processes 
essential for genomic integrity such as sister chromatid cohesion, regulation of 
recombination, and recovery from replication block.  
Thus, for instance, the minichromosome maintenance (MCM) complex, a helicase 
essential for replication initiation and elongation, has been shown to play roles in fork 
stability and recovery. To achieve this, its subunit Mcm4p is bound to and 
phosphorylated by Cds1p during HU treatment, and further interacts with the 
homologous recombination protein Rph51p (Bailis et al., 2008). The regulation of the 
MCM complex by the checkpoint has been proposed to be necessary to avoid the de-
attachement of the replisome from stalled replication forks and thus to be an essential 
mechanism in the maintenance of fork stability (Forsburg, 2008). 
Hsk1p also plays multiple roles during and after replication stress. Hsk1p is a 
serine/threonine kinase homologous to Cdc7p in S. cerevisiae necessary for origin 
activation by regulation of targets such as the MCM (Lee et al., 2003). In addition to its 
mentioned role in Cds1p activation, Hsk1p in its turn gets phosphorylated by the 
checkpoint kinase during early S-phase arrest (Snaith et al., 2000; Takeda et al., 
2001). Depletion of Hsk1p at the recovery stage allows bulk replication but leads to 
aberrant mitosis and loss of nuclear integrity (Snaith et al., 2000). 
In addition Hsk1p, its regulatory subunit Dfp1p/Him1p, and Swi1p-Swi3p have been 
implicated in slowing S-phase in response to DNA-alkylation in a checkpoint 
independent manner (Sommariva et al., 2005). 
Ctf18p, an RFC1-like subunit of the alternative replication factor C complex, and 
Swi1p-Swi3p in addition to their role in Cds1p activation are required for sister 
chromatid association and Ctf18p is also involved in timely replication resumption 
during recovery (Ansbach et al., 2007).  
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Sap1 is also necessary for replication restart after block of replication forks (Noguchi 
and Noguchi, 2007). 
Cds1p is, as presented, the key regulator coordinating fork stability, recovery and 
stress bypass upon replication stress. Further illustrating this, Cds1p kinase activity is 
responsible for the prevention of unwanted recombinational events at stalled 
replication forks through regulation of Mus81p-Eme1p endonuclease complex, Rqh1p 
helicase and Rad60p. The extent of Cds1p activation determines the degree in which 
cells tolerate replication stress. When the activation of the checkpoint kinase is low, 
fork protection is not completely ensured and recombinational processes may occur to 
cope with aberrant DNA structures and to tolerate replication stress (Kai et al., 2005; 
Froget et al., 2007). Rad60p and other proteins involved in homologous recombination 
are necessary for recovery from replication arrest (Miyabe et al., 2006) further 
underscoring the importance of proficient regulation of recombination by the 
checkpoint. Further analysis of Cds1p implication in the regulation of recombinational 
events can be found in section 7.2. 
6. DNA-DAMAGE CHECKPOINT IN S. pombe 
The DNA-damage checkpoint coordinates cell cycle block in G2 with repair 
mechanisms in order to preserve genomic integrity when DNA damage is detected.  
In fission yeast, mitotic entry is inhibited by the activation of the conserved Chk1p 
kinase in response to damaged DNA in late S and G2 phases of the cell cycle 
(Walworth and Bernards, 1996; Martinho et al., 1998). Furthermore, the Chk1p 
pathway is activated in response to damaged or collapsed replication forks, a situation 
that can occur after processing of certain structures during S-phase or as a result of a 
defective response of the replication checkpoint (Boddy et al., 1998; Lindsay et al., 
1998; Wan et al., 1999). 
Cross-talk between the DNA-damage checkpoint and the spindle checkpoint via 
Mad2p occurs to provide adequate cell cycle delay when DNA checkpoints efficiency 
is compromised (Sugimoto et al., 2004; Collura et al., 2005). 
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6.1 Chk1p 
Chk1p is a 496 aminoacid Serine/Threonine protein kinase, consistent of a 
highly conserved N-terminal kinase domain and a C-terminal non-catalytic domain. 
Chk1p is essential for survival in response to DNA damage, as fission yeast cells 
lacking the chk1 gene do not delay cell cycle progression, resulting in hypersensitivity 
to DNA damaging agents (Walworth et al., 1993; al-Khodairy et al., 1994).  
Chk1p presents a basal level of kinase activity that is elevated at least two-fold in 
response to DNA-damage (Capasso et al., 2002). The precise mechanism by which 
Chk1p is activated in response to various DNA lesions has yet to be elucidated.  
Rad1p, Rad3p, Rad9p, Rad17p, Rad26p, Hus1p, Rad4p/Cut5p, and Crb2p are 
essential for Chk1p activation (al-Khodairy and Carr, 1992; Enoch et al., 1992; al-
Khodairy et al., 1994; Walworth and Bernards, 1996; Saka et al., 1997). Rad24p is 
also critical for Chk1p function as it binds to phosphorylated Chk1p and facilitates its 
nuclear localization following DNA damage (Ford et al., 1994; Dunaway et al., 2005). 
Ser345 in fission yeast Chk1p is phosphorylated in vivo by Rad3p and this 
phosphorylation is required to activate Chk1p kinase activity in the presence of DNA 
damage (Ford et al., 1994; Lopez-Girona et al., 2001b; Capasso et al., 2002; 
Dunaway et al., 2005). Human Chk1p is also phosphorylated at S345, emphasizing 
the evolutionary importance of Chk1p in the checkpoint pathway (Liu et al., 2000; 
Zhao and Piwnica-Worms, 2001).  
Recently a conserved aspartic acid at position 469 of fission yeast Chk1p has been 
involved in checkpoint specificity to certain DNA lesions (Palermo et al., 2008). 
Chk1p is also implicated in regulating dNTP production necessary for repair 
processes. Activation of Chk1p in G2 induces Spd1p degradation, necessary for the 
exclusion of the small subunit of ribonucleotide reductase (RNR), Suc22p, from the 
nucleus. In the cytoplasm Suc22p interacts with Cdc22p to form the RNR active 
complex, leading to dNTP production. Chk1p-independent degradation of Spd1p and 
subsequent processes are also necessary for dNTP production during unperturbed S-
phase (Liu et al., 2003). 
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Once repair of damaged DNA has been completed Chk1p activity is down-regulated 
through dephosphorylation by Type 1 protein phosphatase to allow for cell cycle re-
entry (den Elzen and O'Connell, 2004). 
7. DNA DAMAGE AND REPAIR MECHANISMS 
DNA damage is an extremely common event in a cell’s lifetime. Cells are 
exposed to both exogenous and endogenous sources of stress and DNA damage, 
ranging from reactive oxygen species resulting from cellular metabolic processes and 
the inacuracy of DNA replication itself to environmental factors such as ultraviolet 
radiation from the sun and chemical mutagenic compounds.  
Different sources of stress lead to different kinds of DNA damage: DNA base 
modifications (oxidation, alkylation, hydrolysis and mismatches), breaks in the DNA 
backbone (single strand breaks, SSBs, and double strand breaks, DSBs) and 
crosslinking of the DNA (on the same DNA strand, intrastrand, or on the opposite 
strand, interstrand).  
Damaged or inappropiate bases can be repaired either by direct chemical reversal of 
the damage by specific enzymes, or by Excision Repair, in which the damaged base 
or bases are removed and then replaced with the correct ones through localized DNA 
synthesis. There are three types of excision repair (Base Excision Repair, BER, 
Nucleotide Excision Repair, NER, and Mismatch Repair, MMR) differing in the way 
and extent to which bases are removed and the enzymes involved. 
Single-strand breaks are repaired using the same enzyme systems used in BER. 
Double-strand breaks are normally either repaired by direct joining of the broken ends 
in a process known as Nonhomologous End-Joining (NHEJ) or Homologous 
Recombination (HR) by means of which the broken ends are repaired using the 
information of an intact homologous strand.  
7.1 Double-strand Break repair 
Double strand breaks appear both due to endogenous cellular processes, 
such as nucleotide excision repair or meiotic recombination, and to exposure to 
exogenous sources of DNA-damage or replication stress.  
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It is assumed that human cells suffer approximately 10 spontaneous DSBs per cell 
cycle. Spontaneous DSBs are supposed to appear when the replication machinery 
encounters single strand breaks, and also as a result of inadequate action of 
topoisomerase II (reviewed in Haber, 1999). Ionizing radiation is an important external 
source of DSBs. Other DNA-damaging agents, directly or indirectly, lead to DSB 
formation.  
Among the forms of DNA-damage, DSBs are especially deleterious, since they can 
lead to loss of large chromosomal fragments resulting in loss of heterozygosity and 
cell death. Therefore, eukaryotic organisms have evolved different pathways for DSB 
repair: the previously cited NHEJ and HR, together with single strand annealing 
(SSA). Since DSBs normally involve base pair loss, mechanisms which act through 
ligation of the strand ends (NHEJ and SSA) are error-prone. During HR a homologous 
strand from the sister chromatid or the homologous chromosome is used as a 
template to copy the intact sequence missing in the damaged strands, thus normally 
achieving an error-free repair.  
CDK activity may positively regulate HR and thus the choice between NHEJ and HR 
seems to be cell cycle regulated (Ferreira and Cooper, 2001; Caspari et al., 2002). In 
S. pombe, G1 is very short, DNA is replicated before cytokinesis, being G2 the longest 
cell-cycle phase. Thus a sister chromatid is available as a repair template during most 
cell cycle. Therefore HR is the dominant DSB repair pathway in fission yeast, being 
NHEJ the active repair pathway in G1. 
Homologous recombination  
Homologous recombination includes different pathways that apply a common 
mechanism of DSB repair which consists on invasion and copy of a homologous 
strand to replace the sequence missing as a consequence of the break. 
Recognition of DSBs is performed by the MRN complex (Mre11pSpRad32p–Rad50p–
Nbs1p), which is highly conserved and further implicated in NHEJ, HR, telomere 
maintenance and activation of the DNA damage checkpoint. The MRN promotes 
resection of the DSBs to form single stranded DNA overhangs which are subsequently 
coated by RPA. These overhangs serve as primers for invasion and copy of the 
homologous strand which serves as a template.  
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The main event in HR is the strand exchange reaction catalysed by Rad51pSpRhp51p, 
homologue of the bacterial RecA protein. S. pombe Rhp51p binds ssDNA forming a 
nucleoprotein filament and promotes exchange reactions with homologous duplex 
DNA (Sauvageau et al., 2005). Rad51pSpRhp51p binding to ssDNA requires mediator 
proteins to overcome the inhibitory effect of the competitor protein RPA, which 
presents high affinity to ssDNA. Recombination mediators in S. pombe include 
ScRad52p homologues, Rad22p and Rti1p, Rhp54p (ScRad54p homologue), Rhp55p 
(ScRad55p homologue), Rhp57p (ScRad57p homologue), and Rad51-like proteins, 
like Rlp1p and Rdl1p. Rlp1p has been suggested to function in the recombinational 
pathway of DSB repair together with Rhp51p, Rhp55p and Rad22p and may be 
required for proficient DNA recombination and cell survival when replication forks 
collapse (Khasanov et al., 2004). 
 
Figure I9. HR in Fission yeast 
Schematic representation of DSB repair by HR in S. pombe including the main proteins 
involved. Damaged strands are coloured in red and the intact template in blue. 
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The resulting nucleoprotein filament finds its homologous sequence by single-end 
invasion, a process aided by Rad54pSpRhp54p. The 3’ end of the invading strand is 
extended by a DNA polymerase.  
During resolution of HR structures, crossovers between homologous DNA sequences 
can occur, which can lead to abnormal chromosomal rearrangements and other 
deleterious events during mitotic cell cycle. Mitotic crossovers arise primarly through 
the action of Mus81-Eme1 acting downstream of Swi5 (Hope et al., 2007), a small 
protein implicated in an HR process alternative to the action of Rhp55/57p (Akamatsu 
et al., 2003). HR, however, occurs mainly through an Rhp57p dependent pathway 
where Rqh1p-Top3p acts to block crossing over (Hope et al., 2007). Adaptor protein 
Crb2p, regulated by CDK activity and Rad3p phosphorylation, controls the function of 
Rqh1p and Top3 at the late stages of the recombination repair process. 
Rad22p 
In S. pombe two ScRad52p homologues, Rad22p and Rti1p/Rad22Bp have been 
identified. Both Rad22p and Rti1p have been shown to interact with each other and 
with Rhp51p and RPA (Kim et al., 2000; Tsutsui et al., 2001; van den Bosch et al., 
2001; van den Bosch et al., 2002) and they are able to bind to ssDNA and form 
multimeric structures like Rad52p (de Vries et al., 2007). Rad22p seems to play a 
predominant role during HR in mitosis, being ∆rad22 cells sensitive to ionizing 
radiation (IR) (Muris et al., 1997). Rad22p recruitment to DSBs seems to be 
independent of checkpoint signaling and of other HR proteins (Meister et al., 2003). 
Rti1p is expressed to low levels during vegetative growth and is not induced upon 
DNA-damage. Cells deleted for rti1 are only slightly sensitive to DNA-damage but 
over-expression of rti1 is able to partially recue ∆rad22 sensitivity to DSB formation. 
Rti1p seems to be involved in HR during meiosis (van den Bosch et al., 2001; van den 
Bosch et al., 2002).  
Rad22p seems to be central to most HR events in S. pombe. This protein has been 
associated to two Rhp51p-independent recombinational pathways, one associated to 
repair of collapsed forks together with Mus81p, and in the replication of tandem 
repeats of rDNA locus together with Slx1p-Slx4p (Doe et al., 2004; Coulon et al., 
2006). In fact, approximately 50% of the spontaneous Rad22p repair foci that occur in 
cycling cells depend on Slx1p and localize to the nucleolus, which contains the rDNA 
repeats (Coulon et al., 2006). Futhermore Rad22p is involved in other mechanisms of 
DSB repair, such as single strand annealing (van den Bosch et al., 2002).  
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7.2 DNA repair and HR during S-phase and replication stress 
Work in bacterial systems indicate that Holliday Junctions can form at stalled 
replication forks by fork reversal, which are subsequently cleaved to form DSBs (Cox, 
2001). HR has been implicated in the bypass of replication fork barriers and replication 
restart at stalled forks (McGlynn and Lloyd, 2002a).  
In addition to its role in DNA-damage repair, HR machinery is recruited to DNA during 
a perturbed S-phase probably to deal efficiently with structures that may arise from 
replication fork stalling. The regulation of recombinational activity at this stage is 
determinant for cell viability. The presence of recombination machinery can result in 
appearance of non-functional structures if replication forks are not adequately 
stabilized, resulting in toxicity. Thus the double mutant ∆rhp51 ∆cds1 has been proven 
to recover from replication fork stalling whereas ∆cds1 cells rapidly loose viability 
(Meister et al., 2005). 
A direct regulation of the recombination machinery by the Cds1p-branch of checkpoint 
response to preserve genomic integrity has been proposed. Cds1p interacts by means 
of its forkhead-associated domain whith recombination proteins Mus81p, Rad60p and 
Rqh1p (Boddy et al., 2000; Boddy et al., 2003). Endonuclease Mus81p is implicated in 
the maturation or recombination intermediates and in processing of abnormal 
replication structures (Boddy et al., 2000; Doe et al., 2002). The complex Mus81p-
Eme1p has been proposed to be responsible for deleterious deletion mutations in cells 
undergoing replication stress (Boddy et al., 2000). Rad60p is required for DSB repair 
during replication (Morishita et al., 2002). Rqh1p prevents regression of stalled 
replication forks (Doe et al., 2002). Thus, ∆rqh1 cells are unable to recover from HU 
induced S-phase arrest and show strongly increased levels of recombination after HU 
treatment (Stewart et al., 1997). Checkpoint activated Cds1p triggers Mus81p-Eme1p 
dissociation from chromatin (Boddy et al., 2000; Kai et al., 2005), promotes nuclear 
delocalization of Rad60p (Boddy et al., 2003) and enhances Rqh1p activity. These 
events result in prevention of inadequate recombinational repair and stabilization and 
recovery of stalled replication forks. They further prove a direct link between Cds1p 
and regulation of recombinational repair processes. Consistent with this, Rad22p foci 
appear during S-phase in cells presenting an S-phase deficient checkpoint.  
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8. TRANSCRIPTIONAL RESPONSE OF S. pombe TO 
DIFFERENT SOURCES OF STRESS 
Checkpoint response in endogenously or exogenously harassed cells involves 
changes in gene expression which account for consecution of the adequate cell 
environment to prevent genomic instability. Although the way in which cell signaling 
and protection occurs is in most cases specific for each type of stress, there is a 
common set of genes whose expression is altered in response to most stresses. This 
core environmental stress response (CESR) was initially defined in a study involving 
oxidative stress (H2O2), osmotic stress (Sorbitol), heat shock, heavy metal stress (Cd) 
and DNA damage (MMS), and involves 140 induced genes and 11 repressed genes 
common to at least four of the five stresses (Chen et al., 2003). Other studies have 
shown a considerable overlap between the CESR and the genes regulated in 
checkpoint response to Cisplatin (48), Ionizing radiation (108) and HU (50) (Gatti et 
al., 2004; Watson et al., 2004; Chu et al., 2007). The induced genes code mainly for 
antioxidants, regulatory proteins and proteins involved in carbohydrate metabolism. 
Surprisingly, the CESR contains only two heat shock proteins, and two genes 
predicted to be involved in DNA repair. The repressed genes (106 in a less restrictive 
cut off for 3 out of the 5 stresses) are involved in protein synthesis and transport, 
transcription, signaling and cytoskeleton organization. This core response is largely 
dependent on the stress-activated mitogen-activated protein kinase Sty1p, partially by 
means of the transcription factor Atf1p (Chen et al., 2003). Rad3p has also been 
shown to play a minor role in CESR regulation (Watson et al., 2004). The CESR 
overlaps significantly with the CER/ESR of S. cerevisiae, pointing to an evolutionary 
conserved response to environmental stress (Chen et al., 2003). 
In addition to this core transcriptional response there are subsets of genes that are 
specifically regulated depending on the stress source. Sty1p is only important for the 
specific response to oxidative and osmotic stresses (Chen et al., 2003).  
DNA damage caused by H2O2, IR and MMS, alters a common set of 12 genes 
including genes involved in initiation of replication (cdc18 and cdt2) and stress 
response (trr1) (Watson et al., 2004). Homologous recombination genes rhp51 and 
rhp54, as well as translesion DNA synthesis repair gene dinB are induced in IR 
treatment in a Rad3p dependent and Cds1p or Chk1p independent manner (Watson 
et al., 2004). Surprisingly few genes involved in DNA repair are induced by these 
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stresses and genes encoding checkpoint proteins are largely unaffected, indicative of 
a predominant posttranslational modulation.  
Transcriptional response to S-phase block induced by HU involves 49 CESR genes, 
18 of which are Rad3p dependent and 39 Cds1p dependent (Chu et al., 2007). 
Replication stress specific response includes expression of Mlu1-like cell cycle box 
(MCB) motif-containing genes and histone cluster genes as well as repression of FKH 
and ACE2 clusters (Chu et al., 2007). MCB genes (such as cdc22, cdc12, cdt1, cig2 
and mik1) are cell-cycle regulated by MBF-DSC1 (Cdc10p, Res1p, Res2p and Rep2p) 
and peak at G1. Most of them are involved in DNA replication and required for G1/S 
transition (Rustici et al., 2004; Oliva et al., 2005; Peng et al., 2005). Zinc finger 
transcription factor Ace2p regulates ACE2 motif-containing genes which code for 
proteins involved in cytokinesis (Martin-Cuadrado et al., 2003). ace2 expression, in its 
turn, is controlled by forkhead transcription factor Sep1p and Fkh2p members of the 
FKH cluster (Zilahi et al., 2000; Buck et al., 2004). Expression of MCB genes during 
HU block depends on the checkpoint branch Rad3p-Cds1p and should guarantee the 
adequate cellular conditions for re-start of replication at the recovery stage, whereas 
FKH and ACE2 repression, only bypassed in ∆rad3 cells since it can be triggered 
either by the Cds1p or the Chk1p checkpoint pathways, is important for replication 
checkpoint block (Chu et al., 2007). 
9. MATHEMATICAL MODELLING OF BIOLOGICAL NETWORKS 
Many human diseases, such as cancer, diabetes, and neural disorders are 
caused by defective or abnormal intra- or inter-cellular signalling. Studying the 
behaviour and mechanism of action of the respective signalling pathways under 
different situations is thus the key to understand the reasons that lead to pathology 
and to identify possible targets of therapy. Biological research in its different aspects 
generates by means of high-throughput methods and specific low-throughput studies 
an enormous amount of information on the signalling cascades subject to study 
relating their components, the interactions among them and their coordination. 
However, the complexity of biological systems precludes untangling these networks 
with the human mind alone. Due to the complex mechanisms involved, such as 
feedback loops and crosstalk between paths, the resulting behaviour is non-linear and 
often non-intuitive. Therefore, abstraction of complex biological systems such as 
signalling pathways into mathematical models proves to be a useful tool to understand 
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the mechanisms that underlie their observed behaviour. Computational modelling of 
cellular processes has proved to represent experimental knowledge in a 
mathematically testable form, to elucidate design principles, and to describe the 
dynamics of biological pathways under different experimental conditions.  
9.1 Some notions on mathematical modelling of biological 
networks 
Different types of models and simulation techniques can be used for 
mathematical modeling of biological networks. Continuous deterministic models based 
on ordinary differential equations (ODEs) are often used for the modeling and 
simulation of dynamic processes. Continuous models are used to dynamically 
simulate the profile of the network over time, in opposition to discrete models in which 
only certain time points are considered. In deterministic simulation present model 
states influence future ones, in opposition to stochastic simulation that is based in the 
probability of successive states.   
Continuous deterministic models are based on a scheme of the hypothesised 
interactions among the main components involved. This scheme should be built using 
state of the art information derived from the experimental characterisation of the 
network. The resulting diagram is then converted into a set of differential equations 
that describe how the concentration of each component changes over time and 
eventually space. These equations are based on the law of mass conservation after 
which, if diffusion and dilution terms are neglected, a species is accumulated 
depending on the net rate of its production. Such differential equations are expressed 
in the form: 
∑
=
=
r
j
jij
i vn
dt
dc
1
 
where r is the number of reactions in the network, vj the rate of the j reaction and nij 
the stoichiometric coefficient of ci in reaction j (see MATERIALS AND METHODS). 
Taking into account that a considered species is produced and/or consumed in a 
number of reactions, these equations represent the summation term of the reaction 
rates in which a species is produced minus the reaction rates in which it is consumed.  
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In its turn, each reaction rate is mathematically expressed as a function of the 
abundances of the substrate and modifiers or enzymes involved, and includes 
reaction constants or parameters whose values are often not known. If the 
concentrations of some species at determined time points are known, that is, if 
experimental data points are available, these unknown parameters can be estimated 
to obtain an accurate mathematical description of the system.  
Parameter estimation or fit consists on an automated process by means of which the 
parameter set that better fits the experimental data points is searched. It basically 
consists on a refinement loop: an initial set of parameter values is assigned and the 
dynamic equations are solved to give simulated values of the species concentrations 
at each time point. The simulations are compared quantitatively with the available data 
points. If the match between simulation and experimental data is unsatisfactory, then 
the parameter assignments are adjusted to achieve a better fit. There are many 
strategies for searching the optimum parameter set. 
Parameter estimation can be considered as step for model validation itself. Often no 
set of parameters can be found that adequately fits the experimental data points. That 
means that the model is not able to describe the behaviour of the system and the 
initial scheme of the network and/or the kinetic equations for the reactions should be 
written in another way.  
Fitted models should then be validated using experimental data not previously used 
for the parameter fit (for instance, behaviour of different mutants) in order to obtain 
reliable models that can be used to make predictions about the behaviour of the 
system under conditions not tested. 
9.2 Mathematical modelling as a useful tool for biological 
investigation 
Validated models are a valuable tool for biological investigation. First of all, 
they present a mechanistic scheme for the networks usually globalising and 
connecting huge amounts of isolated experimental data and bridging the gaps where 
experimental evidences are missing. The state of the art knowledge based in 
unconnected experiments normally allows for the writing of network interactions in 
different ways, which a priori can be equally valid. Thus, in the process of building and 
validating the model, initial working schemes have frequently to be discarded to favour 
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others that prove to better reproduce the observed behaviour of the pathway. In this 
way, mathematical modelling can be regarded as an iterative process involving a 
close interplay of mathematical and biological inputs and outputs. Modelling itself is 
useful as a process, even if the resulting model is not satisfactory. It forces abstract 
thinking and the extraction of essential features of a process. It highlights aspects 
where our understanding of a matter is wrong or insufficient and it facilitates a unique 
description of our current knowledge and of the gaps therein. 
On the other hand, mathematical analysis of validated models provides us with 
information that is difficult to achieve by undirected biological experiments. For 
instance, by means of sensitivity analyses of the network, one can predict which 
reactions/species play the most important role in maintaining the stability or 
reproducing the output of the system. Validated models are furthermore a valuable 
tool to predict the behaviour of the pathway under different experimental conditions. 
For example, in a given network one can knock-out or increase the concentration of a 
specific component to study the local or global effects of these changes.  
Mathematical modelling of biological networks should be regarded as an emerging 
and highly useful tool for biological investigation that is intimately linked to 
experimental work. Accurate models can only be built upon reliable experimental data, 
necessary for model construction, parameter fit and validation. Models in its turn 
provide investigators with valuable information and a global and local vision of the 
network that can be difficultly obtained without computational power. Once again, 
relevant model predictions should be validated by experiments. In this way, close work 
between experimentalists and modellers often give rise to unexpected and exciting 
discoveries. 
9.3 Mathematical modelling of the cell cycle and checkpoint 
responses 
Understanding the mechanisms underlying cell cycle progression and control 
is a key biological and medical question that greatly helps the advances in treatment 
and prevention of related disorders like cancer.  
Cell cycle progression has been subject to a number of dynamic modelling 
approaches. Early modelling attempts tried to understand the oscillatory nature of the 
cell cycle (Tyson, 1979; Goldbeter, 1991).  
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Comprehensive models for cell cycle progression have been historically developed by 
the Tyson and Novak groups, who paved the way to include more and more molecular 
details and to understand the contribution of individual components of the cell cycle 
machinery. They built models for different aspects of the cell cycle engine in Xenopus 
oocytes (Novak and Tyson, 1993; Marlovits et al., 1998; Ciliberto et al., 2003; Ciliberto 
et al., 2005), fission yeast (Novak and Tyson, 1997; Novak et al., 1998; Sveiczer et al., 
2000; Novak et al., 2001; Sveiczer et al., 2001, 2004; Csikasz-Nagy et al., 2007; 
Csikasz-Nagy et al., 2008), budding yeast (Chen et al., 2000; Chen et al., 2004; Toth 
et al., 2007) and mammalian cells (Novak and Tyson, 2003, 2004). These models are 
based on a huge amount of experimental evidence in the literature and the major test 
for their validity is to reproduce the phenotypes of a large series of mutants correctly. 
While qualitative predictions of these models for wild-type cells agree with available 
data, they do not include time-course data to prove the correctness of the simulated 
dynamics.  
Different approaches to mathematical modelling and analysis of cell cycle related 
events in eukaryotes have been undertaken by numerous groups. The scope of these 
models is diverse, ranging form detailed descriptions of specific cell cycle transitions, 
to the inclusion of transcriptional events and checkpoint modules or even to the study 
of cell cycle in tumour cells (Aguda, 1999b, a; Aguda and Algar, 2003; Qu et al., 
2003a; Qu et al., 2003b; Cokus et al., 2006; Faure et al., 2006; Srividhya and 
Gopinathan, 2006; Alarcon and Tindall, 2007; Barberis et al., 2007; Tindall and 
Please, 2007, among others). 
The relevance of mathematical modelling of cell cycle related events has also led to 
the creation of cell cycle specific databases like the Cell Cycle Database (Alfieri et al., 
2007, 2008) for yeast and mammals (that integrates information about genes and 
proteins involved in the cell cycle process, stores complete models of the interaction 
networks and allows direct simulations), and the Cyclonet database on cell cycle 
regulation in mammals in normal and pathological states (Kolpakov et al., 2007).  

  
OBJECTIVES 

OBJECTIVES 
59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. To elucidate if Schizosaccharomyces pombe phosphatase Flp1p 
is involved in checkpoint response to genotoxic stress. 
2. To study the role of the phosphatase in checkpoint response to 
genotoxic stress: analysis of the phenotypes associated to 
mutation of flp1 in checkpoint response to unreplicated or 
damaged DNA. 
3. To study the mechanism of action of Flp1p in checkpoint 
response to genotoxic stress: analysis of the functional 
relationship between the phosphatase and different proteins 
involved in the cellular response to unreplicated or damaged 
DNA.  
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1. MEDIA AND CULTURE MANIPULATION 
1.1 Schizosaccharomyces pombe 
The standard culture media and conditions used in this work have been 
previously described by Moreno et alter (Moreno et al., 1991). 
Standard rich medium yeast extract plus supplements (YES) or minimal medium (MM) 
adequately supplemented with aminoacids (leucine, histidine) and/or nitrogenated 
bases (adenine, uracil) depending on the auxotrophies of the strain at 225 mg/L final 
concentration in liquid or solid form were used for growth (Moreno et al., 1991).  
Experiments in liquid medium were performed, unless otherwise specified, at 30ºC, 
adjusting exponential growing cultures to an initial optical density of 0.4-0.5 measured 
at 595 nm (4-5·106 cells/ml). For growth in solid medium plates were incubated at 
30ºC unless otherwise specified. 
Over-expression of genes 
Strains containing repressible nmt1-plasmids were grown in minimal medium (MM) 
appropriately supplemented and containing 5mg/ml thiamine. Induction was triggered 
by washing exponentially growing cultures and resuspending in medium without 
thiamine as described previously (Cueille et al., 2001). The standard induction time 
used was 16 hours. 
Repression of genes and synchronization in temperature sensitive 
alleles 
Temperature sensitive alleles were grown to exponential rate at 25ºC.  
Strains containing cdc10-129 or cdc10-M17 alleles were synchronised by temperature 
shift to 36ºC for 4 hours. Release was performed at 25ºC.  
mts1-1/rpn9-1, mts2-1/rpt2-1 and mts3-1/rpn12-1 were incubated in YES to 
exponential growth at 25ºC. Repression of the genes was performed at 36ºC. 
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Drug treatment 
In asynchronous cultures drug was added to exponentially growing (4-5·106 cells/ml) 
cultures.  
In synchronized or temperature sensitive alleles the drug was added at the 
release/temperature shift time point. 
Standard drug concentrations used in liquid medium: 12mM HU, 0.033% MMS or 7.5 
mU BL. Use of other concentrations is specified. 
1.2 Escherichia coli 
E. coli was incubated at 37ºC using the culture media and conditions described in 
Sambrook et al., 1989. 
2. STRAINS USED 
The different S. pombe strains used in the experiments described in 
RESULTS, and the parental strains of the strains specifically generated for this study, 
as well as their genetic characteristics and procedure, are shown in Table M1. 
E. coli DH5α was used in experiments involving plasmid production in bacteria. 
3. GENERATION OF STRAINS AND TRANSFORMATION 
TECHNIQUES 
3.1 Strain crossing  
S. pombe strains generated for this study were normally obtained by genetic 
cross. Spores were selected using random analysis or tetrad selection as described in 
Moreno et al., 1991. 
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GENOTYPE STRAIN SOURCE 
h-  ade6-704 leu1-32 ura4-d18 S88 Dr. Moreno 
h+  ade6-704 leu1-32 ura4-d18 S89 Dr. Moreno 
h+ cdc10-129 leu1-32 ura4-d18  4.75 Dr. Bueno 
h-  cdc10-129  flp1::KanMX6 31.1 Dr. Bueno 
h+ cdc10-129  flp1::flp1-GFP-KanMX6 ura4-d18 41.60 This study 
cdc10-129  flp1::flp1-9a-EGP-leu2-KanMX6 51.11 This study 
cdc10-129 rad3::ura4+ flp1::flp1-GFP-KanMX6 54.06 This study 
cdc10-M17 ade6-704 leu1-32 ura4-d18 53.29 Dr. O’connell 
cdc10-M17 rad3::ura4+ 54.07 This study 
cdc10-M17 flp1::KanMX6 54.08 This study 
h+ cdc17-K12 ura4-d18 263 Dr. Moreno 
cdc17-K12  flp1::flp1-GFP-KanMX6 52.17 This study 
h+ cds1:2HA6his   leu1-32 ura4-d18 Dr. Russell 
cds1:2HA6his flp1::KanMX6 42.05 This study 
h- cds1::ura4+  leu1-32 ura4-d18 Dr. Russell 
h- cds1::ura4+ flp1::flp1-3HA-KanMX6  ade6-704 leu1-32 ura4-d18 42.43 This study 
h- cds1::ura4+ flp1::flp1-GFP-KanMX6  ura4-d18 41.70 This study 
cds1::ura4+ flp1::KanMX6  ade6-704 leu1-32 42.11 This study 
h+ chk1:9myc2HA6his   leu1-32 ura4-d18 Dr. Russell 
chk1:9myc2HA6his flp1::KanMX6    42.23 Dr. Bueno 
h+ chk1:HA ade6-704 leu1-32  S1012 Dr. Moreno 
chk1:HA flp1::KanMX6 51.13 This study 
h- dis2::ura4+  leu1-32 ura4-d18 Dr. Simanis 
h- dis2::ura4+ flp1::KanMX6  ura4-d18 Dr. Simanis 
h- chk1::ura4+  ade6-704 leu1-32 ura4-d18 Dr. Russell 
h- chk1::ura4+ flp1::flp1-3HA-KanMX6  ade6-704 leu1-32 ura4-d18 42.46 This study 
h- chk1::ura4+ flp1::flp1-GFP-KanMX6  ade6-704 leu1-32 ura4-d18 41.72 This study 
chk1::ura4+ flp1::KanMX6  ade6-704 leu1-32 42.17 This study 
h- flp1::flp1-3HA-KanMX6 ade6-704 leu1-32 ura4-d18 44.32 Dr. Bueno 
h- flp1::flp1-GFP-KanMX6 ade6-704 leu1-32 ura4-d18 Dr. Simanis 
h- flp1::flp1-9a-EGP-leu2-KanMX6 50.69-71 This study 
h- flp1::KanMX6 ade6-704 leu1-32 ura4-d18 43.56 Dr. Bueno 
h+ flp1::KanMX6 30.20 Dr. Bueno 
h+ flp1::KanMX6 ade6-704 leu1-32 ura4-d18 30.21 Dr. Bueno 
h+ flp1::flp1-3HA-KanMX6 ade6-704 leu1-32 ura4-d18 30.50 Dr. Bueno 
h+ flp1::flp1-GFP-KanMX6 ade6-704 leu1-32 ura4-d18 43.23 Dr. Bueno 
Table M1. Strains used (continues) 
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3.2 Construction of the strain flp1-9A-EGFP 
Mutation of the 9 RXXS putative phosphorylation sites on Flp1p was performed 
sequentially by PCR (Quick change site-directed mutagenesis protocol, see 4.3) using 
pREP-KZ-flp1 as a template and complementary primers of 30 bases containing the 
desired mutation (S160A AGC->GCC, S396A TCT->GCT, S408A TCA->GCA, S467A 
TCA->GCA, S468A AGT->GCT, S493A AGT->GCT, S499A AGT->GCT, S513A AGC-
>GCC, S537A TCT->GCT). Each mutation was verified by DNA sequencing analysis. 
Oligos used for mutagenesis and sequencing are listed in Table M2. 
The flp1-9A gene was obtained by PCR of pREP-KZ-flp1-9A with flanking BglII-XmaI 
sites and cloned into the pREP41flp1promoter -EGFP (pREP41-EGFP vector in which the 
nmt1 promoter had been previously substituted by the 1.2 Kb endogenous promoter 
region of flp1, see 4.6). The resulting construction was then integrated in a 
flp1::kanMX strain using the unique restriction site SpeI located in the promoter region 
of flp1 by the transformation technique described by Keeney and Broeke (Keeney and  
GENOTYPE STRAIN SOURCE 
H90 gar2-RFP-KanMX leu1ad6-M210 FY13580 YGRC 
gar2-RFP-KanMX  flp1::flp1-GFP-KanMX6 52.10 This study 
gar2-RFP-KanMX - flp1::flp1-9a-EGP-leu2-KanMX6 52.15 This study 
h- mts1-46 leu1-32 S443 Dr. Moreno 
h- mts2 leu1-32 S444 Dr. Moreno 
h- mts3 leu1-32 S445 Dr. Moreno 
mts1-46 flp1::flp1-3HA-KanMX6 leu1-32 42.76 This study 
mts2 flp1::flp1-3HA-KanMX6 leu1-32 42.77 This study 
mts3 flp1::flp1-3HA-KanMX6 leu1-32 42.78 This study 
h+ rad3::ura4+ ade6-704 leu1-32 ura4-d18 S1017 Dr. Moreno 
h+ rad3::ura4+ flp1::flp1-GFP-KanMX6 ura4-d18 44.14 This study 
h+ rad22::rad22-YFP-KanMX leu1-32 ura4-d18 his3-d1 TMN3333 Dr. Russell 
 rad22::rad22-YFP-KanMX cds1::ura4+  48.65 This study 
rad22::rad22-YFP-KanMX flp1-9A-leu2 49.70 This study 
 rad22::rad22-YFP-KanMX flp1::KanMX6 48.64 This study 
h- rad24::ura4+ ade6-704 leu1-32 ura4-d18 Dr. Russell 
h- rad24::ura4+ flp1::flp1-GFP-KanMX6 ade6-704 leu1-32 44.21 Dr. Bueno 
h- rad24::ura4+ flp1::KanMX6 ade6-704 leu1-32 ura4-d18 42.73 This study 
Table M1. Strains used (continued)
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Broeke, 1994). The correct and unique integration in the genome was corroborated by 
Southern blot analysis (Figure M1). Genomic DNA was obtained from the different 
clones and cut using Pst1 as restriction enzyme. The probe (flp1 ORF lacking the first 
120 bases) was constructed by PCR using primers 1.84 and 1.85 (see Table M2).   
 
Figure M1.  Integration of flp1-9A-EGFP in a Δflp1 strain 
(A) Schematic representation of the integration of flp1-9A-EGFP into a Δflp1 strain. The 
plasmid pREP41flp1promoter-flp1-9A-EGFP was cut with SpeI that produces a single cut 
in the promoter region. A Δflp1 strain was transformed with the linear form which should 
be integrated through recombination into the promoter region of the receptor. (B) 
Southern blot analysis to detect the clones that had correctly integrated flp1-9A-EGFP. 
If the fragment was correctly integrated a 18 Kb and a 8 Kb band should be detected by 
digestion with Pst1 using a probe for flp1. If multiple integrations occurred an additional 
3 Kb band should appear. Schematic representation for single and multiple integrations 
are shown. 
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3.3 S. pombe transformation 
S. pombe cells were normally transformed using competent cells using 
Lithium Acetate (Norbury and Moreno, 1997). 
3.4 E. coli transformation 
For E. coli transformation with PCR products we followed the procedure 
described by Kushner (Kushner et al., 1998). For transformation with plasmids we 
followed the fast procedure described by Golub (Golub, 1988). 
4. DNA AND RNA MANIPULATION AND ANALYSIS TECHNIQUES 
4.1 DNA isolation 
Plasmid isolation from E. coli  
For small scale isolation of plasmidic DNA from bacteria the boiling lysis miniprep 
method was used. In this way a single colony of E. coli was grown overnight at 37ºC in 
2 ml of LB supplemented with Ampicillin. 1.5 ml of the culture was processed. Bacteria 
were collected by centrifugation at 8000 r.p.m for 1 minute and resuspended in 200 µl 
Miniprep Lysis Buffer (8% Saccharose, 0.5% Triton x-100, 50 mM EDTA and 10 mM  
Tris-HCl pH 8.0)  containing 0.7 mg/ml Lysozyme. Samples were boiled for 1 minute 
and subsequently centrifuged for 10 minutes at room temperature. Snot pellet was 
pulled out with a sterile toothpick. 20 µl of Natrium Acetate 3M and 200 µl Isopropanol 
were added for DNA precipitation. After centrifugation pellet was washed with 70% 
Ethanol. Pellet was dried and resuspended in 50 µl miliQ water containing 20 µg/ml 
RNase.    
The Plasmid Maxi-Kit (Quiagen) was used for large scale plasmidic DNA isolation.
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Isolation of genomic DNA of S. pombe  
S. pombe genomic DNA extraction was performed following the protocol described in 
Moreno et al. 1991. 
4.2 RNA extraction 
RNA was extracted from 3·108 cells collected by centrifugation at 4ºC from 
exponentially growing cultures. 20 µl of extraction solution (0.1 M EDTA pH 8.0, 0.1 M 
NaCl, 0.05 M Tris pH 8.0), 20 µl phenol/chloroform/isoamilic alcohol at -20ºC, 5 µl 
SDS 10% and 400 µl glass beads were added. Cells were disrupted using a Bio 101 
Fast-Prep® Instrument (2 cycles of 15 s at 5.5 m/s). Lysates were extracted with 200 
µl extraction solution and 200 µl phenol/chloroform. RNA was extracted in five 
subsequent extractions, once using phenol, three times with phenol/chloroform, and 
once with chloroform/isoamilic alcohol. RNA was precipitated with 3M Natrium acetate 
and 2.5 volumes of 100% EtOH at 4ºC, washed with 70% EtOH and resuspended in 
30 µl DEPC water. Concentration was measured at 260 nm.   
4.3 Polymerase chain reaction (PCR) 
DNA amplification and mutagenesis were performed in an Eppendorf 
Mastercycler Personal® instrument. Reaction conditions depended on the 
characteristics of the fragment to be amplified. PCR mix contained template DNA 
(100-200 ng of genomic DNA, 15-20 ng of plasmidic DNA), 100 pM from each 
oligonucleotide, 20 pM of each dNTP and 1 unit of the corresponding polymerase. 
  
Quick change site-directed mutagenesis  
For site-directed mutagenesis of a gene in a plasmidic construction, the quick change 
site-directed mutagenesis was used. The PCR mix (50 µl) contained 5-20 ng of 
template DNA, 125 ng of each specific primer, 2.5 mM of each dNTP, 5 µl of 10x Pfu 
Buffer and 1 µl of Pfu DNA polymerase (PFU Turbo®, Stratagene). Reaction was 
performed in 12 cycles of denaturing at 95ºC for 1 minute, annealing at the 
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corresponding temperature for 1 minute, and extension at 68ºC for 2 minutes/Kb. 10 µl 
of PCR products were digested in 20 µl with Dpn1 at 37ºC for 2-3 hours to degrade 
template DNA. DH5α E. coli cells were transformed with 10 µl of digestion. DNA was 
extracted using the boiling lysis miniprep methods, and mutations were verified by 
sequencing. 
4.4 Oligonucleotides used 
The oligonucleotides used in this study were synthetized by ISOGEN 
Bioscience BV or THERMO Electron GmbH. In Table M2 the complete sequence of 
the oligos, as well as their use in this study is specified.  
4.5 Processing of DNA fragments  
Purification of DNA fragments 
Resuspended DNA was purified using the Jet Quick PCR Product Purification Spin Kit 
of Genomed®. 
DNA fragments contained in agarose plugs were purified using the Jet Quick Gel 
Extraction Spin Kit of Genomed®.  
Alkaline Phosphatase treatment 
To avoid plasmid religation phosphate groups of 5’ end of linearized plasmids were 
removed by incubation with 1 U/mg DNA calf intestine alkaline phosphatase (Roche 
Diagnostics) in the provided buffer for 30 minutes at 37ºC.  
Ligation of DNA fragments 
Ligation of a DNA fragment and a receptor plasmidic vector was performed using DNA 
ligase T4 (Fermentas) either at 16ºC overnight or at room temperature for 4 hours.  
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OLIGO SEQUENCE 5’-3’ NR USE 
3’S14Sp TACCCGGTTAAGAAATAAGCCGGCTTT 1.84 Obtention of Southern probe 
3’INT14 GATACCATGACTATCACTG 2.27 Sequencing of flp1 
5’INT 14 ATGGATTACCAAAGATGATGG 2.28 Sequencing of flp1 
5’BN14Sp TAGGATCCATATGCATTTTTTTACTATCGA 1.85 
Sequencing of flp1 
Obtention of 
Southern probe 
5’MID1782 ATCATGCGAGCACACGTCCA 2.13 Sequencing of flp1 
5’TAP01 CAGTGGTTCGCTTGCGTCGCTC  Sequencing of flp1 
Flp1-
pREP41 
forward 
GAAGATCTTCATGGATTACCAAGATGATGG 379 Cloning of flp1 in pREP41 (BglII site) 
Flp1-
pREP41 
reverse 
TCCCCCCGGGCCAGAAATTAGCCGGCTTTT 380 
Cloning of flp1 in 
pREP41 (XmaI 
site) 
Sequencing of flp1 
Forward 
Flp1 
promoter 
AAAACTGCAGCCAAAGAGTTGCTTGGTGAA 381 Construction of pREP41flp1promoter 
Reverse 
Flp1 
promoter  
GAAGATCTCAGACAAGTAATTGCGAATCTC 383 Construction of pREP41flp1promoter 
S160A 
forward 
GAGCACGAGAGAGCGCCATACTAAATATAC
G  
Mutation of RXXS 
sites 
S160A 
reverse CGTATATTTAGTATGGCGCTCTCTCGTGCT  
Mutation of RXXS 
sites 
S408A 
forward GCGAGACGTCTCCCTGAGCGTCCTCTGTC  
Mutation of RXXS 
sites 
S408A 
reverse 
GCGAGACGTCTCCCTGCAGCGTCCTCTGT
C  
Mutation of RXXS 
sites 
S513A 
forward 
GCTCAGCGAAGTGTTGCCATGTCATCACTT
AAC  
Mutation of RXXS 
sites 
S513A 
reverse 
GTTAAGTGATGACATGGCAACACTTCGCTG
AGC  
Mutation of RXXS 
sites 
S467A 
forward 
GCTTGCGTCGCTCAGCAGCTCAAAGCAATT
ATC 375 
Mutation of RXXS 
sites 
Table M2. Oligonucleotides used (continues) 
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4.6 Plasmids used 
The plasmids used in this study are listed in Table M3. 
Construction of pREP41 flp1promoter-flp1- EGFP  
In order to obtain expression of flp1 under its own promoter in the tagged EGFP 
plasmidic form, the nmt1 promoter of pREP41-flp1-EGFP was replaced by the 
endogenous promoter region of flp1. A 1.2 Kb fragment of the promoter region of flp1 
was amplified by PCR using USB FideliTaqTM polymerase and primers 381 and 383 
(see Table M2). nmt1 promoter was removed from the plasmid by digestion with BglII 
and Pst1 and gel purification of the vector. The insert was also digested with BglII and 
Pst1, purified and ligated to the vector. E. coli was transformed with the ligation 
S467A 
reverse GATATTGCTTTGAGCTGCTGAGCGACGCAAGC 376 Mutation of RXXS sites 
S468A 
forward 
CTTGCGTCGCTCATCAGCTCAAAGCAATATCGAA
C 384 Mutation of RXXS sites 
S468A 
reverse 
GTTCGATATTGCTTTGAGCTGATGAGCGACGCAA
G 385 Mutation of RXXS sites 
S396A 
forward CAACCGAGAAAAGTTGCTGGACATAATCCACCG 386 Mutation of RXXS sites 
S396A 
reverse CGGTGGATTATGTCCAGCAACTTTTCTCGGTTG 387 Mutation of RXXS sites 
S493A 
forward CAATTCGACGTCAGCTGGAAATAGGTGGT 388 Mutation of RXXS sites 
S493A 
reverse GACCACCTATTTCCAGCTGTACGTCGAATTG 389 Mutation of RXXS sites 
S499A 
forward GGAAATAGGTGGTCTGCTGGGTCTAGTCATTC 390 Mutation of RXXS sites 
S499A 
reverse GAATGACTAGACCCAGCAGACCACCTATTTCC 391 Mutation of RXXS sites 
S537A 
forward CTAAAAGCCGGCTAATTGCTTAATAAACCTG 392 Mutation of RXXS sites 
S537A 
reverse CAGGTTTATTAAGCAATTAGCCGGCTTTTAG 393 Mutation of RXXS sites 
Table M2. Oligonucleotides used (continued)
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product and correct constructions were selected by digestion with HincII and 
sequencing of the Minipreps.   
4.7 Southern blot analysis 
Southern probes were constructed by PCR using genomic DNA as a template and 
using DFS-Taq polymerase (Bioron).  In order to dilute the concentration of genomic 
DNA in the probe, a second PCR was performed (300µl) using 1 µl of the first PCR as 
a template. PCR products were purified using Jet Quick PCR Product Purification Spin 
Kit of Genomed®, and eluted in 30µl miliQ water. DNA concentration was quantified in 
gel.  
PLASMID Source 
pREP-KZ-GST Dr. Bueno 
pREP-KZ-GST-flp1+ Dr. Bueno 
pREP-KZ-GST-flp1
CS
 Dr. Bueno 
pREP-KZ-GST-flp1
468
 This study 
pREP-KZ-GST-flp1
396 468 493 499  537
 This study 
pREP-KZ-GST-flp1 
160 396 408 467  468 493 499 513 537
 This study 
pREP-KZ-GST-rad24+ Dr. Bueno 
pREP-KZ-GST-rad25+ Dr. Bueno 
pREP41-EGFP Dr. Moreno 
pREP41-flp1-EGFP This study 
pREP41
flp1promoter
-flp1-EGFP Dr. Russell 
pREP41
flp1promoter
- flp1 160 396 408 467  468 493 499 513 537  -EGFP This study 
Table M3. Plasmids used 
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Genomic DNA of the strains to study was cut with the chosen restriction enzymes. Salt 
transfer to GeneScreen Plus membranes (NEN), UV crosslinking to fix DNA and 
hybridization were performed following the indications of the manufacturer.  
4.8 Analysis of gene expression 
For the analysis of gene expression using microarray technology, exponential 
growing cultures of wt and ∆flp1 (5·106 cells/ml) were treated for 90 minutes with 20 
mM HU. RNA was extracted for the samples (see 4.2). RNA quality and quantity was 
tested using an Agilent Technologies 2100 BioAnalyzer. Gene expression profiles 
were obtained using a Yeast 2.0 array™ of Affymetrix™. Data processing was 
performed using AffymetrixTM GeneChip Operating Software and Data Mining Tool.  
5. PROTEIN MANIPULATION TECHNIQUES 
5.1 Preparation of protein extracts 
To avoid protein degradation the whole process was performed on ice or 
using cooled instruments.  
Protein extracts for Western Blot analysis (denaturing conditions) 
Approximately 3·108 cells were collected by centrifugation, washed with 1mL of STOP 
solution (NaCl 0,9%, NaN3 1 mM, EDTA 10 mM, NaF 50 mM, pH 8,0) and 30 µl of 
RIPA (Na3PO4 10 mM, Triton X-100 1%, SDS 0,1%, EDTA 10 mM, NaCl 150 mM, pH 
7,0) supplemented with protease inhibitors [leupeptin 10 µg/ml, aprotinin 10 µg/ml, soy 
bean 10 µg/ml, TLCK 100 µM (N-a-Tosyl-L-Lysine Chloromethyl Ketone 
Hydrochloride), pepstatin 10 µg/ml] were added. Samples were boiled for 5 minutes 
and immediately frozen in carbonic dry ice and stored at -80ºC until their processing. 
To obtain cell lysates, approximately 750 mg of glass beads and 40 µl of 
supplemented RIPA were added to the samples. Subsequently cells were disrupted 
using a Bio 101 Fast-Prep® Instrument (3 cycles of 15 s at 4m/s). Lysates were them 
extracted using 400 µl of supplemented RIPA. Protein concentration was determined 
in a colorimetric assay using the BCA kit (Pierce). The final set of samples was 
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prepared diluting the individual samples to a standard concentration using 
supplemented RIPA and adding Sample Buffer (Tris-HCl pH 6,8 80 mM, DTT 5 mM, 
SDS 2%, glycerol 7,5%, EDTA 5 mM, bromophenol blue 0,002%). Samples were 
finally boiled for 5 minutes and clarified.  
Protein extracts for Immunoprecipitation (native conditions) 
Approximately 3·108 cells were collected by centrifugation and washed with 1 mL of 
STOP buffer (NaCl 0,9%, NaN3 1 mM, EDTA 10 mM, NaF 50 mM, pH 8,0). For 
immunoprecipitation protein extracts were prepared directly after cell collection using 
immunoprecipitation lysis buffer [50 mM Tris (pH 7.5), 80 mM β-glycerophosphate, 
250 mM NaCl, 15 mM nitrophenylphosphate, 50 mM NaF, 5 mM EDTA, 1 mM DTT, 
and 0.1% NP-40] supplemented with aprotinin, and leupeptin both at 10 µg/ml final 
concentration, vanadate and PMSF (phenylmetylsulfonyl fluoride) both 1mM final 
concentration. The procedure of cell lysis is identical to that specified for denaturing 
conditions. Lysates were extracted in 400 µl of supplemented lysis buffer, and clarified 
by centrifugation (twice, 7 minutes at 12000 rpm and 4ºC). Protein concentration was 
determined in a colorimetric assay using the BCA kit (Pierce).  
5.2 Western blot analysis 
Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis 
(PAGE)   
Depending on the characteristics of the protein to detect 50 to 100 mg of estimated 
total protein contained in denaturalized protein extracts were separated in an 8% to 
16% SDS-polyacrylamide gel. As molecular mass markers we used Invitrogene 
BenchmarkTM pre-stained markers. Electrophoresis was performed in a Mini-
PROTEAN® II Cell (Bio-Rad) at constant voltage (120-150V), using Running Buffer 
(Tris-HCl 25 mM, glycine 192 mM, SDS 0,1% pH 8,3). 
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Immunodetection in nitrocellulose membranes 
The polyacrilamide gel was transferred for two hours at 100 V in a Mini Transblot® 
Cell (Bio-Rad) to a nitrocellulose membrane (Hybond ECL, Amershan) using transfer 
buffer [10mM CAPS (3-cyclohexylamino-1-propane sulfonic acid), 10% methanol pH 
11]. Then the membrane was blocked in 50mL PBS (NaCl 137 mM, KCl 2.7 mM, 
Na2HPO4 8 mM, KH2PO4 1,5 mM, pH 7,2) containing 5% dried milk (Sveltesse, 
Nestle) and 0.1% Tween-20, for 1 hour at room temperature. The membrane was 
incubated (2 hours at room temperature or overnight at 4ºC) with the corresponding 
primary antibody in the same block solution. Then the membrane was washed four 
times for 5 minutes with 50 ml PBS-Tween (0.1% Tween-20), incubated with the 
secondary antibody (anti-mouse 1:2000 or anti-rabbit 1:3500 in block solution) for 1 
hour at room temperature and washed again twice in PBS-Tween for ten minutes and 
once in PBS for at least 10 minutes. In order to detect the antibody signal the 
enhanced chemiluminiscence kit (ECL, Amersham) or the Super Signal kit (Pierce).  
Membranes were re-hybridized with mouse TAT1 anti-tubulin monoclonal antibody 
(1:500) as a loading control, if possible. 
Immunoprecipitation 
For immunoprecipitation of strains tagged with haemagglutinin (HA) a mix of antibody  
[2µg of α-HA (12CA5, Roche) for immunoprecipitation of 1 mg of extract] and 10 μl 
protein A (Protein A Sepharose, Amersham Biosciences) was incubated in 
supplemented lysis buffer (see preparation of extracts for Immunoprecipitation) for 1 
hour at 4ºC.  Then the mix was incubated with 1mg extract in 300µl of supplemented 
lysis buffer for 2 hours at 4ºC and washed 4-6 times with the same buffer.  
5.3 Kinase and phosphatase assays   
GST-Flp1p phosphorylation by Cds1p-Ha 
Exponentially growing cultures of cds1-Ha cells were treated either with 20 mM HU or 
0.033% MMS for 2 hours. Protein extracts were obtaining in native conditions and 
Cds1p-Ha was immunoprecipitated from the different samples following the protocol 
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specified before.  Cds1p activity was assayed using MBP as a substrate as reported in 
(Lindsay et al., 1998).  
Kinase assays were performed over GST purified Flp1p (obtained from a ∆cds1 
strain) and controls. GST purification has been described previously (Shiozaki and 
Russell, 1997). 2.5 µg of the corresponding substrate and protein A-bound kinase 
were incubated with 10 μl of kinase buffer (10 mM Hepes pH 7.5, 75 mM MgCls, 0.5 
mM EDTA, 1 mM DTT) containing 2.5 µCi of γ32P-ATP and ATP 0.2 mM final 
concentration, at 30ºC for 15 minutes. Reaction was stopped by the addition of 20 µl 
of 2X Sample Buffer. 
Assay of phosphatase activity of GST-Flp1p phosphorylated by 
Cds1p-Ha 
Cds1p was inmunoprecipitated after 2 hours of 12mM HU treatment as explained 
above. Phosphorylation assays over GST-Flp1p were performed as mentioned above 
using non hydrolysable ATP (0.2 mM final concentration in buffer) to avoid possible 
auto-dephosphorylation. GST-Flp1p was treated with the immunoprecipitation mix 
without antibody as a control. Samples were washed three times with phosphatase 
buffer pH 6.6 (50 mM Imidazol, 1 mM DTT, and 1 mM EDTA). A dephosphorylation 
assay (30 minutes at 30ºC) of treated and control-treated GST-Flp1p using 250 μM 
DiFMUP as a substrate in 200 μL phosphatase buffer was performed. The activity of 
the immunoprecipitated kinase was assayed as a further control.  Samples were 
analyzed in a TECAN ULTRA EVOLUTION instrument, using 360 nm and 465 nm 
excitation and emission wavelengths respectively. Readings were normalized taking 
intro account the quantity of GST-Flp1p contained in each sample, determined by gel-
electrophoresis and subsequently staining and quantification of the gel. 
5.4 Protein interaction assays 
Analysis of potential protein interactions was performed by GST purification or 
immunoprecipitation of one target protein and Western blot of the resulting sample for 
the detection of the other antibody-tagged target as above mentioned. 
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5.5 Mass spectrometry (identification of phosphorylation sites 
on Flp1p) 
Characterization of phosphorylation sites on Flp1p by checkpoint activated 
Cds1p was performed essentially as described previously (Esteban et al., 2006), by 
real time ionization and precursor ion scanning analysis on a 4000 Q-Trap LC-MS/MS 
hybrid system (Applied biosystems,  MDS, Sciex) mass spectrometer.  
5.6 Antibodies  
The antibodies used in this study and their conditions of use are listed in Table 
M4. 
ANTIBODY M/P ORGANISM USE SOURCE 
α-HA 12CA5 Monoclonal Mouse 1:500 Roche 
α−ΤΑΤ1 Monoclonal Mouse 1:300 Dr. Gull 
α-Cdc2 C2 Polyclonal Rabbit 1:250 Dr. Moreno 
α-Cdc25 Polyclonal Rabbit 1:250 Dr. Moreno 
α-Cdc2Y15P Polyclonal Rabbit 1:1000 Cell Signaling 
α-GFP Monoclonal Mouse 1:5000 BD Biosciences 
α-IgG Rabbit-HRP Polyclonal Sheep 1:3500 Amersham 
α-IgG Mouse-HRP Polyclonal Sheep 1:2000 Amersham 
Table M4. Antibodies used 
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6. SENSITIVITY, RECOVERY AND ADAPTATION ASSAYS 
6.1 Sensitivity assays to chronic drug exposure  
The strains object of study were cultured in fresh YES or adequately 
supplemented MM plates at 25ºC. We took different colonies of each strain and 
resuspended them in 500 µl of MiliQ water in order to determine cell number in each 
dilution, cells were counted in a Thoma Chamber. A dilution containing 107 cells/ml 
was prepared for each strain, and then three serial dilutions were performed (107-104). 
A drop of 10 µl of each strain and dilution was inoculated on control YES or 
adequately supplemented MM plates as a control and plates containing different 
concentrations of the drugs considered in the experiments. The experiment was 
normally performed in duplicates in order to test the growth and sensitivity at 25ºC and 
30ºC.   
6.2 Recovery assays 
Strains were cultured in liquid rich medium to exponential growth. Then each 
culture was divided into four sub-cultures of 10ml each that were treated either with 
12mM HU, 0.033% MMS or 7.5mU BL for four hours (and an untreated culture to 
monitor the growth of the culture during the treatment time). At the 1h, 2h, 3h and 4h 
time points of the treatment a 10 µl drop of each culture was inoculated on a fresh 
drug-free YES plate.   
6.3 Study of checkpoint response and adaptation to long term 
drug exposure 
Kinetics of checkpoint block and adaptation of the checkpoint to long term 
12mM HU exposure of different strains were determined. Strains were grown in rich 
liquid medium to exponential growth and then treated with HU for 10 hours. The 
number of cells presenting septa (for septation index analysis) or binucleated cells (for 
mitotic index) was checked at each hour of treatment. The experiment was performed 
twice and at least 400 cells were counted at each time point and strain (see 7.1). 
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7. CELL MANIPULATION AND ANALYSIS TECHNIQUES 
7.1 Microscopy and cell staining 
Cell and protein imaging was performed in a Leica DM 600B microscope (63x 
objective, 1,32 Oil Plan-APO) equipped with a Hamamatsu ORCA-ER c4742-95 digital 
camera and Improvision software Openlab 4.0.3. 
In vivo nuclear staining was performed with Hoechst (Bisbenzimide H 33342, Sigma). 
Cells were collected by centrifugation at 3000 rpm and incubated in Hoechst for 15 
minutes minimizing exposure to light. 
For in vivo imaging of Rad22p-YFP foci strains were grown in YES at 30ºC or 25ºC to 
minimize background fluorescence. At least 400 nuclei from two separate experiments 
were examined for each strain and each time point. 
In order to quantify the mitotic index, cells were fixed in 70% EtOH, then washed and 
resuspended in PBS 1X previously mixed with DAPI to a 1X concentration of the 
staining agent. At least 400 cells were classified into uni- or binucleated in each count. 
Septation index was determined by counting the number of septated cells using dark 
field microscopy in a population of at least 400 cells for each time point in, at least two 
independent experiments. 
7.2 Flow Cytometry Analysis (FACS) 
DNA content in individual cells was determined by flow cytometry using a FACScalibur 
Benton Dickinson instrument. Cell culture (300 µl) was fixed in ethanol to a 70% final 
concentration. Aliquots of normally 200 µl of fixed cells were washed in Sodium Citrate 
50 mM and resuspended in 500 µl of Sodium Citrate 50 mM containing 0.1 mg/ml 
RNase. Samples were incubated for at least 2 hours (usually overnight) at 37ºC. For 
staining samples were transferred to a 5 ml FACS tube and 500 µl of Sodium Citrate 
50 mM  containing 8 µg/ml Propidium Iodine (4 µg/ml final concentration PI) were 
added (exposure to light should be minimized from this point). Samples were 
sonicated using a Sonic Dismembrator 550 instrument (Fisher Scientific). Cell Quest 
3.2.1f1 software was used for data acquisition and analysis. 
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8. CHEMICAL AGENTS USED IN THIS STUDY AS DNA-
DAMAGE AND REPLICATION-STRESS TRIGGERS 
Hydroxyurea (HU) 
HU is a ribonucleotide reductase inhibitor, which arrests replisome progression by 
depleting the cellular pool of dNTPS, causing stalling of replication forks. 
Methyl methanesulfonate (MMS) 
MMS is an SN2-type alkylating agent that predominantly methylates nitrogen atoms in 
purines, but will also methylate proteins. The consequences of the produced DNA 
methylation are, either degradation of the modified base, giving rise to an abasic site, 
or base mispairing. MMS has been proven to cause fork-associated DNA-damage. 
Bleomycin (BL) 
BL is a glycosylated linear nonribosomal peptide antibiotic produced by the bacterium 
Streptomyces verticillus that acts by induction of DNA strand breaks.  
9. MATHEMATICAL MODELLING 
9.1 Mathematical description of the system 
The model is mathematically described by the set of differential equations 
gathered in APPENDIX 2. The temporal evolution of each species is written in the 
form: 
∑
=
=
r
j
jij
i vn
dt
dc
1
 
for mi ,..,1= , where m is the number of biochemical species with the concentrations 
ic , r is the number of biochemical reactions with the rates jv , and ijn  denote the 
stoichiometric coefficients of the compounds in the corresponding reactions. 
MATERIALS AND METHODS 
82 
Individual rates jv  have been written responding to three types of kinetics: 
Mass Action Kinetics  
∏⋅=
x
xjj ckv  
where jk  is the rate constant, while the index x runs over all substrates and 
modifiers of reaction j. 
 
Michaelis Menten Kinetics 
SM
MS
jj cK
cc
kv +
⋅⋅=  
where jk  is the rate constant, KM is the value of the stimulus at which the 
response is half-maximal, s accounts for the substrate and M  for the modifier.  
Saturation Kinetics 
⎟⎟⎠
⎞
⎜⎜⎝
⎛ −⋅=
max
1
C
S
jj K
c
kv  
where jk  is the rate constant, s accounts for the substrate, and KC max is the 
maximum allowed concentration. 
The set of reactions and the involved species and parameters is summarized in Table 
1 in RESULTS. 
9.2 Simulation tools 
Model building and simulations were performed using COPASI 4.2-4.3 (Hoops 
et al., 2006) and Cell Designer 3.5 (Funahashi et al., 2003).  
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9.3 Parameter fit 
Parameter estimation was performed using SBML-PET 1.4 (Zi and Klipp, 
2006). For the cell cycle fits we used published data generated in our group 
(concentrations of total Cdc25p, of active Cdc25p, of total Cdc13p, and Cdc2p activity) 
(Esteban et al., 2004), and checkpoint fits correspond to data generated in this study 
(concentration of total Cdc25p, of inactive Cdc2p and active Cds1p). Blots were 
quantified using Quantity One® Bio-Rad software and adjusted to the corresponding 
loading controls. Fits were performed using normalized data. In the fits of the cell cycle 
module we used two repetitions of the experimental time courses to favour parameter 
sets that could account for biological oscillations. We took G2 as a starting point for 
cell cycle simulations, thus based on analysis and comparison of the available data, 
data points corresponding to nda3 synchronization were shifted forward 15 minutes 
with respect to cdc25-22 blocks. 
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1. ANALYSIS OF Flp1p LOCALIZATION DURING GENOTOXIC 
STRESS 
In the course of a normal cell cycle Flp1p changes its subcellular location to 
carry out its different functions. Flp1p localizes to the nucleolus and spindle pole body 
in interphase. In prophase it is released from the nucleolus by an unknown 
mechanism to the nucleus, medial ring and mitotic spindle (Cueille et al., 2001; 
Trautmann et al., 2001). 
During vegetative cell cycle Flp1p plays a role in regulation of mitotic exit by triggering 
rapid degradation of Cdc25p and thus indirectly promoting a reduction of Cdc2p 
activity, necessary for mitotic exit. Cdc2p activity must be also kept low in part by 
Cdc25p action to exert the required cell cycle block during checkpoint response to 
genotoxic stress. 
The similarity of the regulatory targets of the mitotic exit cascade and the checkpoint 
response to genotoxic stress lead us to investigate the potential role of the 
phosphatase Flp1p in the cellular response to replication stress and/or DNA damage. 
1.1 Flp1p-GFP changes its subcellular localization in cells 
undergoing replication stress or suffering DNA-damage 
As a first approach it was assumed that if the phosphatase was involved in the 
mentioned checkpoints it would probably leave its nucleolar location during 
checkpoint-mediated cell cycle blocks in order to interact with its potential targets. 
Therefore a study of the localization of the protein in asynchronous populations of a 
flp1-GFP strain was performed under the effect of three different drugs: the 
ribonucleotide reductase inhibitory drug hydroxyurea (HU), the DNA-alkylating agent 
methyl methanesulfonate (MMS) and DNA-breaks inducing drug bleomycin (BL).  
After two hours of 12mM HU treatment most population was unseptated, uninucleated 
and partially elongated as a result of the checkpoint induced block in early S-phase. If 
compared to the nucleolar staining of untreated interphase cells, Flp1p-GFP signal in 
HU treated cells covered a larger, round area, which we considered to be the nucleus. 
In 0.033% MMS and 7.5 mU BL treated cells Flp1p-GFP localization also seemed to 
be nuclear but still presenting predominant nucleolar staining (Figure 1). 
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To check that the observed localization was indeed nuclear and that the expansion of 
the signal was not due to drug-induced nucleolar reorganization, we studied the 
localization of the nucleolar marker Gar2p-RFP in HU treated cells in combination with 
Hoechst, a stain that binds to DNA and thus marks the no-nucleolar region of the 
nucleus. We observed that Gar2p-RFP remained nucleolar after HU treatment, and 
thus Gar2p-RFP and Hoechst proved to be valid markers for Flp1p-GFP localization 
(Figure 2A). In HU treated cells, Flp1p-GFP signal indeed co-localized with Hoechst, 
and was also present in the Gar2p-RFP stained region (Figures 2B and 2C). Gar2p-
RFP staining in treated cells allowed us to state that no observable remodelling of the 
nucleolus took place under exposure to 12mM HU (Figures 2A and 2C) , and that the 
change of localization we observed for Flp1p was not general for nucleolar proteins.  
We could thus conclude that Flp1p was specifically released from the nucleolus to 
occupy the whole nucleus upon HU-induced replication stress.   
To confirm that Flp1p remained nucleolar during unperturbed DNA synthesis we 
monitored the localization of the phosphatase after release from a cdc10-129 G1 block 
throughout S-phase (Figure 3A). cdc10-129 flp1-GFP presented normal Flp1p-GFP 
localization in asynchronous cells. After 4 hours of incubation at the restrictive 
temperature, cells were blocked in G1 with 1C content (Figure 3B). Flp1p-GFP 
presented localization in the nucleolus and SPB at this stage as previously reported 
 
Figure 1. Flp1p-GFP changes its subcellular localization as a consequence of treatment 
with genotoxic agents 
Asynchronous cultures of exponential growing flp1GFP cells were treated with either 
12mM HU, 0.033% MMS or 7.5mU BL. In vivo Flp1p-GFP staining after two hours of 
treatment revealed a change of localization of the phosphatase from its nucleolar and 
SPB localization in untreated interphase cells to the nucleus in treated cells. Staining in 
HU is almost uniform throughout the nucleus, whereas in MMS and BL predominant 
nucleolar staining is still observed. 
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(Trautmann et al., 2001). This localization remained unaltered during release at the 
permissive temperature, until S-phase was completed after 150 minutes, and mitotic 
staining appeared in most population (Figures 3B and 3C). 
Figure 2. Flp1p-GFP localization during HU treatment 
(A) Characterization of Gar2p as a nucleolar marker during replication stress. Gar2p 
localization remains unaltered as a result of treatment with 12mM HU. Gar2p and 
Hoechst staining cover complementary regions of the nucleus. 3.5x magnified nuclei 
are shown. Bar 4 μm. (B) In vivo Flp1p-GFP staining at two hours of 12mM HU 
treatment co-localized both with Hoechst and Gar2p, indicative of pan-nuclear 
localization of the phosphatase under these conditions. (C) 3.5x nuclei magnification of 
untreated interphase (upper panels) and 12mM HU treated cells (lower panels). Note 
that no physical nucleolar reorganization can be observed as a result of HU treatment. 
Bar 4 μm. 
RESULTS 
90 
 
 
Figure 3. Flp1p-GFP localizes to the nucleolus throughout S-phase 
(A) Flp1p-GFP localization during release from a G1 block in a cdc10-129 flp1GFP 
strain. Note that Flp1p-GFP localization is wt in asynchronous interphase cdc10-129 
flp1GFP cells. The culture was incubated for 4h at the restrictive temperature (36.5ºC) 
and then released at the permissive temperature (25ºC). Flp1p-GFP staining was 
monitored during progression through S-phase. (B) FACS analysis showing a G1 block 
of cdc10-129 flp1GFP and S-phase progression kinetics after release at 25ºC. S-phase 
is very slow under these block and release conditions (Segurado et al., 2002) and is 
completed after 150 minutes of incubation at the permissive temperature. (C) Mitotic 
index of a cdc10-129 flp1GFP strain after release from the G1 block. Count of mitotic 
cells corresponds to cells in which Flp1p-GFP is located at the nucleus, mitotic spindle 
and medial ring.   
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Since Flp1p remained at the nucleolus during S-phase in cycling cells, the change of 
subcellular localization observed in HU seems to be specifically triggered by the action 
of the drug and not to be a result of the cell cycle stage at which cells blocked.  
To check if Flp1p-GFP change of localization could be specifically triggered by 
replication stress and/or DNA damage inflicted in S-phase, a localization experiment 
was performed in cdc10-129 flp1-GFP synchronised cultures. After 4h of block at 
36ºC, the cultures were released at 25ºC and simultaneously treated with either 12mM 
HU or 0.033% MMS (Figure 4). After two hours of treatment cells were checkpoint 
blocked. At this time point Flp1p change of localization to the nucleus was indeed 
observed in both HU and MMS treated cultures. In MMS the staining was still 
predominantly nucleolar as previously described for treatment in asynchronous 
cultures.   
Figure 4. Change of localization of Flp1p can be specifically triggered by replication stress 
or DNA damage inflicted in S-phase 
cdc10-129 flp1GFP cells were synchronized by incubation at the restrictive temperature 
and then released to permissive conditions in medium containing either 12mM HU or 
0.033% MMS. Localization to the nucleus was observed after two hours, to the same 
extent as in asynchronously growing populations after treatment. 
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1.2 Flp1p change of localization depends on the checkpoint 
machinery 
We next wanted to prove that Flp1p change localization was dependent on the 
checkpoint and not just an effect of the drugs themselves.  
Δrad3 mutants are unable to block cell division since they lack the main sensor to 
 
Figure 5.  Nuclear accumulation of Flp1p depends on checkpoint response  
(A) Flp1p-GFP does not delocalize in checkpoint deficient ∆rad3 cells after 12mM HU 
treatment. 3.5x magnified nuclei are shown in the bottom panels. (B) HU treated ∆rad3 
cells present cut phenotype as a result of their checkpoint deficiency after 3.5 hours of 
treatment. Flp1pGFP staining corresponding to the different cell cycle stages as well as 
partially defective localization of the phosphatase can be observed in these cells. Bars, 
4 μm. 
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genotoxic stress (Boddy et al., 1998; Brondello et al., 1999). In untreated cells, Flp1p-
GFP localization in this strain was indistinguishable from that of wild-type cells (Figure 
5A).  After 2 hours of 12mM treatment Δrad3 cells continued their progression through 
cell cycle and Flp1p-GFP localization was identical to that of untreated cells, proving 
that Flp1p localization to the nucleolus after drug treatment depends on an active 
checkpoint. As a consequence of lack of checkpoint block anucleated cells and 
fragmented nuclei, characteristic of the cut phenotype of strains which perform 
unscheduled mitosis, could be observed in Δrad3 flp1-GFP after 3.5 hours of HU 
treatment, presenting also altered Flp1p-GFP staining in some cells (Figure 5B). 
If the change of localization of Flp1p was dependent on the checkpoint, it would be 
further expected that the phosphatase re-localized to its interphase and cell cycle 
positions once the source of genotoxic stress was removed. To test this, a block and 
release experiment was performed (Figure 6). After three hours of 12mM HU 
treatment cells were perfectly blocked and Flp1p-GFP was nuclear, as described 
earlier. Then the culture was washed and the cells were allowed to grow in drug-free 
rich medium. After 5 minutes Flp1p-GFP started to localize back to the nucleolus as 
expected for cells re-entering cell cycle. At 20 minutes of release cells entering mitosis 
and the corresponding nuclear, medial ring and spindle localizations of Flp1p could be 
observed.  
 
Figure 6. Flp1p returns to the nucleolus as soon as the source of replication stress is 
removed 
flp1-GFP cells were treated with 12mM HU for three hours. Then, the culture was 
washed three times with drug-free medium in order to release the cells from the 
checkpoint block. After 5 minutes of release, Flp1p-GFP was observed to localize back 
in the nucleolus and spindle pole body and further monitoring revealed that the protein 
localizes normally as cells re-enter cell cycle. 
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1.3 Flp1p change of localization in cds1 and chk1 checkpoint 
mutants  
Given the dependency of Flp1p change of localization on an active 
checkpoint, we next wanted to check if this event could be more concretely associated 
to one of the two branches of the checkpoint response. With this aim, we studied 
Flp1p-GFP localization in strains deleted for either cds1 or chk1 during genotoxic 
treatment, being Cds1p and Chk1p the main effectors of checkpoint signalling in 
response to replication stress and DNA-damage, respectively.  
In untreated cells, Flp1p-GFP localization in these strains was indistinguishable from 
that of wild-type cells (Figures 7 and 8A). In cells treated either with 0.033% MMS or 
7.5mU BL Flp1p is released to a lower or higher extent in both mutant strains.  
However, when treated with 12mM HU for 2h the cds1 mutant presented nucleolar 
 
Figure 7. Flp1p-GFP localization in Δcds1 and Δchk1 mutants during genotoxic stress 
Asynchronous cultures of exponential growing flp1GFP, Δcds1 flp1GFP and Δchk1 
flp1GFP cells were treated with either HU 12mM, 0.033% MMS or 7.5 mU BL. Flp1p 
localization was observed after 2 hours of treatment. 
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and SPB staining resembling that of untreated cells, and clearly differing from Δchk1 
flp1-GFP, which still presented nuclear staining as flp1-GFP cells (Figures 7 and 8B). 
This result indicates that Flp1p localization during replication stress depends directly 
or indirectly on Cds1p.  
To further prove the dependency of Flp1p change of localization on Cds1p, we wanted 
to check if replication stress forms that do not activate Cds1p are still able to trigger 
release of Flp1p to the nucleus. For that we used  the DNA ligase temperature 
sensitive mutant cdc17-K12, which at restrictive temperature delays S-phase 
progression leading to cell elongation but it does not present significant activation of 
Cds1p (Barker et al., 1987; Lindsay et al., 1998). Consistently with the observation 
that Cds1p action is necessary to trigger Flp1p release to the nucleus upon replication 
stress, Flp1p remained at its interphase localization in a cdc17-K12 background during 
incubation at the restrictive temperature (Figure 9).  
Figure 8. Nuclear localization of Flp1p during replication stress depends on checkpoint 
kinase Cds1p  
(A) Flp1p-GFP localizes normally in both ∆cds1 of ∆chk1 untreated cells. (B) Flp1p-
GFP localization in 12mM HU treated cells lacking either ∆cds1 or ∆chk1.  Whereas 
∆chk1 cells localize Flp1p-GFP to the nucleus in response to replication stress like 
wild-type cells, the phosphatase remains nucleolar in cells deleted for cds1. 3x 
magnified nuclei are shown. Bar 4 μm. 
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2. ANALYSIS OF THE STABILITY OF Flp1p DURING 
GENOTOXIC STRESS 
2.1 Stability of Flp1p during HU, MMS and BL treatment  
Levels of Flp1p remain constant during a normal cell cycle (Cueille et al., 
2001; Esteban et al., 2004). At sight of the protein’s change of localization and given 
the different degree to which Flp1p seems to be released to the nucleus depending on 
the type of alteration inflicted, we studied if DNA-damage or replication stress altered 
Flp1p stability/levels. A Western blot assay was performed to analyse the levels of Ha-
tagged Flp1p in asynchronous cultures during 4 hours of 12mM HU, 0.033% MMS or 
7.5mU BL treatment. flp1-Ha has been previously shown to present a wt like 
behaviour (Cueille et al., 2001; Esteban et al., 2004).  
Flp1p-Ha levels remained constant throughout a four hour HU treatment, whereas 
Flp1p-Ha levels decreased significantly during MMS treatment, and more moderately 
in BL (Figure 10).  
Figure 9. Flp1p-GFP localizes to the nucleolus in a cdc17-K12 mutant at restrictive 
temperature 
Flp1p-GFP localization in temperature sensitive cdc17-K12 DNA ligase mutants at 
permissive temperature and during incubation at restrictive temperature. Incubation at 
restrictive temperature delays S-phase progression leading to cell elongation but not to 
significant activation of Cds1p (Barker et al., 1987; Lindsay et al., 1998). Bar 4 μm. 
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2.2 Flp1p-Ha levels during MMS treatment are stabilized in 
∆cds1 
Given the relationship between Flp1p and the signalling pathway of Cds1p, we 
were next interested in finding out if Cds1p could regulate the degradation of the 
phosphatase. Since according to the last point Flp1p seemed to be more dramatically 
degraded in response to MMS treatment than in BL, we compared the levels of the 
protein during a 4 hour 0.033% MMS treatment in flp1-Ha, ∆cds1 flp1-Ha and ∆chk1 
flp1-Ha. Whereas in ∆chk1 flp1-Ha the phosphatase was degraded as in control cells, 
Flp1p-Ha levels were stabilized in a ∆cds1 flp1-Ha strain (Figure 11A).  
This result points again to functional interaction between Flp1p and the Cds1p 
signalling cascade in response to genotoxic stress. 
2.3 MMS-induced Flp1p-Ha degradation depends on the 
proteasome 
In order to understand the mechanism underlying the degradation of Flp1p triggered 
by treatment with DNA-damaging agents, Flp1p levels were studied in three 
 
Figure 10. Treatment with MMS or BL induces Flp1p-Ha degradation  
Asynchronous cultures of Flp1p-Ha tagged strains were treated either with HU 12mM, 
0,033% MMS or 7.5mU BL. Flp1pHa levels remained stable in the course of a 4 hour 
HU treatment whereas the protein was degraded in cultures exposed to MMS and BL.  
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proteasome mutant strains mts1-1/rpn9-1, mts2-1/rpt2-1 and mts3-1/rpn12-1 during 
MMS treatment. mts mutants (Metylbenzylcabamylate-resistant temperature sensitive) 
are conditional lethal mutants of different subunits of the regulatory complex (19S) of 
the 26S protease (Gordon et al., 1993; Gordon et al., 1996; Seeger et al., 1996; 
Wilkinson et al., 1998). These mutants undergo a conformational change at the 
restrictive temperature, which renders them defective in selectively degrading proteins 
targeted for destruction by the ubiquitin pathway.  
mts1-1/rpn9-1, mts2-1/rpt2-1 and mts3-1/rpn12-1 mutants and a wild-type control 
were grown at the permissive temperature and shifted to 36ºC when MMS was added. 
 
Figure 11. Degradation of Flp1p in MMS depends on Cds1p and the proteasome 
(A) Flp1p-Ha levels in strains deleted for cds1 or chk1 during 0,033% MMS treatment. 
Flp1p-Ha is degraded in a ∆chk1 strain whereas no such protein levels variation is 
produced in ∆cds1. (B) Western blot showing stabilization of Flp1pHa levels during 
MMS treatment in proteasome mutant strains. Three proteasome temperature sensitive 
mutant strains (mts1-1/rpn9-1, mts2-1/rpt2-1 and mts3-1/rpn12-1) and control cells 
were grown at permissive temperature until exponential growth and then shifted to 
restrictive temperature and treated with 0,033% MMS. 
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Flp1p-Ha levels were strongly stabilized in the three proteasome mutants indicating 
that Flp1p-Ha may be a substrate of the ubiquitin pathway (Figure 11B). Differences in 
the degree of stabilization in these mutants seemed logical attending to the different 
nature of the proteins which compose the 26S regulatory complex, responsible for 
substrate specificity.  
3. ANALYSIS OF THE RELATIONSHIP OF Flp1p AND Cds1p IN 
CHECKPOINT RESPONSE 
3.1 Flp1p and Cds1p interact physically in vivo 
Having related Flp1p-GFP localization to Cds1p during checkpoint response, 
one attractive possibility was that Flp1p interacted with Cds1p in vivo. Therefore we 
performed a pull-down assay to check for GST-Flp1p/Cds1p-Ha physical interaction. 
We also included in the assay the catalytic inactive form of Flp1p, since our group has 
shown earlier that GST-Flp1pCS is more effective in interacting with Cdc25p in vivo 
than GST-Flp1p (Esteban et al., 2004; Vazquez-Novelle et al., 2005). 
GST-Flp1p and GST-Flp1CS were induced and affinity-purified (see Methods) both 
from untreated and checkpoint activated cells either in 12mM HU or 0.033% MMS. 
Blots were incubated with α-Ha antibody in order to detect Cds1p-Ha.  
Although no interaction was found in untreated cells, our assay showed interaction 
between Cds1p and Flp1p both in cells treated with 20mM HU or 0.033% MMS. As 
expected, this result was more evident in a strain expressing the catalytic inactive form 
of Flp1p, were physical interaction between the studied proteins can also be seen in 
untreated cells (Figure 12A). These results indicate that Cds1p is able to form a 
complex with both the catalytically inactive Flp1pCS mutant and with the wild type 
protein in vivo, suggestive of a substrate/enzyme interaction. The low degree of 
interaction found may be explained by the transient nature of phosphatase 
interactions.  
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Figure 12. Cds1p and Flp1p interact physically. 
 Δflp1 presents reduced Cds1p protein levels and kinase activity in response to 
genotoxic stress  
(A) Flp1p and Cds1p can interact physically in vivo. Pull-down assay showing physical 
interaction between Cds1p and Flp1p or catalytic inactive Flp1p (Flp1pCS). GST-Flp1p 
and GST-Flp1pCS were purified both from untreated and checkpoint activated cells, 
blots were incubated with α-Ha antibody in order to detect Cds1pHa. Higher interaction 
is detected in catalytic inactive Flp1p samples. (B) Western blot analysis of Cds1pHa 
and Chk1pHa protein levels in wild-type and Δflp1 cells treated with 20mM HU. 
Samples were quantified and normalized to loading controls. Quantification is shown in 
bar diagrams. Whereas ∆flp1 cells accumulate less Cds1p in checkpoint response to 
HU, Chk1p levels are similar in both strains. (C) Cells deleted for flp1 present 
decreased in vivo Cds1p activity in checkpoint response. Kinase assay of Cds1p using 
MBP as substrate. Active Cds1pHa was immunoprecipitated from wild-type and Δflp1 
strains, both from HU and MMS treated cells. Activity was quantified taking into account 
the amount of Cds1pHa immunoprecipitated in each sample and represented in a bar 
diagram. Cds1p-associated kinase activity in wild-type cells, both for HU and MMS 
treated cells, was arbitrarily normalized to 100%. Error bars are shown for three 
independent experiments.
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3.2 Protein levels and activity of Cds1p are altered in ∆flp1  
Flp1p, as a phosphatase, could be involved in down-regulation of the 
checkpoint response by removing activating phosphate residues from certain effectors 
of the signalling cascade to genotoxic stress. Cds1p appeared as an appealing 
potential target of Flp1p activity, given our previous evidences relating the Flp1p to the 
kinase.  
As a first approach, levels of Cds1p during checkpoint response to replication stress 
were analysed by western blot. Cds1p protein levels significantly increased in the first 
two hours of HU treatment in wt cells, to decrease again in the last stages of the 4 
hour treatment. In ∆flp1 cells, although basal Cds1p levels are similar to those of the 
wt, the quantity of the kinase rises only moderately after three hours of drug treatment, 
to decrease normally at the four hours time point (Figure 12B).  Levels of the other 
main effector or the checkpoint response in S. pombe, Chk1p, were examined in 
response to HU. Almost constant protein levels were detected for both wt and ∆flp1 
cells throughout the treatment.   
We next studied if the activity of Cds1p in checkpoint response was altered in a ∆flp1 
strain. With this purpose Cds1p-Ha was immunoprecipitated from untreated and 
12mM HU treated cells every 30 minutes during a 4 hours exposure to the drug. 
Cds1p-Ha activity was assayed using myelin basic protein (MBP) as a substrate. The 
obtained activity was then normalized taking into account the quantity of Cds1p-Ha 
immunoprecipitated in every sample. Interestingly the activity of the kinase in the ∆flp1 
background resulted to be lower than in wt cells during the whole treatment (Figure 
12C). The most significant difference in activation between wt and ∆flp1 was observed 
at 90 minutes of treatment, time of maximum activation, when Cds1p in cells depleted 
of Flp1p only reaches about 70% of the activity achieved in a wt. Interestingly, we also 
proved that the kinase was activated during treatment with MMS, being the difference 
in activation between wt and ∆flp1at 90 minutes even greater under these conditions. 
Surprisingly, taken together these data indicate that rather than enhancing Cds1pHa 
activity, absence of Flp1p results in reduced activity and levels of Cds1p, suggesting 
that Flp1p may act as an activator of Cds1p either directly or by its action over some 
inhibitor or activator of Cds1p activity.  
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Figure 13. Cds1p phosphorylates Flp1p in vitro resulting in an enhancement of its 
phosphatase activity 
(A) Checkpoint activated Cds1p phosphorylates Flp1p in vitro. Kinase assay of Cds1p 
using Flp1p as substrate. Cds1pHa was immunoprecipitated from untreated cells and 
checkpoint activated cells respectively and assayed using purified GST-Flp1p and GST 
(control) as substrates. Activity of checkpoint activated Cds1pHa and of an untagged 
strain as a control were assayed using MBP as substrate (lower panel). Flp1p is 
phosphorylated by the checkpoint activated kinase. Phosphorylated Flp1p is marked by 
an arrow. The band marked by a star corresponds to a protein which co-
immunoprecipitates with active Cds1p. (B) Cds1-mediated Flp1p phosphorylation 
enhances the phosphatase activity of Flp1p in vitro. Quantification of phosphatase assay 
using DiFMUP as a substrate. Unphosphorylated and Cds1p phosphorylated GST-Flp1p 
were assayed in vitro for their ability to dephosphorylate the fluorescent substrate 
DiFMUP. Active immunoprecipitated Cds1p was used as a control. (C) Plot of the activity 
of Flp1p using DiFMUP as a substrate during 4 hour exposure to replication stress. 
Exponentially growing Flp1p-Ha cells were treated with 20 mM HU and samples were 
taken at the indicated time points (minutes). A phosphatase assay using Flp1p-Ha 
immunoprecipitated from each sample and DiFMUP as a substrate was performed, by 
incubation in phosphatase buffer at 30ºC for 30 minutes. Fluorescence was quantified in 
each sample as an output.   
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3.3 Cds1p phosphorylates Flp1p in vitro 
We showed before that Flp1p-GFP change of localization during replication 
stress depended on Cds1p presence. This seemed indicative of an action of the 
kinase over the phosphatase in checkpoint response. We therefore studied if Flp1p 
could be phosphorylated by active Cds1p.  
Activated Cds1pHa was immunoprecipitated after 2 hours of treatment with 20mM HU 
and 0.033% MMS. Activity of the immunoprecipitated kinase was tested using MBP as 
a substrate. Immunoprecipitates from untreated cells were used as controls. Cds1p 
was then assayed over GST-purified GST-Flp1p and over GST as a control, resulting 
in specific phosphorylation of Flp1p both by HU- and MMS-activated Cds1p (Figure 
13A). A lower band of unspecific phosphorylation was found, which was proven to 
account for a protein present in the immunoprecipitates from the kinase.  
3.4 Phosphorylation of Flp1p by Cds1p enhances its 
phosphatase activity   
Our in vitro observations suggest that Flp1p may be an in vivo substrate for 
the Cds1p-S-phase checkpoint kinase in response to replication arrest or to replication 
fork-associated DNA damage. We next tested if the phosphorylation of Flp1p by 
Cds1p was able to alter its phosphatase activity in vitro. With this purpose, GST-Flp1p 
was purified to homogeneity from S. pombe ∆cds1 cells expressing the GST-fusion 
protein. GST-Flp1p was phosphorylated by activated Cds1p using non-hydrolysable 
ATP in order to prevent possible auto-dephosphorylation events during the 
subsequent phosphatase assay. In vitro Cds1p-phosphorylated and unphosphorylated 
GST-Flp1p activities were assayed using DiFMUP as a substrate. Phosphorylated 
GST-Flp1p resulted to be more active, proving an enhancement of Flp1p phosphatase 
activity by the in vitro Cds1p-mediated phosphorylation (Figure 13B). 
Interestingly, we were also able to detect alterations of Flp1p phosphatase activity 
during replication stress in vivo assaying over DiFMUP the activity of 
immunoprecipitated Flp1p-Ha at different times of HU treatment. The activity of Flp1p 
decreased immediately after addition of the drug to the culture and increased abruptly 
after two hours of treatment (Figure 13C). Stimulation of the phosphatase’s activity 
correlates thus with the observed timing for Cds1p-dependent release of Flp1p to the 
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nucleus, indicating that Flp1p change of localization and enhancement of its 
phosphatase activity may be related.  
3.5 Determination of Cds1p phosphorylation sites on Flp1p by 
mass spectrometry 
Since Cds1p was able to phosphorylate Flp1p in vitro to enhance its 
phosphatase activity, we were interested in finding out the residues in the 
phosphatase in which this reaction occurred. Mutation of these residues to construct a 
non phosphorylatable form of Flp1p would then be a useful tool to check the effects of 
the disruption of the possible in vivo modification of the phosphatase by Cds1p as a 
result of genotoxic stress.  
 
Figure 14. Construction of a Flp1p mutant protein that can not be phosphorylated by Cds1p 
(A) Schematic representation of Flp1p showing the location of its 9 RXXS sites. (B) 
Kinase assay showing that mutation of Ser468 to Ala did not abolish phosphorylation of 
GST-Flp1p by activated Cds1p. Ser468 located at a RXXS consensus phosphorylation 
site for Chk2p on Cdc25A, had been identified as a residue phosphorylated with high 
score in a mass spectrometric assay on GST-Flp1p phosphorylated in vitro by Cds1p. 
(C) Simultaneous mutation of Ser468 and the 4 RXXS sites located in not analyzed 
regions in the spectrometric assay, practically abolished phosphorylation on Flp1p. In 
the mutant for all 9 RXXS sites phosphorylation could not be detected. 
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No consensus phosphorylation sequence has been described for SpCds1p. However 
analysis of the sequence of Flp1p revealed nine RXXS consensus phosphorylation 
sites for hChk2p in Cdc25A and an I/L/V/M X S/T X I/L/V/M Rad53p consensus 
phosphorylation site, putative candidate residues for Cds1p phosphorylation on the 
phosphatase.  
Identification of phosphorylation sites on Flp1p by checkpoint activated Cds1p was 
performed by mass spectrometry. Samples were obtained by means of a kinase assay 
of immunoprecipitated Cds1pHa over GST-Flp1p as described before, using no-
radioactive ATP. The analysis identified phosphorylation of serine 468 in samples 
incubated with both HU-activated and MMS-activated Cds1p kinase. Interestingly 
Ser468 lies in a RXXS consensus phosphorylation site for Chk2p mammalian kinase 
in Cdc25A (O'Neill et al., 2002). The protein contains a total of 9 RXXS sites (Figure 
14A). 
3.6 Construction of a Flp1p mutant protein non 
phosphorylatable by Cds1p: flp1-9A 
Following the goal of constructing a form of Flp1p which Cds1p was not able 
to phosphorylate, we mutated the identified aminoacid Ser468 to the non 
phosphorylatable residue Alanine. The mutation was performed in the Prep-KZ-flp1+ 
plasmid by PCR as described in MATERIALS AND METHODS, and checked by DNA 
sequencing. The expressed GST-Flp1pS468A mutant protein was then used as a 
substrate for Cds1p phosphorylation. The mutant protein could be still phosphorylated 
by the checkpoint kinase (Figure 14B).  
As mentioned before there are 8 further RXXS sites in Flp1p located at Serines 160, 
396, 408, 467, 493, 499, 513 and 537. 4 of them (Ser396, Ser493, Ser499, Ser537) 
lied in protein fragments that had not been analysed in the mass spectrometric assay 
probably due to its size or difficulty to become ionized.  In order to check if any among 
these residues was responsible for the phosphorylation, we constructed the (S468A 
S396A S493A S499A S513A S537A) 5A mutant. Although the expressed GST-
Flp1p5A mutant could not be phosphorylated to the same extent as the native protein, 
some phosphorylation still took place. We therefore decided to construct the 9A 
mutant, mutating all nine RXXS sites of Flp1p to RXXA. The resulting GST-Flp1p9A 
mutant was not phosphorylated in the Cds1p kinase assay (Figure 14C). 
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Study of Flp1p-9A-EGFP localization during replication stress 
According to our previous observations Cds1p was able to determine Flp1p 
localization during replication stress. Moreover, Cds1p and Flp1p interacted physically 
and checkpoint activated Cds1p was able to in vitro phosphorylate Flp1p. These facts 
lead to the hypothesis that disruption of Flp1p phosphorylation sites by Cds1p could 
lead in vivo to an abolishment of Flp1p movement from the nucleolus to the nucleus 
during replication stress.  
In order to check this hypothesis, we constructed an integrated form of EGFP tagged 
flp1-9A (see MATERIALS AND METHODS), and we characterized the behaviour of 
the resulting flp1-9A-EGFP strain during HU treatment. 
First we checked Flp1p-9A-EGFP localization during unperturbed cell cycle. Flp1p-9A-
EGFP correctly localized to the nucleolus and spindle pole body in interphase cells, to 
the nucleus and spindle during early mitosis and also to the medial ring in the late 
stages of mitosis (Figure 15A).  
However, whereas treatment with 12mM HU triggered nuclear localization in control 
cells, the 9A mutant protein remained in its nucleolar and SPB localizations throughout 
the treatment (Figures 15B and 15C). This result interestingly, points to an in vivo 
phosphorylation of Flp1p by Cds1p, which disruption results in abolishment of Flp1p 
shuttle to the nucleus.   
flp1-9A presents reduced Cds1p activity during replication stress 
We showed earlier that the ∆flp1 strain presented reduced Cds1p activity in response 
to replication stress induced blocks. If Flp1p plays a role in somehow regulating Cds1p 
activity, it would be expected that cells that can not release the phosphatase to the 
nucleus would present a similar phenotypes to that observed in ∆flp1.  By means of a 
kinase assay using immunoprecipitated Cds1p-Ha from flp1-9A cells and MBP as a 
substrate we confirmed that flp1-9A cells presented indeed reduced Cds1p activity 
with respect to wt cells (Figure 15D). 
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Figure 15. Characterization of the flp1-9A mutant: localization of Flp1p and Cds1p activity in 
response to replication stress 
(A) The integrated flp1-9A strain presents unaltered subcellular localization of the protein 
during the different stages of an unperturbed cell cycle. In vivo Flp1p-9A-EGFP staining 
shows interphase and  mitotic cells undergoing normal changes in the subcellular 
localization of Flp1p-9A as described before for wild-type Flp1p (Cueille et al., 2001). Dot 
lines represent the cells contour. Bar, 4 μm. (B) Flp1p-9A-EGFP staining in cells 
undergoing replication stress. Flp1p-9A-EGFP is not released to the nucleus in checkpoint 
response to HU treatment. Bars, 4 μm. 3x magnified nuclei are shown in the bottom right 
corners. Note that flp1-9A-GFP cells elongate indicating that they are responding to the 
checkpoint arrest. (C) 4x Magnified nuclei showing co-localization of Flp1p-9A-EGFP with 
the nucleolar marker Gar2p-RFP in both untreated and 12mM HU treated cells. (D) Kinase 
assay of active Cds1p-Ha over MBP. A control western blot showing the quantity of 
immunoprecipitated Cds1p-Ha in each sample has been included. The kinase resulted to 
be less active in the flp1-9A mutant than in a wt background, resembling the behaviour in 
Δflp1.   
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4. ANALYSIS OF THE INFLUENCE OF Flp1p ON THE 
CHECKPOINT RESPONSE TO GENOTOXIC STRESS  
4.1 Sensitivity to long term drug exposure 
In order to analyse the possible role of Flp1p in checkpoint response, the first step we 
took was the study of the sensitivity associated to the deletion of flp1 alone or 
combined with ∆cds1 or ∆chk1, mutants for the main effectors of checkpoint signalling, 
in response to chronic exposure to replication stress or DNA-damaging agents. 
Deletion of flp1 behaved in a wt fashion in terms of survival on drug containing plates 
and did not add any significant defect to the impeded growth of checkpoint mutants at 
the concentrations used (Figure 16A).  
On the other hand we were able to detect long term sensitivity plating G1 
synchronized Δflp1 cells (Figure 16B). Exponentially growing cultures (25ºC) of cdc10-
129, cdc10-129 Δflp1 and cdc10-129 Δrad3 were incubated for 4.5 hours at the 
restrictive temperature to obtain G1 synchronized cultures and then assayed for their 
survival in HU 5mM and drug-free medium. The same experiment was performed in a 
cdc10-M17 background. cdc10-129 Δflp1 and cdc10-M17 Δflp1 resulted to be more 
sensitive to long term exposure to HU than the respective flp1+ controls, and in their 
turn, less sensitive than Δrad3 cells. It should be noted that synchronized cdc10-
M17 Δflp1 and cdc10-M17 Δrad3 readily show a loss of viability in drug-free medium 
when compared to cdc10-M17 control strain.  
To assess the sensitivity of the flp1-9A mutant to chronic exposure to replication 
stress, a plate assay comparing the behaviour of this strain to that of wt, flp1-GFP, 
∆flp1 and ∆cds1 in HU was performed. Paying attention to flp1 mutants and tagged 
forms, whereas the GFP tag seemed to confer the strain a slight resistence to the drug 
flp1-9A presented a ∆flp1-like behaviour with smaller colonies than the wt (Figure 
16C). 
RESULTS 
109 
 
 
Figure 16. Sensitivity of flp1 mutants to chronic exposure to HU 
(A) 10-fold dilution plate assay of Δflp1, Δcds1 Δflp1 and Δchk1 Δflp1 sensitivity to 
chronic exposure to HU, MMS and BL compared to wt and the simple mutants. Plates 
were incubated for 72 hours at the indicated temperatures. (B) Plate assay showing 
sensitivity of Δflp1 to HU after G1 synchronization using cdc10-129 and cdc10-M17 
alleles. Note that cdc10-M17 Δflp1 and cdc10-M17 Δrad3 show already a defect in 
growth in drug free medium after synchronization. (C) Plate assay showing the sensitivity 
of three different clones of flp1-9A-GFP to HU. It can be observed that the behaviour is 
similar to that of ∆flp1, presenting only a decrease on colony size when compared to 
wild-type cells.  
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Figure 17. flp1 mutants present a defect on checkpoint block upon replication stress 
(A) In vivo fluorescence microscopy images showing the difference in behavior of flp1-
9A and wild-type cells after 2h of 12mM HU treatment. Whereas in flp1-GFP cells, 
nuclear staining of the protein is generally observed, in flp1-9A-GFP the protein can be 
detected not only in the nucleolus but also in the mitotic spindle in some cells, indicating 
that a subpopulation of this strain is undergoing mitosis and not blocking in S-phase as 
expected. (B) Plots of uninucleated and mitotic cells observed upon 0, 2 and 4 hours 
treatments with HU in flp1-9A and wild-type strains. In vivo Flp1p-GFP localization was 
scored in both strains, note that more than 20% of flp1-9A-GFP cells had a mitotic 
pattern of Flp1p-GFP subcellular localization at the 2 hours time point. (C) Quantification 
of checkpoint defects in flp1 mutants. Septation and mitotic index was measured in wild-
type and flp1 mutants by means of dark field microscopy. Whereas this parameter 
significantly decreases in a wild-type strain after 2h of 12mM HU treatment, correlating 
with an adequate checkpoint response, this change is not patent in flp1 mutant cells. 
The FACS monitoring DNA content of the strains during the treatment has been 
included.  
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4.2 Short-term response of flp1 mutants to replication stress 
While flp1-9A did not present any significant alteration in checkpoint response 
in terms of end-term survival, when studying their behaviour in liquid cultures we could 
detect a higher rate of cells undergoing mitosis in this mutant than in wt after two 
hours of 12mM HU treatment (Figure 17A).  
As a first approach to quantify this effect, we determined the percentage of cells 
undergoing mitosis in the presence of HU by counting duplicated SPBs, short spindle, 
long/extended spindles and binucleated cells (Figure 17B), by in vivo following the 
pattern of Flp1p-9A-EGFP and Flp1p-GFP as a control. While wt cultures were 
blocked to a high extent after two hours of treatment (reduction from 23% of cells 
undergoing mitosis in asynchronous cultures to 9% in treated cells), the 9A mutant did 
not reduce its mitotic rate in the first two hours of treatment (21% in untreated cultures, 
24% in treated cultures). Surprisingly, after 4 hours exposure to the drug the mutant 
presented 95% of blocked cells, equalling wt behaviour.  
We next checked if this transient defect in checkpoint block could be seen in Δflp1 to 
uncover the potential parallelism in between flp1-9A and ∆flp1 mutants in dealing with 
HU treatments. Septation index of wild-type, ∆flp1 and flp1-9A strains were measured 
at 0, 2 and 4 hours time points during a 12mM HU treatment in YES-liquid media 
(Figure 17C). FACS analysis and cell elongation indicated that all three strains were 
responding to the HU-induced nucleotide depletion. However, in these experiments 
both flp1 mutants presented higher numbers of septated cells than the wild-type after 
2 hours of drug treatment. Consistently with the previous quantification of mitotic forms 
in the flp1-9A mutant, septation index in both mutants was similar that of wt after 4 
hours of exposure to the drug. 
We were next interested in finding out if aberrant DNA segregation could be detected 
as a consequence of this deficiency in checkpoint block in Δflp1 cells. In order to rule 
out a possible interference of cell cycle kinetics of Δflp1 mutants in our observations, 
we checked checkpoint proficiency of this mutant in synchronized cells. cdc10-129, 
cdc10-129 Δflp1 and cdc10-129 Δrad3 strains were synchronized in G1 by incubation 
at 36.5ºC for four and a half hours and then released at the permissive temperature in 
the presence of 12mM HU, samples were taken at regular intervals and processed for 
nuclear staining, DNA content and cell size analysis (Figure 18). Binucleated (normal 
and cut) cells were monitored at indicated intervals after release (Figure 18A). While in 
synchronized cdc10-129 cells (control) the percentage of binucleated (normal and cut) 
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cells remained low all throughout the experiment, cdc10-129 Δflp1 mutants already 
presented a moderate percentage of cells undergoing mitosis as soon as 60 minutes 
after the release in HU (up to 15%) with a steady increase (in percentages) as cells 
were exposed longer to the replication block (reaching a maximum of 22%). As 
expected, we found that the checkpoint defects observable in cdc10-129 Δrad3 mutant 
cells were more severe than those found in cdc10-129 Δflp1 mutant cells, as the 
percentages of cells undergoing mitosis in the absence of DNA replication ranked 
from 18%, at the block point, to 62%, at the last time point in Δrad3 mutants. 
Examination of cells (Figure 18B) and FACS analysis of DNA content (Figure 18C) 
confirmed that cdc10-129 Δflp1 and cdc10-129 Δrad3 were defective in their response 
to the HU arrest, as cells with less than an haploid content of DNA (1C) were 
detected.  
To rule out a possible allele-specific interference of cdc10-129 in our results, due to 
the extended time this mutant needs to complete S-phase after release, we performed 
the same experiment using another temperature sensitive allele, cdc10-M17 (Figure 
19). To our surprise we found that cdc10-M17 Δflp1 and cdc10-M17 Δrad3 readily 
presented aberrant nuclei as a consequence of incubation at the restrictive 
temperature (Figure 19A), indicating that rad3+ and flp1+ are required to preserve the 
G1 block and prevent unscheduled progression into mitosis in a cdc10-M17 strain. 
During release at the permissive temperature in the presence of 12mM HU, cdc10-
M17 Δflp1 cells presented a significant increase of cells undergoing aberrant mitosis 
90 minutes after the release in HU. This percentage was moderate when compared to 
data obtained with cdc10-M17 Δrad3 cells (Figure 19B). However, even though the 
results were consistent with those in a cdc10-129 background, we are fully aware that 
the observed defect during incubation at the restrictive temperature makes the 
interpretation of the response of these cells to replication stress difficult. In fact, as 
inferred from the severity of the synthetic lethality in cdc10-M17 Δrad3 cells and, to a 
lesser extent, in cdc10-M17 Δflp1 cells, we observed only a moderate increase in the 
percentage of aberrant mitosis (cut cells) after the exposure to HU compared to 
cdc10-129 data.  
Taken together the data obtained form treatment of asynchronous cultures and G1 
pre-synchronized cells reflect a defect in checkpoint response associated to mutation 
of flp1 in cells undergoing replication stress.   
RESULTS 
113 
 
 
Figure 18. Defects on checkpoint block in Δflp1 results in aberrant mitoses 
(A) Quantification of mitotic nuclei during HU treatment after synchronization in G1. 
cdc10-129 (c), cdc10-129 Δflp1 (Δf), cdc10-129 Δrad3 (Δ3) strains were synchronized 
(4.5h at 36.5ºC), and then they were released from the G1 block (25ºC) in the presence 
of 12mM HU. Percentages of binucleated and cut cells were determined by 
visualization and counting of DAPI stained nuclei. At least 200 cells were counted for 
every strain at each time point and the experiment was repeated twice. (B) Strains 
deleted for flp1 and rad3 in a cdc10-129 background accumulate binucleated and cut 
cells (marked by arrows) upon HU treatment after synchronization. Bar, 10 μm. (C) 
DNA content and cell size analyses by FACS during block and release in HU 
(experiment described in A) confirm that cdc10-129 Δflp1 and cdc10-129 Δrad3 are 
defective in their response to checkpoint mediated arrest, as cells with less than an 
haploid content of DNA (1C) are detected. Note that cdc10-129 Δflp1 presents a 
subpopulation of small cells. As shown in B, both small and elongated cells undergo 
aberrant mitoses in the presence of HU. 
RESULTS 
114 
 
 
Figure 19. Analysis of Δflp1 in a cdc10-M17 background 
(A) Deletion of flp1 and rad3 in a cdc10-M17 background results in unscheduled mitoses 
during incubation at the restrictive temperature. DAPI nuclear staining of cdc10-M17 , 
cdc10-M17 Δflp1 and cdc10-M17 Δrad3 strains after 4.5 hours at 36.5ºC showing 
binucleated and cut cells exclusively in flp1 and rad3 mutants (indicated by arrows). Bar, 
10 μm. (B) cdc10-M17, cdc10-M17 Δflp1 and cdc10-M17 Δrad3 strains were incubated 
at the restrictive temperature (36.6ºC) for 4.5 hours and then released to the permissive 
temperature (25ºC) in the presence of 12mM HU. Percentages of binucleated and cut 
cells at the release point and after 90 minutes of treatment were determined. At least 
200 cells were examined for each strain and time point, and the experiment was 
performed three times. The corresponding standard deviations are for the time point 0 
minutes: cdc10-M17 binucleated 0.79 cut 0.29, cdc10-M17 Δflp1 binucleated 1.1 cut 
0.51 and cdc10-M17 Δrad3 binucleated 0.75 cut 1.51. For the time point 90 minutes: 
cdc10-M17 binucleated 0.23 cut 0.86, cdc10-M17 Δflp1 binucleated 0.55 cut 1.82 and 
cdc10-M17 Δrad3 binucleated 1.21 cut 1.79. (C) DNA content and cell size analysis by 
FACS for the experiment described in B, including additional time points. Note that 
FACS analysis data are consistent with the results obtained in a cdc10-129 background. 
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4.3 Cdc25p accumulation and Cdc2p Tyr15 phosphorylation 
during checkpoint response are not significantly altered in 
∆flp1 
Checkpoint response promotes nuclear exclusion of Cdc25p (Lopez-Girona et 
al., 1999; Lopez-Girona et al., 2001b). Since Flp1p controls rapid degradation of 
Cdc25p to promote  adequate down-regulation of Cdc2p/Cd13p-associated kinase 
activity at mitotic exit  in the course of normal cell cycle (Esteban et al., 2004; Wolfe 
and Gould, 2004), we were interested in studying the possible role of Flp1p in 
degrading Cdc25p during a HU-mediated block triggered by DNA replication inhibition 
or MMS-induced replication fork-associated DNA-damage. 
Figure 20. Checkpoint dependent accumulation of Cdc25p and phosphorylation of Cdc2p in 
tyrosine 15 are not significantly altered in ∆flp1 cells.  
(A) Western blot analysis of Cdc25 levels in asynchronous cultures of wt and ∆flp1 
strains during treatment with 12mM HU or 0.033% MMS. (B) Western blot analysis of 
Cdc2p and Tyr15 levels in the same samples. No significant difference in the dynamics 
of Cdc25p accumulation or Cdc2p tyr15 phosphorylation is observed for cells deleted for 
flp1. 
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We analysed Cdc25p protein levels in a wt and a ∆flp1 strain in the course of either 
12mM HU or 0.033% MMS treatment by western blot analysis (Figure 20A). The 
amount of cellular Cdc25p increased as a result of drug treatment both in wt and 
∆flp1. Taking into account that Cdc25p basal levels are higher in ∆flp1 than in wt, the 
kinetics of Cdc25p accumulation seemed to be similar in both strains, allowing us to 
conclude that Flp1p is not involved in Cdc25p degradation during checkpoint response 
to genotoxic stress. 
Given the relationship between Flp1p and Cds1p checkpoint branch, we next wanted 
to check if this interaction could affect the net checkpoint response in terms of cell 
cycle block in response to replication stress or DNA damage. We therefore examined 
Tyr15 phosphorylation levels of Cdc2p in a wt and a ∆flp1 strain in the course of either 
12mM HU or 0.033% MMS treatment by western blot analysis.  
Phosphorylation of Tyr15 increased in both strains a result of a 4 hour drug treatment 
(Figure 20B), indicating that Flp1p is not involved in the control of Cdc2p activity 
during checkpoint response.  
4.4 flp1 mutants present enhanced recombination in response 
to replication stress 
Apart from regulating Cdc2p activity during genotoxic stress, the Cds1p kinase 
pathway of checkpoint response is involved in certain mechanisms of DNA protection 
that Chk1p is not able to perform. As detailed in the introduction, Cds1p plays a 
central role in stabilization of replication forks and coordination of checkpoint recovery, 
retaining the replisome assembled during arrest and regulating the recombination 
machinery. Cds1p prevents unscheduled recombination events at stalled forks by 
stabilizing their components, and through regulation of endonuclease Mus81p, 
helicase Rqh1p and Rad60p. S-phase checkpoint deficient ∆cds1 mutants harbour 
multiple recombination-associated foci when exposed to HU (Meister et al., 2005). 
Concentration of Rad22p, fission yeast Rad52p homologue into a few bright nuclear 
spots, or foci, is an indication of the induction of homologous recombination  (Lisby et 
al., 2001; Du et al., 2003; Meister et al., 2003; Noguchi et al., 2003). Single foci 
appear with relative frequency even in wt cells and are assumed to be sites of post-
replicative DNA repair (Meister et al., 2003; Noguchi et al., 2003). 
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Since no clear implication of Flp1p could be found in regulating checkpoint block by 
influencing Cdc2p Tyr15 phosphorylation, we were interested in testing whether the 
 
Figure 21. flp1 mutants present Rad22p recombination foci when exposed to replication 
stress 
(A) Quantification of nuclei containing single or multiple Rad22p-YFP foci in 
asynchronous exponentially growing flp1 mutant cells (untreated) and after 2h of 12mM 
HU treatment. Control counts in checkpoint proficient wt cells and checkpoint mutant 
∆cds1 are shown. Results are representative of at least two independent experiments. 
Standard deviations are: untreated cells, wt % no foci 1.16, % one focus 1.64, % multi 
foci 0.48, ∆flp1 % no foci 1.05, % one focus 0.80, % multi foci 0.24, flp1-9A % no foci 
3.02, % one focus 3.40, % multi foci 0.37 and ∆cds1 % no foci 3.51, % one focus 1.09, 
% multi foci 2.41; HU treated cells, wt % no foci 1.74, % one focus 1.47, % multi foci 
0.27, ∆flp1 % no foci 6.32, % one focus 5.16, % multi foci 1.15, flp1-9A % no foci 0.75, 
% one focus 1.25, % multi foci 0.5 and ∆cds1 % no foci 0.36, % one focus 1.34, % 
multi foci 0.97. (B) Live imaging of Rad22p-YFP foci (bright spots) in flp1 mutants and 
control strains after 2h of 12mM HU treatment. Bar 4 μm. While recombination foci are 
rarely seen in wt, single and multiple Rad22p-YFP foci are detected in flp1 mutants.  
This effect is however weaker than in checkpoint mutant ∆cds1. 
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putative interaction of the phosphatase with the Cds1p pathway could affect the 
functions of the kinase in inhibiting recombination during checkpoint response.  
With this aim, Rad22p-associated recombination foci were visualized in vivo in either 
untreated or HU-treated wild-type, ∆cds1, ∆flp1 and flp1-9A cells harbouring a single 
rad22-YFP allele (Figure 21). Over 400 nuclei were classified (for each strain in three 
independent experiments) depending on the number of foci they born (no foci, single 
focus, multi foci). The counts for the wt and ∆cds1 correlated with those found in the 
literature (Meister et al., 2005). ∆cds1 presented an enhanced number of 
recombination foci readily in untreated cells, giving account of the importance of 
surveillance mechanisms and their collateral functions even in exogenously unaltered 
cell cycles. Importantly, the percentage of ∆flp1 and flp1-9A mutant cells with multiple 
nuclear Rad22p-YFP spots showed a marked increase when exposed to HU for two 
hours (from 1% to 25% in ∆flp1, from 1% to 15% in flp1-9A), whereas the number of 
foci in wild-type cells remained almost constant (from 1% to 2.5%), probably indicating 
a defect in checkpoint response associated to depletion or mislocalization of Flp1p. It 
should be noted that the number of recombination foci present in flp1 mutants upon 
HU treatment is moderate when compared to that of ∆cds1 (up to 57%), which again 
points to a partial loss of checkpoint activity in the flp1 mutant strains.  
4.5 Analysis of the effect of the moderate over-expression of 
Flp1p 
Over-expression of Flp1p is lethal since it leads to G2 arrest due to 
constitutive dephosphorylation Cdc25p, in a process dependent on active Wee1p 
(Cueille et al., 2001; Esteban et al., 2004).  
However, by substitution in a pREP41-flp1-EGFP plasmid of the nmt1 promoter by 
flp1 endogenous promoter region and transformation of a ∆flp1 strain we were able to 
constitutively over-express Flp1p to moderate levels without altering the viability of the 
strain under normal growth conditions. This transformed strain is hereafter referred to 
as opflp1. The over-expressed protein was stable during HU treatment (Figure 22A). 
Flp1p-EGFP expressed by this plasmid localized normally during mitotic cell cycle, but 
showed a slight accumulation of fluorescence in the spindle pole bodies. FACS 
analysis during HU treatment showed a retard in the establishment of the 1C peak, 
and a broader distribution of DNA content in opflp1. When we examined the behaviour  
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Figure 22. Effect of the moderate over-expression of flp1 
(A) A moderate increase in Flp1p protein levels was achieved by expression of flp1 
under its own promoter in a Δflp1 strain transformed with a pREP41 plasmid in which 
1200bp of the intergenic region ahead flp1 substituted for the nmt1 promoter (opflp1). 
This increase in protein levels does not imply loss of viability in rich medium. (B) opflp1 
presented normal interphase and mitotic localizations of Flp1p in cyclin cells, although 
the protein seemed to accumulate differentially to a low extent in the cytoplasm and 
more importantly in the SPB. Upon replication stress release of Flp1p form the nucleolus 
occurred in opflp1 but cycling cells and aberrant mitosis could be detected. (C) FACS 
analysis revealed retardation in checkpoint block in opflp1 cells as well as incremented 
population between 1C and 2C when compared to the non over-expressing flp1GFP 
strain. (D) opflp1GFP is sensitive to chronic exposure to HU. 
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of the tagged protein in response to HU treatment, we found that it was released to the 
nucleus like endogenously produced Flp1p. However, we observed an abnormal 
number of cycling cells after three hours of treatment, and the nuclei we detected by 
Flp1p-EGFP staining pointed to the existence of aberrant mitoses (Figure 22B-C). 
We therefore checked the sensitivity of the strain to chronic HU exposure. In a plate 
assay (in MM to avoid loss of the plasmid) we found that according to the qualitatively 
observed partial loss of checkpoint block, opflp1 was more sensitive to different 
concentrations of HU than the control strain (Figure 22D).  
4.6 Adaptation to the checkpoint in flp1 mutants 
In response to replication stress, cells block their progression through cell 
cycle as a result of checkpoint activation. However, if the source of stress is not 
 
Figure 23. Dynamics of adaptation to HU in flp1 mutants 
Representation of the variation of septation index in wt and flp1 mutants during extended 
exposure to HU (time in minutes). Asynchronous cultures of wt, Δflp1 and flp1-9A strains 
were treated with HU 12mM and septation index was determined each hour after 
treatment for 9 hours. 400 cells were analyzed in each count using dark field 
microscopy. According to the graphic two regions can be distinguished: before 6 hours 
of treatment cells are responding to checkpoint signal and septation index sinks, 
whereas after 6 hours of treatment cells start to adapt to the presence of the drug and 
override checkpoint block, indicated by an increase in septation index.  
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removed, in the course of the treatment an adaptation to the new conditions occurs. 
The checkpoint is progressively deactivated and cells finally enter mitosis. Thus cells 
undergoing replication stress caused by HU treatment have been reported to re-enter 
the cell cycle after six hour of exposure to the drug (Sazer and Sherwood, 1990). In 
order to check if Flp1p could somehow play a role in the processes that regulate 
checkpoint adaptation, we treated exponential growing cultures of ∆flp1 and flp1-9A 
and wt cells with 12mM HU and monitored the behaviour of the strains in terms of 
checkpoint block and cell cycle re-entry for 10 hours (Figure 23). During the first hour 
of treatment the three strains presented an increase in their septation index, most 
likely due to the asynchrony of the cultures at the initial conditions. As described 
before, at two hours of treatment the septation index of flp1 mutants was higher than 
that of wt cells, and was reduced almost to wt levels at the four hours time point. After 
6 hours of treatment the septation index increased, indicating that cells started to 
adapt to the new environmental conditions and overrode the checkpoint block. From 
this point to the 10 hours of treatment the septation index increased in the three 
strains, indicating that cells accumulated in this stage and did not undergo cytokinesis 
to progress into a new cell cycle. No remarkable difference could be observed 
between the kinetics of the wt strain and those of flp1 mutans at this stage, indicating 
that Flp1p does not play an important role in the regulation of adaptation.  
5. STUDY OF THE RELATIONSHIP BETWEEN Flp1p AND 
OTHER PROTEINS IMPLICATED IN CHECKPOINT 
RESPONSE TO GENOTOXIC STRESS 
5.1 14-3-3 proteins: Rad24p and Rad25p 
Release of Flp1p to the nucleus during replication stress depends 
on Rad24p 
14-3-3 S. pombe proteins Rad24p and Rad25p are required for proper localization and 
function of proteins implicated in checkpoint response, like Chk1p and Cdc25p (Chen 
et al., 1999b; Lopez-Girona et al., 1999; Lopez-Girona et al., 2001b; Dunaway et al., 
2005). Furthermore Rad24p and Flp1p have been shown to interact in response to 
cytokinetic stress (Mishra et al., 2005; Trautmann and McCollum, 2005).  
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We were therefore interested in finding out if Rad24 was involved in the nuclear 
accumulation of Flp1p upon DNA stress. With this aim we examined Flp1p-GFP 
localization in a Δrad24 strain (Figure 24A). Nuclear dispersion of Flp1p-GFP relied on 
a functional rad24+ wild-type allele, indicating that Rad24p is required for release of 
the Flp1p phosphatase from the nucleolus in response to replication stress. 
Flp1p interacts with 14-3-3 proteins during replication stress 
To check if the dependence of Flp1p localization on Rad24p availability could rely on a 
direct interaction between the phosphatase and 14-3-3 proteins, we performed a pull-
down assay for GST-tagged Rad24p in cultures treated with 12mM HU and detected 
Flp1p-Ha in the samples (Figure 24B). No interaction between Flp1p and Rad24p 
could be detected in untreated cells, whereas interaction was clearly detected after 1 
hour of HU treatment. In a similar experiment we detected that Flp1p and Rad25p also 
interacted physically.  
Flp1p and Rad24p interact genetically 
As mentioned before, 14-3-3 protein homologues Rad24p and Rad25p are required 
for adequate checkpoint response in fission yeast (Ford et al., 1994). In particular, it 
has been published that ∆rad24 mutants are defective in the checkpoint response to 
the DNA replication inhibitor HU at 37ºC but proficient at lower temperatures (Forbes 
et al., 1998). We combined ∆rad24 and ∆flp1 mutations and found that the double 
mutant was more sensitive to HU than single ∆rad24 mutants even at 25ºC (Figure 
24C). This genetic interaction indicates that deletion of flp1 enhances the replication 
stress defect of ∆rad24 cells and suggests that Flp1p and Rad24p may play certain 
roles implicated in different branches of the checkpoint response. 
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Figure 24. Interaction of Flp1p with 14-3-3 proteins 
(A) Flp1p is not released to the nucleolus in a Δrad24 background. Live imaging of 
Flp1p-GFP in a strain deleted for rad24 after 3 hours of 12mM HU treatment. Flp1p 
remains nucleolar whereas in control cells the staining is nuclear, as previously 
described. Bars, 10 μm.  3x magnified nuclei are shown in the lower panel. Bars, 1 μm. 
(B) Rad24p can interact physically with Flp1p in vivo during checkpoint response to 
HU. GST-Rad24p was purified from untreated cells and at different times of 12mM HU 
treatment. The membrane was incubated with α-Ha antibody in order to detect 
Flp1pHa. Purified GST was used as a control. In lanes 1 and 2, 10 μg and 20 μg 
respectively of whole cell protein extracts were included as references. (C) Sensitivity 
assay of ∆rad24 and ∆rad24 ∆flp1 cells to chronic HU exposure at 25ºC. ∆rad24 is 
partially sensitive to HU treatment. ∆rad24 ∆flp1 presents a more sensitive phenotype 
than each simple mutant. 
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5.2 Dis2p 
Dis2p is the phosphatase responsible for Chk1p dephosphorylation to 
inactivate checkpoint control over cell cycle once DNA-damage has been repaired 
(den Elzen and O'Connell, 2004). We were interested in checking if Flp1p could in 
some way interact with Dis2p during genotoxic stress, to uncover a possible role for 
Flp1p in checkpoint recovery.  
Flp1p and Dis2p interact genetically 
Due to the role of Dis2p in regulating Chk1p activity, ∆dis2 strains are hypersensitive 
to certain concentrations of MMS (den Elzen and O'Connell, 2004). This fact has been 
interpreted to be a result of an over-activation of Chk1p in cells which lack Dis2p. In a 
plate assay we compared ∆dis2, ∆flp1 and the double mutant’s sensitivities to 0.005% 
MMS (Figure 25A). At this concentration ∆dis2 resulted to be starkly sensitive and 
∆flp1 presented a wt behaviour. Interestingly, deletion of flp1 partially rescued ∆dis2 
sensitivity.  
 
Figure 25. Genetic interaction between dis2 and flp1 
(A) Plate assay showing sensitivity of Δdis2 and the double mutant Δdis2Δflp1 to 
MMS. Δdis2 is markedly sensitive to the concentration of MMS used whereas deletion 
of flp1 in this background partially suppresses the loss of viability. (B) Plate assay 
showing sensitivity of Δdis2 and the double mutant Δdis2Δflp1 to HU.  Δdis2 is 
sensitive to high concentrations of HU. The double mutant displays a similar 
behaviour. 
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Intriguingly, we found that deletion of dis2 also resulted in sensitivity to HU at certain 
concentrations (Figure 25B), pointing to a possible role of the phosphatase in the 
Cds1p branch of the checkpoint response. Under these conditions the double mutant 
∆dis2∆flp1 behaved as the simple ∆dis2 mutant. 
Recovery studies 
At sight of the interaction of both genes in the response to chronic drug exposure, we 
next studied the behaviour of the strains at the recovery stage from drug treatment. wt, 
∆dis2, ∆flp1 and ∆dis2∆flp1 cultures were treated with 12mM HU, 0.033% MMS or 
7.5mU BL and a fixed number of cells were plated after each hour of treatment on 
drug-free rich medium plates (Figure 26). ∆flp1 presented wt-like recovery after 
treatment with HU and seemed to recover slightly worse from BL and from long term 
exposure to MMS. ∆dis2, as expected, clearly showed defective recovery from 2h and 
longer MMS treatments. Coherently with the results obtained for long-term drug 
exposure ∆dis2∆flp1 double mutant recovered better from exposure to MMS than the 
 
Figure 26. Recovery assay of cells deleted for dis2 and/or flp1 
Δflp1, Δdis2 and the double mutant Δdis2Δflp1 were assayed for their ability to recover 
from treatment with genotoxic agents. Asynchronously growing cultures of these strains 
were treated with 12mM HU, 0.033% MMS or 7.5mU BL. Samples were taken after 
every hour of treatment and 10μm of 1:1000 dilutions were plated on drug-free medium. 
Plates were incubated at 30ºC for 72h.
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single ∆dis2 mutant especially from an extended 4 hour treatment.  Recovery from BL 
was also impeded in ∆dis2 and ∆dis2∆flp1 to a similar extent. 
6. ANALYSIS OF THE TRANSCRIPTIONAL RESPONSE TO 
REPLICATION STRESS IN ∆flp1 
Gene expression after 90 minutes of 20 mM HU treatment in asynchronous 
cells deleted for flp1 was studied using a Yeast 2.0 array from AffimetrixTM and results 
were generated using as a reference wt expression profile (see MATERIALS AND 
METHODS). We chose this early point of checkpoint block in order to get the first 
transcriptional wave of checkpoint response minimizing the effects of cell cycle 
dependent transcription.  
APPENDIX 1 contains a classification of the most relevant genes whose expression 
was repressed or induced at least twofold in Δflp1 with respect to the expression 
profile for the wt at this point of treatment. 688 genes were repressed and 466 were 
induced in ∆flp1 applying this criterion, from which 230 and 221, respectively, were 
found to be implicated in protein synthesis and degradation, DNA replication and 
repair, stress response or meiosis and mitotic cell cycle. Expression profile of genes 
involved in stress response and DNA repair seems to be specially altered in ∆flp1. 
Among the 30 repressed genes which belong to these categories, 13 genes involved 
in response to oxidative stress were found, including transcription factors pap1 and 
prr1, the gene encoding their target trr1, 5 genes encoding heat shock proteins and 
two encoding proteins involved in checkpoint response to genotoxic stress, rad25 and 
cdc18, whose product in addiction to its role in DNA replication initiation is also 
implicated in Cds1p activation (Murakami et al., 2002). Among the 43 induced genes, 
4 are involved in spindle checkpoint response, 6 in nucleotide excision repair, 2 in 
ssDNA repair and 9 in recombination including rad22, whose product appears in repair 
loci under replication inhibition when intra S-checkpoint is not active (Meister et al., 
2005), top3 and eme1 encoding for a endonuclease which together with Mus81p may 
be implicated in processing collapsed replication fork intermediates (Kai et al., 2005). 
Regarding genotoxic stress related genes, chk1, wee1 encoding for kinases directly 
implicated in Cdc2p Tyr15 phospho-regulation and cid11, cid12 and cid13 were found 
to be induced. Cid13p, a poly(A) polymerase, targets genes involved in dNTP 
metabolism, and its over-expression suppresses loss of viability in defective S-M 
checkpoint under DNA replication inhibition (Read et al., 2002).  
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Attending to the CESR (Core Environmental Stress Response, see INTRODUCTION), 
of the 88 induced genes with known function, 16 were found to be down-regulated 
(gdp1, ctt1, gpx1 and rds1, among others) and 8 were up-regulated (mpr1/spy1, 
among others) in ∆flp1 with respect to wt behaviour. Of the accepted 106 CESR 
repressed genes, 27 were found to be over-repressed in ∆flp1. 
Importantly, three components of the MBC known to be induced as a result of the 
specific stress response to HU (Chu et al., 2007), cig2, cdc22 and cdc18 resulted to 
be down-regulated in cells deleted for flp1 with respect to wt.  
7. A SYSTEMS BIOLOGY APPROACH TO THE STUDY OF 
CELL CYCLE AND REPLICATION STRESS AND THE 
IMPLICATION OF Flp1p IN THE CORRESPONDING 
SIGNALLING PATHWAYS IN S. pombe 
In the framework of our investigation, we are currently building a mathematical 
model for the checkpoint response to replication stress in S. pombe. Our goal is to 
achieve a fitted and validated model, by means of which we intend to better 
understand the complex interplay among the different components involved in control 
of cell cycle progression both in unperturbed and stress conditions.  
It should be noted that the data here presented are preliminary results of an ongoing 
project in collaboration with the Computational Systems Biology group of the Max 
Planck Institute for Molecular genetics (Bsc. Christian Diener, PhD. Matteo Barberis 
and PhD. Edda Klipp).  
7.1 Model development 
Our model for the cellular response to replication stress is formed by two 
different modules. The first module accounts for a model for cell cycle progression in 
S. pombe, and the second supplementary module accounts for checkpoint response 
to replication stress (Figure 27). This organisation responds to the need for an 
adequate representation of the cell cycle in unaltered conditions in order to accurately 
simulate checkpoint block under stress conditions. The two modules can be put 
together and the whole model can still account for unperturbed cell cycle if the input 
for checkpoint response, the variable “Replication_stress” is given the value 0. 
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Model assumptions for the cell cycle 
As stated before, in order to correctly simulate checkpoint response and therefore cell 
cycle block in response to replication stress we needed a model for the cell cycle that 
could autonomously drive progression through all cycle stages. Self-regulation of the 
system is of special importance for our approach since external orders to drive cell 
cycle progression would interfere with any attempt of stopping cell cycle by means of 
checkpoint response.  Since all published cell cycle models for S. pombe include 
switches in model parameters to regulate cell cycle progression (Novak et al., 1998; 
Sveiczer et al., 2000), the construction of an improved cell cycle model was required.  
Figure 27. Global scheme of the mathematical model for checkpoint response to replication 
stress in S. pombe 
This diagram shows the species and interactions considered for the mathematical 
modelling of checkpoint response to replication stress. For a detailed description of 
model assumptions see text.  
The model is composed of two modules: an independent model for cell cycle 
progression (blue box) and a sub-module for the checkpoint response (red box). Active 
species are highlighted by an additional dot box. Reactions specific of checkpoint 
response are marked by red lines. Dot lines indicate the action of the complex Cdc13p-
Cdc2p in reactions that are not directly driven by the kinase but are specific of the cell 
cycle stage. Arrows indicate conversion of one species into another, and circular heads 
indicate the action of a modifier. Ø indicates degradation. Regarding protein 
modifications P stands for phosphorylation and a point stands for an undefined 
modification. 
In the model, cell cycle progression is driven by the kinase activity of the Cdc13p-
Cdc2p complex. Kinase activity is inhibited by Wee1p/Mik1p and by timely degradation 
of Cdc13p from the active complex Cdc13p-Cdc2p by APC. Kinase activity is enhanced 
by the phosphatase Cdc25p and by the synthesis of the cyclin Cdc13p. Active Cdc13p-
Cdc2p complex promotes its own activation by inactivating Wee1p/Mik1p and activating 
Cdc25p. Cdc25p is in its turn inactivated by activated Flp1p. The inactive form of 
Cdc25p is thus targeted for degradation. Flp1p is activated dependently on the cell 
cycle stage and its own phosphatase activity. APC activation is also cell cycle driven. 
Synthesis of degraded species is considered. 
In the checkpoint module only active if the species “Replication_stress” > 0, replication 
stress triggers Cds1p activation. Cds1p acts activating Wee1p/Mik1p and turning 
Cdc25p into an inactive, non-degradable form. It also triggers accumulation of the 
checkpoint active form of Flp1p that in turn drives further activation of Cds1p.  
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Our main goal when modelling the cell cycle was thus to achieve a self-regulated 
system capable of accurately reproducing the oscillations of Cdc2p kinase activity and 
of all other model components. 
Figure 27 shows the scheme of all species and interactions included in our cell cycle 
model. This scheme was built on the basis of the state of the art knowledge about 
regulation of cell cycle progression in fission yeast, specified in INTRODUCTION. The 
model scheme contains the main cell cycle regulators and definitively those implied in 
Cdc2p activity regulation also during checkpoint response. On the other hand, the 
model has been kept as simple as possible so that the mathematical description of the 
system does not require too many parameters to favour an adequate posterior fit to 
experimental data.  The following assumptions were made to achieve a simple but still 
functional model: 
The trigger of cell cycle progression is the activity of the Cdc2p-Cdc13p complex over 
time. Cdc2p-Cdc13p is thus the only CDK-cyclin complex considered. This 
assumption has been made on the basis that Cdc13p is the only essential cyclin in S. 
pombe. On the other hand checkpoint effects have been shown to play a major role in 
regulation of the mitotic CDK complexes.  
The effect of the CKI Rum1p on Cdc13p-Cdc2p inactivation has been lumped in the 
APC mediated degradation of Cdc13p. 
Cdc13p is considered to be the limiting species for the formation of the Cdc2p-Cdc13p 
complex. This is logical considering that the cyclin is regulated by periodic expression 
and degradation. According to this, in the cell cycle fits the concentration of the 
Cdc2p-Cdc13p is considered to be equal to that of the detected Cdc13p.    
A single species accounts for both Cdc2p kinase inhibitors Wee1p and Mik1p.  
Synthesis is considered for the two species that get degraded as a consequence of 
cell cycle progression, that is, the active form of the Cdc2p-Cdc13p complex (because 
of Cdc13p degradation) and the inactive form of Cdc25p. Synthesis has been 
assumed to follow saturation kinetics, that is, a maximal concentration of the species 
can not be trespassed, even under checkpoint block.  
Species that are cell cycle regulated but whose regulators are unknown or not part of 
the scheme (APC and Flp1p) achieve their balances through the action of the cell 
cycle trigger itself.  
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Flp1p is activated during mitosis (when Cdc13p-Cdc2p activity is high) dependently on 
its own phosphatase activity. 
Model assumptions for the checkpoint 
The checkpoint module is also shown and explained in Figure 27. Checkpoint 
response to replication stress is modelled primarily as the action of the checkpoint 
kinase Cds1p on cell cycle block. However, we also intend to obtain some information 
about the role of the kinase in fork stabilization (see DISCUSSION). The following 
assumptions were made when modelling the checkpoint module: 
The model accounts only for the stages of checkpoint activation. Since the 
mechanisms of adaptation and recovery are poorly understood, no reactions for 
checkpoint inactivation are included in this first approach. Therefore, for parameter fit 
only points up to 180 minutes of HU treatment are used. Consequently, simulations 
should not be run in time courses longer than 180 minutes.  
Cds1p is activated by checkpoint response. No synthesis or degradation of Cds1p is 
considered as a first approach. 
Cds1p drives inactivation of Cdc25p turning it into an inactive, non-degradable form.  
A module for the action of Flp1p in the checkpoint has been included, based on our 
interpretation of the experimental results for the role of the phosphatase in response to 
replication stress (see section 2. and Figure D1 in DISCUSSION).       
7.2 Mathematical structure of the model 
The mathematical construction of the model was based in the biological 
structure depicted in Figure 27 and on the above mentioned model assumptions. The 
complete model for cell cycle and checkpoint response consists of 15 species, 17 
reactions and 23 parameters, as specified in Table 1. The set of differential equations 
accounting for all kinetics and for the complete mathematical description of the system 
can be found in APPENDIX 2.  
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Name Reaction Kinetics Modifiers Parameters 
rCdc2_input -> Cdc2_on S  
Kinput 
Kconc_max 
Cdc2_tot 
rCdc2_deg Cdc2_on -> MA APC_on Kcdc2_deg 
rCdc2_on Cdc2_off -> Cdc2_on MA Cdc25_on Kcdc2_on 
rCdc2_off Cdc2_on -> Cdc2_off MA Wee1_on Kcdc2_off 
rCdc25_input -> Cdc25_off S  
Kinput 
Kconc_max 
Cdc25_tot 
rCdc25_deg Cdc25_off -> MA  Kcdc25_deg 
rCdc25_on Cdc25_off -> Cdc25_on MM Cdc2_on 
Kcdc25_on 
Jcdc25_on 
rCdc25_off Cdc25_on -> Cdc25_off MM Flp1_on 
Kcdc25_off 
Jcdc25_off 
rCdc25_check Cdc25_on -> Cdc25_checkpoint MA Cds1_on Kcds1_cdc25 
rWee1_on Wee1_off -> Wee1_on MM Cds1_on 
Kwee1_on 
Jwee1_on 
Kcds1_wee1 
rWee_off Wee1_on -> Wee1_off MM Cdc2_on 
Kwee1_off 
Jwee1_off 
rAPC_on APC_off -> APC_on MA Cdc2_on Kapc 
rAPC_off APC_on -> APC_off MA Cdc2_off Kapc 
rFlp1_on Flp1_off -> Flp1_on MA 
Cdc2_on 
Flp1_on Kflp1 
rFlp1_off Flp1_on -> Flp1_off MA Cdc2_off Kflp1 
rFlp1_check Flp1_off -> Flp1_checkpoint MA Cds1_on Kcds1_flp1 
rCds1_on Cds1_off -> Cds1_on MA 
Replication_stress 
Flp1_checkpoint 
Krs 
Kflp1_cds1 
Table 1. Model reactions 
Set of reactions describing the model. Reactions where no substrate has been 
specified represent synthesis and reactions with no product represent degradation. The 
column Kinetics stands for the type of kinetic written for each reaction: MM = Michaelis 
Menten, MA = Mass Action, S = Saturation. A list of the species that catalyze each 
process (modifiers) and the parameters involved in each reaction has been included. 
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Table 2. Initial concentrations and parameter values of the fitted model 
Concentrations are expressed in μM. Parameters have different units 
depending on the order of the reaction in which they are involved 
(concentration unit μM, time unit min). Values in green are parameters 
fitted using cell cycle data for Δflp1, values in blue are parameters fitted 
using cell cycle data for wt, and values in red were fitted using checkpoint 
data of wt. 
Species Concentration (μM) Parameter Value 
Cdc25_off 0.4810 0.4114 Kcdc2_on 10.4652 
Cdc25_on 0.3020 0.8063 Kcdc2_off 36.0696 
Cdc2_on 0.3128 0.4210 Kcdc2_deg 0.1571 
Cdc2_off 2.0709 1.5500 Kinput 0.0287 
Wee1_on 0.5812 0.8593 Kcdc25_on 456.8510 
Wee1_off 0.0652 0.1407 Kcdc25_off 4331.51 
APC_on 0.0695 0.1070 Kcdc25_deg 0.0502 
APC_off 0.4602 0.3930 Kwee1_on 0.1070 
Cds1_off 7.463 7.463 Kwee1_off 0.2269 
Cds1_on 0 0 Kapc 187.4180 
Flp1_off 3.8531 0 Kflp1 0.5560 
Flp1_on 1.3409 0 Krs 0.0134 
Flp1_check 0 0 Jcdc25_on 103.7280 
Cdc25_check 0 0 Jcdc25_off 4661.9000 
Replication_stress 0 / 0.5 0 / 0.5 Jwee1_on 0.0383 
   Jwee1_off 0.0035 
   Kconc_max 10.2600 
   Kflp1_cds1 4.1020 
   Kcds1_wee1 0.0086 
   Kcds1_cdc25 68.5300 
   Kcds1_flp1 0.0090 
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Parameter Fit 
Three sequential fits of parameters were performed, in order to maximize the 
experimental input for the election of parameters and initial concentrations: fit of Δflp1 
in cell cycle progression, fit of wt in cell cycle progression and fit of wt in checkpoint 
response. For the cell cycle fits, we used published data generated in our group 
(concentrations of total Cdc25p, of active Cdc25p, of total Cdc13p, and Cdc2p activity) 
(Esteban et al., 2004), and checkpoint fits correspond to data generated in this study 
(concentration of total Cdc25p, of inactive Cdc2p and active Cds1p). An explanation 
about the proceeding for experimental data processing and fit can be found in 
MATERIALS AND METHODS. The set of fitted parameters and initial concentrations 
that account for the fitted model can be seen in Table 2. Figure 28 shows the 
correlation between experimental data and the corresponding simulated behaviour of 
the system using the chosen parameter set. This set accounted for reasonably 
accurate profiles for all fitted variables but for Cdc25p total amount during cell cycle 
progression. We were not able to find a parameter set that could better reproduce this 
variation in Cdc25p levels, indicating that the biological/mathematical description used 
for Cdc25p accumulation and degradation in this model structure is inaccurate (see 
DISCUSSION).  
7.3 Simulation of cell cycle and checkpoint response to 
replication stress 
Simulations were run to check the behaviour of the non-fitted species. As 
shown in Figure 29, the curves for Wee1p/Mik1p and APC during cell cycle 
progression account for the documented experimental behaviour both for wt and Δflp1. 
The model is also able to reproduce Flp1p dynamics of nuclear sequestration and 
release (note however that we are considering the active and inactive species of Flp1p 
and that the simulated activation of Flp1p is slightly advanced in mitosis).  
Another not trivial output of the cell cycle model is the achievement of periodic, stable 
oscillations of the involved species accounting for the ability of the system to 
reproduce cell proliferation (progression through numerous cell cycles). 
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Figure 28. Simulated results for the fitted model vs experimental data points 
The dynamic behaviour of the model species (grey lines) were compared to the 
experimental data points to which they were fitted (black dots). (A) Plot for Δflp1 (Flp1p 
species = 0) in unaltered cell cycle (Replication stress = 0). (B) Plot for wt in unaltered 
cell cycle (Replication stress = 0). (C) Checkpoint response in wt (Replication stress = 
0.5) 
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Figure 29. Simulation of cell cycle progression 
Simulation of the time courses for specified species in wt (A) and Δflp1 (B) 
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Furthermore, comparison of wt and Δflp1 simulations (fitted independently for initial 
concentrations) reveals higher concentration of Cdc25p and deficient down-regulation 
of the active form in Δflp1 together with inefficient down-regulation of the Cdc13p-
Cdc2p active complex in this mutant (Figure 30).  
 
Figure 30. Comparison of Cdc25p and Cdc2p profiles in wt and Δflp1  
The model in its current state is able to account for experimental observations. Cdc25p 
basal levels are higher in Δflp1 and this mutant presents altered profiles of Cdc25p 
activation and inactivation with respect to wt. On the other hand, a higher basal level of 
active Cdc2p (time 0 of the simulation, corresponding to G2 could be considered as the 
model state that could better describe the characteristics of an asynchronous 
population) and inefficient down-regulation of the kinase at mitotic exit are observed in 
Δflp1. 
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On the other hand, when turning the input “Replication_stress” on, we could observe 
the action of the checkpoint sub-module in stopping cell cycle progression. The model 
accounts for the down-regulation of active Cdc2p and Cdc25p and up-regulation of the 
active Wee1p/Mik1p species (Figure 31). An important outcome of the model is its 
ability to simulate a smooth curve for Cds1p activity in the Δflp1 mutant in contrast to 
the almost switch like response observed in wt. Thus even with the same amount of 
the checkpoint kinase in the system (no input for Cds1p synthesis during checkpoint 
 
Figure 31. Simulation of checkpoint response 
Simulation of the time courses for the specified species in wt and Δflp1 
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response was considered in this first approach), we could observe slower and 
weakened activation of Cds1p in cell lacking Flp1p. 
In addition to the study of the simulated qualitative behaviour of non fitted species, we 
used experimental data points for Δflp1 under replication stress for validation (Figure 
32). Once again the model is able to reproduce accurately enough the behaviour of 
Cdc2p inactivation and Cds1p activation, but not the dynamics of Cdc25p 
accumulation in this mutant.  
We are currently building an improved model, in order to better reproduce the 
experimental and documented profiles of cell cycle progression and checkpoint 
response, concentrating mainly in the regulation of Cdc25p. With this validated model 
we intend to reach the prediction stage, so that by means system manipulation and 
mathematical analyses we will be able to test, for instance, the contribution of the 
different species and reactions to the stability of periodic oscillation in the case of cell 
cycle progression or to the robustness of checkpoint response under stress 
 
Figure 32. Model validation for checkpoint response in Δflp1 
We used the comparison between simulated behaviour and experimental data points 
for checkpoint response in Δflp1 (not used in parameter fit) as a validation for the fitted 
model. As previously stated at sight of the quality of the fits for the cell cycle, this 
validation points to a defect in model description for Cdc25p regulation. 
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conditions. See DISCUSSION for an insight into the new model structure and some of 
the data we intend to achieve by means of the validated model.  
  
DISCUSSION 

DISCUSSION 
143 
In the present work we have explored by means of different approaches the 
consequences of mutating S. pombe Cdc14-like phosphatase Flp1p in checkpoint 
response to genotoxic stress.  
In the course of an unperturbed cell cycle, Flp1p antagonizes mitotic CDK activity by 
promoting phosphorylation of the conserved tyrosine 15 residue of Cdc2p by 
dephosphorylating and, thus, down-regulating the Cdc2p Tyr15 phosphatase Cdc25p 
(Esteban et al., 2004; Wolfe and Gould, 2004). Cdc25p is also a regulated target of 
the checkpoint cascade activated by genotoxic stress (Lopez-Girona et al., 1999; 
Lopez-Girona et al., 2001b). Thus, a role of Flp1p in regulating retardation of cell cycle 
progression in response to DNA-damage or replication stress seemed reasonable. 
However, according to our results, deletion of flp1 does not significantly affect Cdc2p 
Tyr15 phosphorylation in response to genotoxic stress. Cdc2p becomes 
hyperphosphorylated on tyrosine 15 upon HU, MMS or UV light treatments (O'Connell 
et al., 1997; Chu et al., 2007 and this work). In this context, it is surprising that Flp1p, 
the phosphatase that reverts phosphorylation events on Cdc25p downregulating its 
activity as cells exit from mitosis, does not appear to exert a similar control under 
genotoxic stress.  
The results of our study indicate that checkpoint-related events control Flp1p 
localization and levels upon genotoxic stress. Importantly, they clearly reveal a close 
interplay between Flp1p and the main effector of the checkpoint cascade response to 
replication stress, Cds1p. Interestingly, this interplay results in the full activation of the 
Cds1p checkpoint kinase. Flp1p has also been shown to interact physically or 
genetically with other proteins involved in checkpoint signalling upon different types of 
DNA-stress. In addition, alteration of Flp1p levels or localization results in deregulation 
of checkpoint response in different aspects including loss of efficiency in checkpoint 
block and appearance of unscheduled recombination events.   
On the other hand, according to our preliminary gene expression studies, deletion of 
flp1 results in a strong alteration of the checkpoint associated transcriptional response 
to genotoxic stress. 
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1. Flp1p LOCALIZATION DURING GENOTOXIC STRESS 
During mitotic cell cycle, Flp1p localizes to the nucleolus and SPB during interphase 
and to the nucleus, spindle and medial ring during mitosis (Cueille et al., 2001; 
Trautmann et al., 2001).  
Here we have shown that Flp1p is released to the nucleus to a higher or lower extent 
in cells undergoing genotoxic stress, even if checkpoint blocked cells remain at cell 
cycle stages at which Flp1p is normally located in the nucleus. This change of location 
does not occur in a ∆rad3 strain, indicating that Flp1p changes its subcellular 
localization in a checkpoint dependent manner. Flp1p nuclear accumulation during 
genotoxic stress is also abolished in Δrad24 mutants, pointing to a role of the 14-3-3 
protein in the transport of the phosphatase. However, it must be noted that deletion of 
rad24 affects multiple cellular processes (Δrad24 cells present an orb morphology as 
well as mislocalization of proteins involved in cell cycle and checkpoint control) so the 
alteration of Flp1p localization in this strain could just be a consequence of an altered 
cellular environment. 
Interestingly, whereas the cellular mechanism by which Flp1p is released to the 
nucleus at mitotic entry during an unperturbed cell cycle remains to be clarified (Chen 
et al., 2006), our results show that under replication stress Cds1p triggers nuclear 
accumulation of the fission yeast Cdc14p phosphatase homologue: First,  Flp1p does 
not localize to the nucleus during HU treatment in a Δcds1 strain and second, mutation 
of the in vitro phosphorylation sites for Cds1p on flp1 abolishes the release of the 
phosphatase to nucleus  specifically during checkpoint response. Further supporting 
the role of Cds1p in releasing Flp1p to the nucleus by direct phosphorylation, we could 
also detect Cds1p-Flp1p physical interaction during checkpoint response.  
According to our results and since Cds1p seems to be present to a higher or lesser 
extent in the whole cell (Brondello et al., 1999; Matsuyama et al., 2006), the 
phosphorylation of Flp1p by the phosphatase may take place in the nucleolus. 
Alternatively, Cds1p phosphorylation could be required for the retention of Flp1p in the 
nucleus once released. The precise spatio-temporal determination of Cds1p action 
over Flp1p should be addressed in future studies.   
During MMS and BL treatment the localization of Flp1p in Δcds1 cells seems to be 
similar to that of wt, probably because the checkpoint response in these cases is 
mainly independent of Cds1p when Chk1p is active. However, Flp1p seems to be 
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strongly released to the nucleus in chk1 flp1-GFP both in MMS and BL resembling 
Flp1p localization during HU treatment in a flp1-GFP strain.  Since Cds1p is also 
activated in response to MMS treatment, these results may further point to a 
relationship between Flp1p nuclear localization and the Cds1p branch of the 
checkpoint. 
Flp1p in the nucleus during genotoxic stress 
In S. cerevisiae, checkpoint response to DNA-damage involves activation of both 
response pathways, involving Chk1p and Rad53p respectively, which results in 
inhibition of both FEAR and MEN networks. This results in retention of ScCdc14p in 
the nucleolus during checkpoint activation (Liang and Wang, 2007). Our study proves 
that in S. pombe checkpoint response to DNA-damage leads to the release of Flp1p to 
the nucleus. Since both orthologous phosphatases are implicated in the regulation of 
mitotic CDK activity, the fact they seem to be regulated in opposite ways by 
checkpoint response is intriguing. However, the predominant nucleolar localization of 
Flp1p and its degradation during MMS treatment could indicate that checkpoint 
response in S. pombe acts to prevent Flp1p activity when DNA damage is detected 
just like the S. cerevisiae counterpart, but through a different mechanism.    
Studies in S. cerevisiae have shown that ScCdc14p sequestration in the nucleolus 
during S-phase may be necessary to allow for the adequate kinase-associated events 
required for correct DNA replication. When artificially released to the nucleus 
ScCdc14p is able to dephosphorylate replication factors Sld2p and Dpb2p, which are 
phosphorylated by Clb5-CDK during S-phase to guarantee recruitment of polymerases 
to origins of replication. In this way unscheduled Cdc14p release from the nucleolus in 
S-phase in the absence of cyclin Clb5p prevents the completion of DNA replication 
(Bloom and Cross, 2007). In this study we have proven that the accumulation of Flp1p 
in the nucleus in S phase is a checkpoint specific event, and seems to be dependent 
not only on Cds1p presence but also on its activation. On the other hand we proved by 
synchronisation in G1 and release into cell cycle progression that the phosphatase is 
restricted to the nucleolus at these stages in an unperturbed environment.  At sight of 
these results and the abovementioned observations in S. cerevisiae it is tempting to 
speculate that Flp1p could be released to the nucleus during replication stress to 
inhibit the replication machinery by counterbalancing CDK S-phase activities.  
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Our results show that Δflp1 and flp1-9A present the same phenotypes of enhanced 
Rad22p foci appearance, modest checkpoint block defect and reduced Cds1p 
activation upon replication stress. This indicates that these defects are derived from 
the absence of the phosphatase in the nucleus. The fact that flp1-9A presents reduced 
Cds1p activation as Δflp1 proves that Flp1p release from the nucleolus is a key event 
in the (auto-) control of checkpoint kinase activity during replication stress. The 
defectiveness of checkpoint block and Rad22p foci appearance in flp1 mutants may 
well be consequences of reduced Cds1p activity. However, expression of genes 
involved in recombination and other aspects of checkpoint response is enhanced in a 
Δflp1 strain, so a direct role of nuclear Flp1p in regulating transcriptional response to 
replication stress can not be ruled out. 
2. INTERPLAY BETWEEN Cds1p AND Flp1p: A MECHANISM 
FOR FULL ACTIVATION OF CHECKPOINT RESPONSE TO 
REPLICATION STRESS 
The results presented in this study relate Flp1p to the main effector of 
checkpoint response to replication stress, Cds1p. Interestingly our study evidences 
both an action of Cds1p over Flp1p and of Flp1p over Cds1p during checkpoint 
response to replication stress.  
According to our observations Cds1p would act over Flp1p to regulate its localization, 
stability and phosphatase activity: (1) Flp1p is not released to the nucleus upon 
replication stress in a Δcds1 background. This change of localization is also abolished 
if the replication stress source does not trigger sufficient Cds1p activation, as 
observed upon conditional inactivation of cdc17. (2) Checkpoint activated Cds1p 
phosphorylates Flp1p in vitro. This phosphorylation does most likely also occur in vivo 
to trigger Flp1p release to the nucleus during replication stress, since mutation of all 
putative Cds1p phosphorylation sites on Flp1p (which disrupts Flp1p phosphorylation 
by the kinase in vitro) leads to specific abolishment of Flp1p change of localization 
upon checkpoint activation. (3) Phosphorylation of Flp1p by Cds1p in vitro leads to an 
enhancement of its phosphatase activity. Our preliminary in vivo studies show that 
Flp1p phosphatase activity increases after 2 hours of HU treatment, further pointing to 
a relationship between phosphorylation, localization and phosphatase activity 
enhancement. (4) Degradation of the phosphatase during MMS treatment is abolished 
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in Δcds1 background. This observation points to a dependence of Flp1p nuclear 
localization and degradation. 
Flp1p in turn, would directly or indirectly regulate the levels and activity of the 
checkpoint kinase. (1) Δflp1 cells present lower protein levels of Cds1p than the wt 
upon replication stress. (2) In a Δflp1 background Cds1p presents lower kinase activity 
than in wt cells, both upon HU and MMS activation.  
Regarding the timing of Flp1p-Cds1p interactions, the fact that disruption of Cds1p 
action over Flp1p in the flp1-9A mutant leads to the same checkpoint defects than 
deletion of flp1 indicates that the influence of Flp1p on Cds1p activation and levels is 
dependent on a previous activator step of the kinase over the phosphatase. 
We have shown that deletion of flp1 leads to two different defects on checkpoint 
response. First, we could observe the appearance of recombination foci during 
replication stress in Δflp1 and second, a modest percentage of Δflp1 cells override 
checkpoint block and progress into mitosis presenting aberrant nuclei. These two 
kinds of defects could be explained by the reduced activity of Cds1p observed in 
 
Figure D1. A model for Flp1p function in the regulation of the replication stress response in 
fission yeast 
Upon replication stress Cds1p is activated through Rad3p phosphorylation. Active 
Cds1p phosphorylates Flp1p to regulate its release to the nucleus and its activity. 
According to our results, Rad24p may be involved in this shuttle mechanism. Nuclear 
Flp1p would in its turn directly or indirectly regulate full activation of Cds1p in response 
to replication stress. 
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Δflp1.   
Taken together, all these observations led us to propose the model for the 
involvement of Flp1p in checkpoint response to replication stress described in Figure 
D1.   
A direct action of Flp1p on Cds1p? 
Whether the control of Flp1p over Cds1p can be explained by a direct interaction is 
still unclear. A direct control is an interesting possibility since, according to our results 
dephosphorylation of the kinase should then act as an activating mechanism. If the 
phosphatase can enhance the activation of the kinase by playing a role in the 
dimerization and autophosphorylation steps of Cds1p activation will be addressed in 
future studies. Pointing to a direct action of the phosphatase over the kinase, physical 
interaction between Flp1p and Cds1p could be detected during genotoxic stress. The 
interaction is better detected in a flp1CS background. This can be justified appealing to 
the transient nature of phosphatase- substrate interactions, indicating that the 
interaction in this case could certainly occur to dephosphorylate Cds1p.  However, it 
should be kept in mind that this interaction was detected in conditions of over-
expression of flp1 and that Flp1p-Cds1p interaction is weak even in a flp1CS 
background.  
On the other hand, elements capable of regulating Cds1p protein levels and Cds1-
associated kinase activity may be targets of Flp1p, leading to an indirect regulation of 
Cds1p by the phosphatase. Proteins implicated in replication and fork stabilization 
could thus be possible targets of Flp1p during replication stress, since as underscored 
in the introduction, many of them (Swi1p-Swi3p, Sap1p, Hsk1p, Cft18p, Orc1p 
Cdc45p, among others) are involved in Cds1p activation under stress conditions.  
Among the feasible targets for Flp1p indirect action over the checkpoint kinase it 
would be reasonable to include uncharacterized fission yeast Ssa1p and Ssa2p 
chaperone homologues (Wood et al., 2002) that may eventually play a role in 
maintaining Cds1p levels. The study of a possible the role of these chaperones in 
Cds1p activation during genotoxic stress would be of particular interest in the 
framework of our investigation since we seem to co-immunoprecipitate Ssa2p with 
GST-Flp1p. 
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3. RECOMBINATION RELATED EVENTS IN flp1 MUTANTS 
Rad22p foci formation during an unperturbed cell cycle is indicative of ssDNA 
appearance and of post-replication repair. The observation that flp1 mutants do not 
present more Rad22p foci than the wt during vegetative growth indicates that Flp1p is 
not required for replication or fork stabilization under these conditions. Whereas 
activation of the replication checkpoint in wt cells makes the appearance of Rad22p 
foci very rare, a considerable number of Δflp1 and flp1-9A cells present multiple 
recombination foci upon HU treatment. If Rad22p foci appearance under these 
circumstances was associated to fork collapse, activation of Chk1p should be 
detected. Contrary to this hypothesis, we could not detect the checkpoint associated 
mobility shift of Chk1p in HU treated Δflp1 cells (data not shown).  
Appearance of Rad22p foci could also correlate with the checkpoint block defect we 
observe in a small percentage of Δflp1 and flp1-9A cells. Rad22p and the 
recombination machinery are normally loaded into nuclear foci immediately as cells 
are released from replication arrest. In this way, Rad22p foci could appear in cells that 
override the checkpoint. However, this is not likely to be the explanation for the 
appearance of foci in flp1 mutants, since, according to our experiments, the 
percentage of cells in these strains presenting multiple recombination foci is over two-
fold that of cells that override the checkpoint.  
The fact that the studied flp1 mutant strains present an intermediate behaviour 
between wt and Δcds1 in terms frequency of Rad22p foci appearance, rather 
correlates with the reduced activation of Cds1p that the phosphatase mutants present. 
Since we could not detect viability loss in flp1 mutant strains as a consequence of the 
unscheduled appearance of recombination foci, an alternative mechanism is likely to 
override their potential deleterious effects. Identification of such mechanism would aid 
to further understanding the role of Flp1p in checkpoint response and the functioning 
of the checkpoint itself.  
It should be kept in mind, however, that a delayed activation of Cds1p in flp1 mutants 
to checkpoint proficient levels in terms of fork stabilization may be enough to make a 
putative loss of viability in the early stages of HU treatment undetectable.  
DISCUSSION 
150 
4. Flp1p OVER-EXPRESSION AND SPB LOCALIZATION 
According to our results moderate over-expression of flp1 leads to defective 
checkpoint block and loss of viability in response to replication stress.  
Since our previous results involved Flp1p in the timely full activation of Cds1p during 
replication stress, the fact that moderate over-expression of the protein leads to a 
partial override of the checkpoint response is intriguing. 
In addition, over-expression of flp1 under stronger promoters has been shown to 
induce a G2 delay. In this case overexpression of flp1 leads to excessive Cdc25p 
down-regulation and cells can not reach the adequate CDK activity levels to induce 
entry into mitosis. Since checkpoints act to down-regulate CDK activity and prevent 
mitosis, a cell cycle alteration caused by moderate over-expression of Flp1p would 
therefore rather contribute to checkpoint arrest than produce further progression into 
mitosis.   
Coherently with the role of Flp1p as an inducer of Cds1p activity, loss of viability in 
opflp1 could be explained by an overactivation of the checkpoint. A too tight 
checkpoint control can lead to loss of viability during sustained exposures to stress, as 
observed in Δdis2 cells. However, since we observed that a number of opflp1 cells 
override checkpoint control during exposure to HU, the loss of viability in opflp1 cells is 
most likely to be a consequence of the unscheduled progression of cells into mitosis 
with unreplicated DNA. 
As underlined in RESULTS, this mutant presents enhanced Flp1p-EGFP signal in the 
SPB. The mechanisms regulating the different cellular localizations of Flp1p remain 
unknown. Ectopical expression of Flp1p in this case could be somehow responsible 
for Flp1p accumulation in the SPB.   Many regulators of mitosis and cell division are 
located to the SPB, among them SIN components (Alfa et al., 1990; Eng et al., 1998; 
Sohrmann et al., 1998; Cerutti and Simanis, 1999; Mulvihill et al., 1999; Chang and 
Gould, 2000; Guertin et al., 2000; Hou et al., 2000, among others). It would be 
interesting to test if the selective accumulation of Flp1p in the SPB could cause an 
override of checkpoint response through deregulation of some of these components.  
DISCUSSION 
151 
5. A POSSIBLE ROLE FOR Flp1p IN RECOVERY FROM 
CHECKPOINT ARREST? 
After checkpoint activation, cells resume cell cycle progression when the 
source of stress is removed. It has been suggested that the type I phosphatase Dis2p 
downregulates Chk1p activity during this recovery stage to allow for cell cycle 
resumption (den Elzen and O'Connell, 2004). The mechanism responsible for Cds1p 
downregulation remains unclear, although interruption of Rad3p signalling seems to 
be enough to abolish replication checkpoint response (Martinho et al., 1998). At sight 
of our first results relating Flp1p to the checkpoint effector Cds1p, we were interest in 
finding out if Flp1p could play a role in the inhibition of Cds1p activity. We found 
indeed genetical interaction between Flp1p and Dis2p in MMS. Deletion of flp1 
rescues to some extent the sensibility of Δdis2 to this drug. Given our later discovery 
that Flp1p may enhance Cds1p activity rather than inhibit it, and since Cds1p is 
activated during MMS treatment, this result could reflect the advantage of a partial 
loss of Cds1p activity when Chk1p is overactivated in checkpoint response. However, 
the observed recovery of Δdis2 by Δflp1 could simply be a result of the own nature of 
the Δflp1 strain. Δflp1 presents high basal levels of Cdc2p activity during mitotic cell 
cycle. This could counterbalance the deleterious effects of checkpoint over-activation 
associated to the deletion of dis2 in response to DNA damage. 
According to our results Flp1p is required for the full activation of Cds1p during 
replication stress and can be phosphorylated by the kinase. This reciprocal interaction 
between Flp1p and Cds1p resembles that observed between some proteins 
implicated in checkpoint recovery like Hsk1p or Mcm4p and Cds1p. However, our 
preliminary work on the matter does not indicate the requirement of Flp1p for survival 
after replication stress.  
In addition, two observations derived form our work speak against a role of Flp1p in 
recovery from checkpoint block. First, we have identified the functionality of the 
phosphorylation of Flp1p by Cds1p in triggering the release of the phosphatase from 
the nucleolus. Furthermore, although we have seen that this phosphorylation activates 
the phosphatase in vitro, the activation in vivo seems to be transient, pointing to a role 
of Flp1p in the early stages of checkpoint response. Second, Flp1p returns to its 
localization immediately after removal from the source of stress, further pointing to a 
role of the phosphatase during replication arrest rather than in cell cycle resumption.  
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6. SPECIFIC TRANSCRIPTIONAL RESPONSE OF ∆flp1 CELLS 
TO REPLICATION STRESS  
As specified in RESULTS and MATERIALS AND METHODS, we performed a 
gene expression analysis to uncover the specific transcriptional response of ∆flp1 cells 
to replication stress in terms of up or down regulation of specific genes when 
compared to the wt behavior. It should be noted that all the results here discussed 
were obtained in a single microarray analysis. We consider this experiment 
significative, since its outcome correlates with some important aspects of the 
biochemical and genetical analysis presented in this study. Further investigation of the 
potential role of Flp1p in regulating transcriptional-related events is being currently 
carried out in our group.   
Analysis of the alteration of the global expression profile in 
response to HU in ∆flp1 
Attending to the overall deregulation in gene expression of ∆flp1 after 90 minutes of 
HU exposure, we found over 1100 genes whose expression was amplified or reduced 
at least twofold in this mutant with respect to wt behavior. This can be considered as 
an important deviation in the expression profile of the mutant, pointing to an important 
role of Flp1p in directly or indirectly controlling gene expression in checkpoint 
response to replication stress. However it must be kept in mind that, in this analysis, 
deviation in the gene expression derived of checkpoint response and deviations 
intrinsic to the mutant’s nature are indistinguishable.  
Expression of genes involved in stress response is specially altered in ∆flp1 in our 
study. 25 genes presented reduced expression (rad25, pap1, prr1, trr1, cdc48 and 
cdc18 among others) and 24 enhanced expression (chk1, wee1, csn2, top3, eme1, 
cid11, cid12 and cid13 among others) with respect to wt. The clusters of genes 
involved in oxidative stress (11 repressed genes), osmotic stress (3 repressed, 4 
induced genes) and spindle checkpoint (4 induced genes) responses seem to be 
highly deregulated in the mutant. Since Flp1p has been proposed to play a role in 
checkpoint response to oxidative stress, osmotic stress and unassembled spindle, the 
deregulation observed in genes involved in these responses, like the extensive 
induction of meiotic genes (77), may be due to the absence of the phosphatase in the 
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corresponding pathways rather than to a specific transcriptional regulation in 
checkpoint response to replication stress. 
Although our studies of the implication of Flp1p in the response pathways to genotoxic 
stress have proven that the phosphatase is required to acquire adequate protein 
levels of Cds1p, no alteration in the expression of this checkpoint kinase was found in 
this analysis. This is indicative of a post-translational regulation of the protein levels, 
mechanism that could also account for the modified activity of Cds1p in checkpoint 
response. However, we did find enhanced expression of chk1 and genes involved in 
its signaling pathway (such as top3 and dcr1) and wee1, which can be seen as a 
compensatory mechanism to the loss of Cds1p in terms of checkpoint block 
proficiency. Enhancement of expression of genes like cid13 (whose over-expression 
has been shown to compensate the hypersensitivity of S-M checkpoint mutants under 
DNA replication inhibition (Read et al., 2002)) and rpl1 could on their turn account for 
suppression of the loss of viability associated to replication checkpoint defectiveness. 
19 genes implicated in DNA repair presented enhanced expression in ∆flp1 (eme1, 
rad22, rti1, pol4, rlp1, top3, rev1, nse1, rad16, slx1 and slx4 among others). DNA 
damage and instability derived of defective Cds1p checkpoint response in cells 
deleted for flp1 could account for this transcriptional effect, as well as for the induction 
of genes involved in the telomere protection machinery also observed in this assay.  
Eme1p is required in mitosis for the processing of stalled or collapsed replication fork 
intermediates, and Rlp1p (known to work together with Rad22p and Rhp51p) is 
required for the full extent of DNA recombination and cell survival under condition of a 
replication fork collapse. Nse1p, Slx1p and Slx4p, are also involved in the processing 
of collapsed forks and stalled forks recovery. Top3p, which works in the Chk1p branch 
of checkpoint response, is essential for the processing of aberrant DNA structures that 
arise in S-phase (Win et al., 2004). The induction of all these proteins could indicate 
an enhanced rate of fork instability in ∆flp1, which also correlates with Cds1p partial 
loss of function in this mutant. Accordingly, 10 genes involved in recombinational 
processes were also found to present increased expression. Among them both 
homologues of S. cerevisiae rad52, rad22 and rti1/rad22B, whose products have been 
shown to interact with each other and with Rhp51p (Rad51p in S. cerevisiae) and 
Rad11p/RPA (Kim et al., 2000; Tsutsui et al., 2001; van den Bosch et al., 2002). 
Although the expression of rph51 remained unaffected in our study, expression of rlp1, 
which codifies for a Rad51p like protein that works in the Rhp51p branch, also 
DISCUSSION 
154 
resulted enhanced. Rad22p has been shown to appear in repair foci together with 
Rhp51p when the S-phase checkpoint is not active (Meister et al., 2005).  In S. 
cerevisiae RPA inhibits Rad51p binding to recombination sites, due to its high affinity 
to ssDNA, and Rad52p acts as a mediator protein to help Rad51p binding to ssDNA 
during homologous recombination. Interestingly RPA codifying gene in S. pombe, 
rad11, resulted to be repressed in ∆flp1. In this way induction of rad22 and rti1 and 
repression of rad11 could account for a favoring of Rhp51p function during replication 
stress in cells deleted for flp1. On the other hand, the induction of genes implicated in 
recombinational processes in cells deleted for flp1 may indicate that the phosphatase 
is directly (acting as a transcriptional repressor) or indirectly (through its action in 
Cds1p) involved in inhibiting recombination. This may explain the need for Flp1p 
degradation in the course of MMS treatment to allow for DNA repair and its 
stabilization during replication stress to inhibit detrimental recombinational processes 
during S-phase block. 
Analysis of the modification on expression levels of CESR genes 
in ∆flp1  
Global transcriptional response of wt cells to HU has been shown to partially overlap 
with the previously defined Core Environmental Stress Response (CESR) (Chu et al., 
2007). According to our results, the Core Environmental Stress Response is partially 
deregulated in a ∆flp1 strain. Approximately 25% of the CESR genes regarded in our 
analysis presented an altered level of expression with respect to the wt transcriptional 
response (51 deregulated, 206 CESR, see RESULTS). This significant deregulation of 
genes included in the central mechanism of transcriptional response to stress, could 
point to a role of Flp1p in directly controlling gene expression in perturbed 
environmental conditions. This hypothesis is supported by observations from our 
laboratory that relate flp1 to atf1 (Canete & Bueno, unpublished results).  A specially 
deregulated CESR group is that of antioxidants with three down-regulated genes in 
∆flp1 (ctt1, gpx1 and pmp20) with respect to the stress triggered induction in wt. As 
stressed in the introduction, only two genes coding for proteins involved in DNA repair 
and two coding for heat shock proteins present an enhanced transcription in the 
environmental stress response. Correlating with the deregulation of CESR in ∆flp1, 
this strain presents up-regulation of one of the genes involved in DNA repair 
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(SPBC23G7.11) and down-regulation of the heat-shock protein encoding gene hsp16. 
The CESR stress response gene rds1 is also down-regulated in Δflp1.  
Analysis of the deregulation of the specific checkpoint response 
to HU in ∆flp1 
Genome wide micro-array analyses of the gene expression profiles during HU 
treatment revealed that two clusters of genes are specifically regulated as a result of 
checkpoint response to replication stress: the MCB (up-regulated during the S-phase 
arrest) and the FKH (down-regulated during the S-phase arrest) clusters of genes 
(Chu et al., 2007). The S-phase peak of expression of MCB cluster during replication 
stress (which includes genes such as cdc22, cdc18, cdt1, and cig2, essential for DNA 
replication) is dependent on both Rad3p and Cds1p, and probably occurs to maintain 
forks in a replication competent state to allow for an adequate recovery from 
checkpoint block. According to our analysis ∆flp1 presents reduced gene expression 
of the MCB components cig2, cdc22, cdc18 and SPAC644.05c during HU treatment. 
Expression of MBF genes, responsible for MCB induction, did not appear to be 
modified in our analyses, although the gene pas1, whose product is known to be 
involved Res2p-Cdc10p activation, was repressed in ∆flp1 with respect to wt. 
Repression of MCB induction in ∆flp1, correlates with our observations showing 
reduced Cds1p levels and activity during HU treatment in cells deleted for flp1, further 
supporting a role of the phosphatase in regulating adequate checkpoint response, in 
this case at the transcriptional level. 
7. A MATHEMATICAL MODEL FOR CHECKPOINT RESPONSE 
TO REPLICATION STRESS IN S. pombe 
In the framework of our investigation involving the role of Flp1p in checkpoint 
response to replication stress, we undertook the task of building a mathematical model 
for this signalling pathway in S. pombe. As emphasized previous sections, the model 
here presented is the result of an ongoing collaboration with the Computational 
Systems Biology Group of the Max Planck Institute for Molecular Genetics in Berlin, 
and should be regarded as preliminary. Including the sections involving our 
mathematical approach to checkpoint response we intend to give an insight into the 
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general process of developing mathematical models for biological networks, and show 
our achievements in building a novel model that accounts both for a simplified vision 
of cell cycle progression and for checkpoint response to replication stress. In this 
section, we will also discuss some of the improvements that will be made to the model 
and the future applications of the final, validated model. 
Novel features of the presented model 
As underscored in RESULTS, in order to develop an accurate model for checkpoint 
response, we first put our efforts in building a model for cell cycle progression 
adequate for our requirements. The currently available models for global cell cycle in 
S. pombe (that is, including progression through all cell cycle phases) (Novak, 1998 et 
al.; Sveiczer, 2000 et al.), force cell cycle progression by means of switches or 
programmed changes in the values of some parameters. These switches are activated 
if some species or reactions reach a certain threshold and are purely mathematical 
triggers inspired in biological observations. Since cell cycle and checkpoint regulation 
involve common species that are differently regulated, these external switches for 
cycle progression in unaltered conditions would interfere with the control of cell cycle 
progression during checkpoint activation. Therefore, in order to build a checkpoint 
module for replication stress conditions, we needed a cell cycle model entirely 
regulated by the species and reactions included in the model. We have thus presented 
here a self-regulated model, able to reproduce without mathematical switches the 
biological oscillations describing cell cycle progression. This model has been greatly 
simplified according to the assumptions listed in RESULTS and does not intend to 
account for a detailed mechanistic description of each cell cycle phase, but can still 
reproduce an adequate profile of Cdc2p activity during the entire cycle and includes 
the main players involved both in cell cycle and in checkpoint response to replication 
stress. The need to build the model in a reductionist way is linked to the lack of 
quantitative data for protein concentrations and reaction rates in S. pombe. This 
forced us to estimate all parameters and initial concentrations of the model, and made 
us keep the parameter set as reduced as possible.  
On the other hand, a remarkable feature of our cell cycle model is that it has been 
fitted to experimental data points. That is, the parameter set has been selected in a 
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way that the system is not only able to reproduce the qualitative behaviour of the 
system but can also account for specific dynamic profiles represented by experimental 
time courses.  
Regarding the checkpoint module, we present a model that is able to describe the 
observed down-regulation of Cdc2p activity as a result of detection of replication 
stress, as well as Cds1p activation and Cdc25p accumulation. In this model, we have 
included for validation a module for our proposed model for the role of Flp1p in 
checkpoint response to replication stress, discussed in previous sections. We have 
used once again experimental data to fit the parameters of the module, and we were 
able to validate the model using experimental data points for Δflp1. Importantly, in 
addition to accounting for correct profiles for checkpoint response in wt, the model in 
its current state already accounts for a decrease in Cds1p activation in cells lacking 
Flp1p, as well as modified activation dynamics of the checkpoint kinase.  
Outlook 
As stated in RESULTS the presented model does not adequately account for 
regulation of Cdc25p protein levels during cell cycle progression or during checkpoint 
in Δflp1. Due to this defect at the validation stage, we are currently developing an 
improved version based on a new scheme for Cdc25p regulation. On the other hand, 
some other changes are being included to improve the biological description of the 
system homogenize the kinetics of the involved reactions. The new scheme and an 
explanation of the planned improvements are found in Figure D2. 
Once we obtain a fitted and validated model capable of satisfactorily reproducing the 
dynamic behaviour of all species involved, we will subject the system to different 
analyses. With them, we intend to better understand some issues arising from our 
investigation, like the differential role of Flp1p in maintaining cell cycle and checkpoint 
stability: a mathematical/mechanistic explanation for our observations of moderate 
defectiveness in checkpoint response for Δflp1 and opflp1; A mathematical description 
of the different thresholds of Cds1p activity linked to fork stability and checkpoint 
block, and the role of Flp1p in reaching them, etc. On the other hand, both built 
modules for cell cycle progression and checkpoint response can be used as basis for  
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Figure D2. A new working model for checkpoint response to replication stress in S. pombe. 
As explained in the main text some changes in the working scheme are planned to 
obtain an improved version of the model. These include a refinement of Cdc25p 
regulation: inclusion of the dependence on APC of Cdc25p degradation, enforcement 
of Flp1p action over Cdc25p inactivation and inclusion of a secondary degradation 
system for Cdc25p. This new regulatory mechanism will allow us to include only one 
inactive form of Cdc25p both for cell cycle and checkpoint response. On the other 
hand, input to the degraded species will be written to their respective inactive forms, 
which better accounts for biological observations. Regarding checkpoint response, we 
plan to use the experimental activation profile of Cds1p as an input to reduce the 
uncertainty of the system. 
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more descriptive and comprehensive models. This will be of special interest once 
measured data for species concentrations and/or reactions rates will be available for 
S. pombe 
. 

  
CONCLUSIONS 
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1. The phosphatase Flp1p is involved in checkpoint response to genotoxic stress: 
a. Mutants of flp1 present moderate defects in checkpoint response to 
replication stress. 
b. Flp1p changes its subcellular localization in cells exposed to genotoxic 
stress in a checkpoint dependent manner: 
i. Release of Flp1p to the nucleus during replication stress depends on 
Cds1p and most likely occurs through phosphorylation of the 
phosphatase.  
ii. Release of Flp1p to the nucleus is a determinant step for its activity in 
checkpoint response. Retention of Flp1p in the nucleolus during 
replications stress results phenotypes similar to that of the deletion of 
flp1.  
c. Flp1p performs a function in checkpoint response that is independent from 
its regulatory role during unperturbed cell cycle. Flp1p does not alter 
Cdc25p accumulation or Cdc2p Tyr15 phosphorylation profiles during 
checkpoint response to genotoxic stress, even if Cdc2p and Cdc25p are 
regulatory targets of this signalling cascade. 
d. Flp1p and Cds1p show a close interplay during checkpoint response to 
replication stress that results in the full activation of the kinase. The 
phenotypes associated to a partially deficient checkpoint in flp1 mutants 
can be explained appealing to the reduced Cds1p activity they present. 
e. Flp1p might play an active role in the regulation of the transcriptional 
response to replication stress.  
2. We have achieved a mathematical model that accounts for the simulation of 
both unperturbed cell cycle and checkpoint response to replication stress in S. 
pombe. An improved model is under development. By means of this future 
improved and validated model we intend to clarify some aspects of our 
investigation relating the mechanism of action of Flp1p in checkpoint response 
to unreplicated DNA. 
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Ribosomal proteins and protein sintesis 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPBC11G11.03 
 60S acidic ribosomal 
protein (predicted) -4.20 0.999980 
S. pombe 
SPBC947.07   
Involved in ribosome 
biogenesis and 
assembly (predicted)
2.11 0.000492 
S. pombe 
SPAC3A12.10  rpl2001  
60S ribosomal 
protein L20a -3.30 0.998514 
S. pombe 
SPCC1840.10  lsm8  
Ribonucleoprotein 
(RNP) complex 3.54 0.000030 
S. pombe 
SPCC1322.15  rpl3402  
60S ribosomal 
protein L34 -3.15 0.998168 
S. pombe 
SPMIT.08  rps3  
Ribosomal small 
subunit 5.57 0.000020 
S. pombe 
SPBC11C11.09c  rpl502  
60S ribosomal 
protein L5 -3.13 0.998799   
   
S. pombe 
SPAC3H5.07  rpl701  
60S ribosomal 
protein L7 -3.25 0.999562   
   
S. pombe 
SPAC664.06  rpl703  
60S ribosomal 
protein L7 -4.33 0.999980   
   
S. pombe 
SPBC839.04  rpl803  
60S ribosomal 
protein L8 -3.26 0.999954   
   
S. pombe 
SPAC31G5.17c  rps1001  
40S ribosomal 
protein S10 -2.58 0.998514   
   
S. pombe 
SPAC3H5.05c  rps1401  
40S ribosomal 
protein S14 -3.68 0.999980   
   
S. pombe 
SPAC1805.11c  rps2602  
40S ribosomal 
protein S26 -3.39 0.999034   
   
  
Ribosomal proteins and protein sintesis 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC8C9.08  rps5  
40S ribosomal 
protein S5 -4.14 0.999980   
   
S. pombe 
SPBC14F5.03c  kap123  Karyopherin -3.71 0.999980   
   
S. pombe 
SPCC1840.03  sal3  Karyopherin -3.80 0.999980   
   
S. pombe 
SPAC1B1.03c  kap95  
Karyopherin 
(predicted) -3.54 0.999965   
   
S. pombe 
SPAC30D11.04c nup124 Nucleoporin -3.56 0.999899   
   
S. pombe 
SPBC20F10.01  gar1  
Ribonucleoprotein 
(RNP) complex 
(PMID 8502556) 
-4.97 0.999980      
S. pombe 
SPBC646.10c  
 
Ribonucleoprotein 
(RNP) complex 
(predicted) (PMID 
12068309) 
-3.39 0.999382      
S. pombe 
SPCP1E11.08  
 
Ribosomal protein 
(S8E subunit) 
(predicted) 
-3.62 0.999886      
S. pombe 
SPAC18G6.07c  mra1  
Functions 
downstream of 
Ras1p 
-3.53 0.999382      
  
Ribosomal proteins and protein sintesis 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC140.02  gar2  GAR family -5.18 0.999980   
   
S. pombe 
SPBC2D10.10c  fib1  Fibrillarin -3.02 0.999899   
   
S. pombe 
SPAC12G12.06c  
 
RNA 3-terminal 
phosphate cyclase 
(predicted) 
-4.05 0.999965      
  
 
Putative transcription factors and general transcription 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC17H9.04c   RNA-binding protein -3.72 0.999034 
S. pombe 
SPCC338.16 pof3 F-box protein 3.24 0.000020 
S. pombe 
SPAC644.16   RNA-binding protein -3.66 0.999308 
S. pombe 
SPCC1223.04c   
Histone lysine 
methyltransferase 
(predicted) 
2.78 0.000020 
S. pombe 
SPCC1183.07   RNA-binding protein -3.36 0.999226 
S. pombe 
SPBC1718.02  hop1  
Horma domain 
protein (inferred from 
context) 
2.75 0.000020 
S. pombe 
SPCC550.14   RNA-binding protein -4.12 0.999980 
S. pombe 
SPCC584.02  cuf2  
Involved in copper 
homeostasis 6.18 0.000020 
S. pombe 
SPBP8B7.11  nxt3  RNA-binding protein -2.79 0.999562 
S. pombe 
SPBC1778.02  rap1  
Involved in telomere 
maintenance 3.01 0.000020 
S. pombe 
SPAC10F6.06  vip1  
rrm RNA recognition 
motif -3.40 0.999970 
S. pombe 
SPBC317.01  pvg4  
MADS-box 
transcription factor 3.05 0.000020 
S. pombe 
SPAC1783.07c  
pap1/ 
caf3 Transcription factor -2.89 0.999135 
S. pombe 
SPAC31G5.10  eta2  Myb family 2.32 0.000020 
S. pombe 
SPAC8C9.14  prr1  Transcription factor -4.21 0.999811 
S. pombe 
SPBC31F10.04c  srb4  
RNA polymerase II 
holoenzyme 
component (PMID 
10625684) 
2.68 0.000027 
S. pombe 
SPAC25G10.03  zip1  Transcription factor -3.48 0.999448 
S. pombe 
SPAC1002.15c  pmc5  
RNA polymerase II 
holoenzyme 
component (PMID 
10625684) 
2.64 0.000020 
  
Putative transcription factors and general transcription 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC23C4.19  spt5  
Involved in 
transcriptional 
regulation 
-3.59 0.998168 S. pombe SPAC23H4.17c  srb10  
Serinethreonine 
protein kinase 
(predicted) 
2.27 0.000020 
S. pombe 
SPAC26H5.05   
Involved in 
transcriptional 
regulation 
(predicted) 
-3.05 0.999034 S. pombe SPCC1739.05   SET domain 1.98 0.000020 
S. pombe 
SPBC11B10.10c  pht1  Histone H2A variant -3.46 0.999833 
S. pombe 
SPBC215.04  git11  
Heterotrimeric G 
protein (gamma 
subunit) (PMID 
11238401) 
2.73 0.000040 
S. pombe 
SPCC622.09  htb1  
Histone H2B (alpha) 
(PMID 3018512) -4.49 0.999980 
S. pombe 
SPBC1861.07   SKP1 family 2.52 0.000147 
S. pombe 
SPBC1105.11c  h3.3  Histone H3 -3.08 0.999811 
S. pombe 
SPBC2D10.06 rep1 Transcription factor 2.83 0.000020 
S. pombe 
SPBC8D2.04  hht2  Histone H3 -3.00 0.999948 
S. pombe 
SPAC22F3.09c mcs1 Transcription factor 2.65 0.000214 
S. pombe 
SPBC1105.12  h4.3  Histone H4 -3.30 0.999980 
S. pombe 
SPAC22F3.02  atf31  Transcription factor 3.32 0.000035 
S. pombe 
SPAC1834.03c  hhf1  Histone H4 -3.03 0.999980 
S. pombe 
SPBC2F12.09c  atf21  Transcription factor 5.92 0.000020 
S. pombe 
SPBC8D2.03c  hhf2  Histone H4 -2.92 0.999811 
S. pombe 
SPAC11E3.06  map1  Transcription factor 3.05 0.000020 
S. pombe 
SPBC1289.07c  rpc40  
DNA-directed RNA 
polymerase (I and III 
subunit) (predicted) 
-3.92 0.999965 S. pombe SPBC32H8.11  mei4  
Transcription factor 
(meiotic) (PMID 
9528784) 
3.64 0.000020 
  
Putative transcription factors and general transcription 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC1B3.12c  rpb10  
DNA-directed RNA 
polymerase (I, II, and 
III subunit) 
-2.63 0.999922 S. pombe SPBP4H10.09  rsv1  
Transcription factor 
(predicted) 3.50 0.000020 
S. pombe 
SPCC1020.04c  rpb6  
DNA-directed RNA 
polymerase (I, II, and 
III subunit) 
-3.35 0.999226 S. pombe SPBC13E7.10c  brf1  
Transcription factor 
TFIIIB complex 
(PMID 12682361) 
2.07 0.000046 
S. pombe 
SPAC23C4.15  rpb5  
DNA-directed RNA 
polymerase (I, II, and 
III subunit) (PMID 
9077438) 
-3.45 0.999932 S. pombe SPCC1919.14c  bdp1  
Transcription factor 
TFIIIB complex 
(predicted) 
2.01 0.000020 
S. pombe 
SPAC23G3.01  rpb2  
DNA-directed RNA 
polymerase (II 
subunit) 
-3.98 0.999786 S. pombe SPCC61.02  spt3  
Transcription 
initiation factor 
activity 
2.94 0.000020 
S. pombe 
SPAC3F10.03   Glycine tRNA-ligase -3.83 0.999980 
S. pombe 
SPAC10F6.08c   
Transcriptional 
regulator 3.36 0.000020 
S. pombe 
SPCC364.06  nap1  -4.02 0.999562 
S. pombe 
SPAC16A10.02   
TREX complex 
(predicted) 2.21 0.000035 
S. pombe 
SPBC4C3.05c  nuc1  
DNA-directed RNA 
polymerase I 
complex (large 
subunit) (PMID 
2537310) 
-3.92 0.999853 S. pombe SPBPB8B6.04c  grt1  zinc finger protein 2.35 0.001077 
S. pombe 
SPAC29E6.08  tbp1  
TATA-binding 
protein (TBP) -4.07 0.999973 
S. pombe 
SPBP35G2.10  cfp1 Zinc finger protein 2.75 0.000027 
     S. pombe SPBC1685.08   Zinc finger protein 2.11 0.000020 
  
Putative transcription factors and general transcription 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
     S. pombe SPCC576.13  swc5 
Chromatin 
remodeling complex 2.41 0.000052 
     S. pombe SPAC31G5.12c  
n150/ 
maf1 
Conserved 
eukaryotic protein 2.99 0.000020 
  
 
Translation 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC3C7.08c  elf1  AAA family ATPase -4.26 0.999562 
S. pombe 
SPAC167.03c snu66 
Involved in mRNA 
splicing 2.48 0.000020 
S. pombe 
SPBC9B6.04c   
Translation 
elongation factor 
(predicted) 
-4.56 0.999980 S. pombe SPBC3E7.13c  
Involved in mRNA 
splicing (predicted) 2.64 0.000046 
S. pombe 
SPAC29A4.02c   
Translation 
elongation factor 1 
(gamma subunit) 
(PMID 9099890) 
-3.10 0.999922 S. pombe SPCC126.14 prp18 
Involved in mRNA 
splicing (predicted) 
(2nd step) (PMID 
12212850) 
5.89 0.000020 
S. pombe 
SPCC417.08  tef3  
Translation 
elongation factor 
activity (TAS) (PMID 
9099890) 
-3.68 0.999853 S. pombe SPBC660.10   
Involved in 
translational 
elongation (factor g) 
2.04 0.000020 
S. pombe 
SPAC1006.07   
Translation initiation 
factor -4.06 0.999980 
S. pombe 
SPAC323.08   
Involved in tRNA 
processing (ISS) 3.01 0.000020 
S. pombe 
SPAC25G10.08   
Translation initiation 
factor -5.26 0.999853 
S. pombe 
SPAC1805.09c  fmt1 
Methionyl-tRNA 
formyltransferase 
(predicted) 
3.54 0.000020 
S. pombe 
SPAC2F7.05c   
Translation initiation 
factor -3.80 0.999886 
S. pombe 
SPBC2F12.08c  ceg1  
mRNA guanylyl 
transferase 2.19 0.000020 
S. pombe 
SPAC343.14c   
Translation initiation 
factor -3.20 0.999693 
S. pombe 
SPCC63.07   
tRNA 
guanylyltransferase 
activity (predicted) 
2.11 0.000020 
  
Translation 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC821.05   
Translation initiation 
factor -3.40 0.999922 
S. pombe 
SPBC1289.02c  uap2  
U2 snRNA-
associated protein 2.09 0.000020 
S. pombe 
SPCC11E10.07c   
Translation initiation 
factor -3.52 0.999980 
S. pombe 
SPAC4A8.08c   
Valine-tRNA ligase 
(predicted) 2.98 0.000020 
S. pombe 
SPAC637.07  moe1  
Translation initiation 
factor -3.82 0.999977 
S. pombe 
SPBC1685.06  cid11  Cid1-related 4.42 0.000020 
S. pombe 
SPBC18H10.04c  sce3  
Translation initiation 
factor -4.55 0.999980 
S. pombe 
SPCC663.12  cid12  Cid1-related 2.36 0.000020 
S. pombe 
SPAC4D7.05  sum1  
Translation initiation 
factor -3.30 0.999693 
S. pombe 
SPBC18H10.10c  cwc16  
Conserved 
eukaryotic protein 4.13 0.000020 
S. pombe 
SPBC25H2.07  tif11  
Translation initiation 
factor -3.82 0.999973      
S. pombe 
SPAC3G9.09c  tif211  
Translation initiation 
factor -4.37 0.998799      
S. pombe 
SPAC32A11.04c  tif212  
Translation initiation 
factor -4.13 0.999980      
S. pombe 
SPAC8C9.15c  tif225  
Translation initiation 
factor -3.19 0.999226      
S. pombe 
SPBC17D11.05  tif32  
Translation initiation 
factor -4.96 0.999980      
S. pombe 
SPAC4A8.16c  tif33  
Translation initiation 
factor -3.43 0.999977      
S. pombe 
SPBC18H10.03  tif35  
Translation initiation 
factor -4.08 0.999970      
  
Translation 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC16E8.15  tif45  
Translation initiation 
factor -3.48 0.999970      
S. pombe 
SPAC17C9.03  tif471  
Translation initiation 
factor -4.21 0.999980      
S. pombe 
SPAC26H5.10c  tif51  
Translation initiation 
factor -4.87 0.999960      
S. pombe 
SPCC1919.09  tif6  
Translation initiation 
factor -4.13 0.999886      
S. pombe 
SPBC646.09c  yin6  
Translation initiation 
factor -3.74 0.999833      
S. pombe 
SPBC17G9.09  tif213  
Translation initiation 
factor 2 (gamma 
subunit) 
-3.62 0.999980      
S. pombe 
SPAC56F8.03   
Translation initiation 
factor if-2 (predicted) -3.26 0.999759      
S. pombe 
SPAC1834.01  sup45  
Translation release 
factor (PMID 
9701287) 
-3.04 0.999382      
S. pombe 
SPCC584.04  sup35  
Translation release 
factor eRF3 (class II) 
(PMID 9701287) 
-3.84 0.999980      
S. pombe 
SPCC830.07c  psi1  
DNAJ domain 
protein -3.90 0.999965      
S. pombe 
SPBC14F5.06   Iron-sulfur protein -4.66 0.999980      
  
Translation 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPBC8D2.06   
Isoleucine-tRNA 
ligase (predicted) -4.04 0.999980      
S. pombe 
SPAC26F1.13c   
Leucine-tRNA ligase 
(predicted) -3.86 0.999899      
S. pombe 
SPBC17G9.03c   Lysine-tRNA ligase -4.13 0.999759      
S. pombe 
SPBC17A3.04c   
Methionine-tRNA 
ligase (predicted) -3.61 0.999922      
S. pombe 
SPBC25B2.09c   Arginine-tRNA ligase -3.99 0.999980      
S. pombe 
SPBC28F2.02  mep33  mRNA export protein -2.65 0.998923      
S. pombe 
SPAC29A4.15   Serine-tRNA ligase -3.63 0.999980      
S. pombe 
SPBC25H2.02  ths1  
Threonine-tRNA 
ligase (predicted) -3.80 0.999980      
S. pombe 
SPBC19C7.06   
Proline-tRNA ligase 
(predicted) -4.54 0.999973      
S. pombe 
SPAC2F7.13c   
Tryptophan-tRNA 
ligase (predicted) -3.23 0.999980      
S. pombe 
SPCC1672.05c   
Tyrosine-tRNA 
ligase (predicted) -2.90 0.999833      
S. pombe 
SPBC1709.02c   
Valine-tRNA ligase 
(predicted) -3.28 0.999980      
 
  
 
Protein Folding and Degradation 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPBC3E7.02c hsp16 Heat shock protein -3.57 0.999980 
S. pombe 
SPAC19G12.01c  cut20  
Anaphase-promoting 
complex (APC) 1.97 0.000020 
S. pombe 
SPAC12G12.04 mcp60 
Heat shock protein 
60 -4.34 0.999980 
S. pombe 
SPBC83.04  apc15  
Anaphase-promoting 
complex (APC) 
(PMID 12477395) 
1.99 0.000035 
S. pombe 
SPAC57A7.12  
Heat shock protein 
70 family -4.17 0.999980 
S. pombe 
SPBC28E12.01c  apc13  
Anaphase-promoting 
complex (APC) 
(PMID 12477395) 
3.71 0.000068 
S. pombe 
SPAC110.04c pss1 
Heat shock protein 
70 family -3.50 0.999980 
S. pombe 
SPBC1A4.01  apc10  
Anaphase-promoting 
complex (APC) 
(PMID 9736616) 
2.14 0.000241 
S. pombe 
SPAC13G7.02c ssa1 
Heat shock protein 
70 family -4.20 0.999980 
S. pombe 
SPAC21E11.05c  cyp8  Cyclophilin 3.63 0.000020 
S. pombe 
SPBC12D12.03  cct1  
Chaperonin-
containing T-
complex 
-4.82 0.999980 S. pombe SPCC10H11.02  cwf23  
DNAJ domain 
protein 3.41 0.000020 
S. pombe 
SPBC1A4.08c  cct3  
Chaperonin-
containing T-
complex 
-3.82 0.999932 S. pombe SPBC1773.09c  mug184 
DNAJ domain 
protein 3.30 0.000020 
S. pombe 
SPBC646.11  cct6  
Chaperonin-
containing T-
complex 
-3.00 0.999960 S. pombe SPCC63.03   
DNAJ domain 
protein 3.91 0.000020 
  
Protein Folding and Degradation 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPBC25H2.12c  cct7  
Chaperonin-
containing T-
complex 
-4.85 0.999980 S. pombe SPCC63.13   
DNAJ domain 
protein 3.41 0.000167 
S. pombe 
SPBC337.05c  cct8  
Chaperonin-
containing T-
complex 
-3.72 0.999954 S. pombe SPAC4G9.19   
DNAJ domain 
protein 2.48 0.000020 
S. pombe 
SPBP19A11.03c  mts4  
19S proteasome 
regulatory subunit -4.18 0.999973 
S. pombe 
SPAC17G6.05c   
Endosome 
associated protein 
(predicted) 
3.08 0.000023 
S. pombe 
SPAC637.10c  pus1  
19S proteasome 
regulatory subunit -3.18 0.999448 
S. pombe 
SPBC3H7.06c  pof9  F-box protein 2.61 0.000020 
S. pombe 
SPBC16G5.01  rpn12  
19S proteasome 
regulatory subunit -3.72 0.999226 
S. pombe 
SPCC338.16  pof3  F-box protein 3.24 0.000020 
S. pombe 
SPBC17D11.07c  rpn2  
19S proteasome 
regulatory subunit -3.64 0.999833 
S. pombe 
SPAC16A10.03c  vps11  
Involved in 
intracellular protein 
transport (predicted) 
2.29 0.000020 
S. pombe 
SPAC23G3.11  rpn6  
19S proteasome 
regulatory subunit -4.39 0.999448 
S. pombe 
SPBC1734.05c  spf31  
Spliceosome 
associated protein 
(predicted) 
2.12 0.000040 
S. pombe 
SPBC582.07c  rpn7  
19S proteasome 
regulatory subunit -4.35 0.999980 
S. pombe 
SPCC777.10c  ubc12  
Ubiquitin conjugating 
enzyme 2.49 0.000618 
S. pombe 
SPCC1682.10  rpn8  
19S proteasome 
regulatory subunit -3.36 0.999980 
S. pombe 
SPBP8B7.27   
Ubiquitin-protein 
ligase (E3) 2.77 0.000020 
S. pombe 
SPBC16C6.07c  rpt1  
19S proteasome 
regulatory subunit -4.24 0.999980 
S. pombe 
SPBC32H8.02c  nep2 Ulp1 protease family 2.47 0.000020 
  
Protein Folding and Degradation 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPCC1682.16  rpt4  
19S proteasome 
regulatory subunit -2.99 0.999899 
S. pombe 
SPCC4G3.03   WD repeat protein 2.69 0.000020 
S. pombe 
SPBC23G7.12c  rpt6  
19S proteasome 
regulatory subunit -3.89 0.999226 
S. pombe 
SPBC3D6.11c  slx8  Zinc finger protein 2.37 0.000020 
S. pombe 
SPAC1420.03  rpn501  
19S proteasome 
regulatory subunit 
(PMID 12783882) 
-3.40 0.999980 S. pombe SPAC16E8.13   Zinc finger protein 2.22 0.000020 
S. pombe 
SPBC4.07c  rpt2  
19S proteasome 
regulatory subunit 
(PMID 8247131) 
-3.44 0.999654 S. pombe SPBC1685.08   Zinc finger protein 2.11 0.000020 
S. pombe 
SPBC646.16   
20S proteasome 
component (alpha 1) -4.58 0.999980 
S. pombe 
SPAC6B12.08   Zinc finger protein 4.55 0.000035 
S. pombe 
SPCC1442.06   
20S proteasome 
component (alpha 2) -3.27 0.999886      
S. pombe 
SPAC323.02c   
20S proteasome 
component (alpha 5) -3.39 0.999899      
S. pombe 
SPAC6G10.04c   
20S proteasome 
component (alpha 6) -4.55 0.999980      
S. pombe 
SPCC1795.04c   
20S proteasome 
component (alpha 7) -3.82 0.999448      
S. pombe 
SPBC4C3.10c   
20S proteasome 
component (beta 1) -4.11 0.999980      
S. pombe 
SPAC23D3.07   
20S proteasome 
component (beta 2) -4.27 0.999980      
S. pombe 
SPCC63.12c   
20S proteasome 
component (beta 3) -4.19 0.999980      
  
Protein Folding and Degradation 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC31A2.04c   
20S proteasome 
component (beta 4) -3.45 0.999226      
S. pombe 
SPAC4A8.13c  pts1  
20S proteasome 
component (beta 5) -3.97 0.999948      
S. pombe 
SPAC22F8.06  pam1  
20S proteasome 
component (beta 6) -4.08 0.999977      
S. pombe 
SPBC577.10   
20S proteasome 
component (beta 7) -3.64 0.998168      
S. pombe 
SPAC18B11.07c  rhp6  
Ubiquitin conjugating 
enzyme -3.27 0.999727      
S. pombe 
SPCC338.05c  spm2  
Ubiquitin conjugating 
enzyme -3.60 0.999948      
S. pombe 
SPBC1105.09  ubc15  
Ubiquitin conjugating 
enzyme -2.81 0.998664      
S. pombe 
SPBC713.02c  ubp21  
Ubiquitin C-terminal 
hydrolase activity -2.88 0.999382      
S. pombe 
SPAC26A3.16  dph1  
Ubiquitin family 
protein -4.23 0.999508      
S. pombe 
SPAC1805.12c  uep1  
Ubiquitin family 
protein -2.81 0.998799      
S. pombe 
SPAC15A10.11  ubr11  
Ubiquitin-protein 
ligase (E3) -3.18 0.999870      
S. pombe 
SPAC3C7.11c  cnx1  
Calnexin (PMID 
7876257) -3.79 0.999973      
  
Protein Folding and Degradation 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPBC3B9.19  mge1 
Chaperone activity 
(predicted) -3.83 0.999886      
S. pombe 
SPBC1734.11   
Chaperone regulator 
activity (predicted) -4.94 0.999980      
S. pombe 
SPAC2E1P5.03   
DNAJ domain 
protein -3.22 0.999940      
S. pombe 
SPCC830.07c  psi1  
DNAJ domain 
protein -3.90 0.999965      
S. pombe 
SPAC19D5.04  ptr1  HECT domain -3.60 0.999973      
S. pombe 
SPCC14G10.03c   
Proteasome 
maturation factor 
(predicted) 
-3.18 0.999886      
S. pombe 
SPAC19G12.10c  cpy1  
Serine 
carboxypeptidase 
(IDA) (PMID 
9209031) 
-4.00 0.999977      
S. pombe 
SPCC645.14c  sti1  TPR repeat protein -4.99 0.999980      
S. pombe 
SPCC1795.11  sum3  
DEADDEAH box 
helicase -5.40 0.999980      
S. pombe 
SPAC17G6.14c  uap56  
DEADDEAH box 
helicase -4.07 0.999965      
S. pombe 
SPAC1F7.02c   
DEADDEAH box 
helicase -3.24 0.998514      
  
Protein Folding and Degradation 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC694.02   
DEADDEAH box 
helicase -2.54 0.999811      
S. pombe 
SPBC17D1.06   
DEADDEAH box 
helicase -3.94 0.999980      
S. pombe 
SPCC285.03   
DEADDEAH box 
helicase -2.95 0.999135      
S. pombe 
SPAC16C9.06c  upf1 
Involved in mRNA 
catabolism, 
nonsense-mediated 
-3.19 0.999786      
 
  
 
Stress response 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC17A2.13c  rad25  14-3-3 protein -4.56 0.999811 
S. pombe 
SPBC16G5.12c top3 DNA topoisomerase III 3.61 0.000020 
S. pombe 
SPAC1565.08  cdc48  AAA family ATPase -5.00 0.999980 
S. pombe 
SPBC3D6.10  apn2  
DNA-(apurinic or 
apyrimidinic site) lyase 
activity (predicted) 
2.72 0.000052 
S. pombe 
SPAC1783.07c  
pap1/ 
caf3 Transcription factor -2.89 0.999135 
S. pombe 
SPAPB1E7.06c  eme1  
Endodeoxyribonuclease 
RUS activity (PMID 
11741546) 
3.27 0.000438 
S. pombe 
SPBC3F6.03  
trr1/ 
caf4 
Thioredoxin 
reductase -3.27 0.999562 
S. pombe 
SPCC191.09c  gst1  
Glutathione S-
transferase (PMID 
12063243) 
4.69 0.000020 
S. pombe 
SPAC8C9.14  prr1  Transcription factor -4.21 0.999811 
S. pombe 
SPCC1281.07c   
Glutathione S-
transferase (predicted) 2.38 0.000241 
S. pombe 
SPCC757.07c  
ctt1/ 
cta1 Catalase -4.13 0.999980 
S. pombe 
SPBC20F10.06 mad2 Horma domain protein 2.49 0.000020 
S. pombe 
SPAC25G10.03  zip1  Transcription factor -3.48 0.999448 
S. pombe 
SPCC417.02  
dad5/ 
hos3  
Involved in osmotic 
stress response 
(required) (PMID 
10879493) 
3.40 0.000020 
S. pombe 
SPBC14C8.07c  cdc18  
Cell division control 
protein 18 -3.85 0.999886 
S. pombe 
SPAC27F1.04c  nuf2  
Localization spindle 
pole body 3.62 0.000020 
S. pombe 
SPBC649.04  uvi15  
Involved in stress 
response (required) -3.40 0.999693 
S. pombe 
SPBC336.08  spc24 
Localization spindle 
pole body (predicted) 3.13 0.000078 
  
Stress response 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPBC3E7.02c hsp16 Heat shock protein -3.57 0.999980 
S. pombe 
SPAC31G5.10  eta2  Myb family 2.32 0.000020 
S. pombe 
SPAC12G12.04 mcp60 
Heat shock protein 
60 -4.34 0.999980 
S. pombe 
SPBC14C8.01c  cut2  Securin 2.42 0.000241 
S. pombe 
SPAC57A7.12  
Heat shock protein 
70 family -4.17 0.999980 
S. pombe 
SPCC1259.13  chk1  
Serinethreonine protein 
kinase 4.52 0.000020 
S. pombe 
SPAC110.04c pss1 
Heat shock protein 
70 family -3.50 0.999980 
S. pombe 
SPCC18B5.03  wee1  
Serinethreonine protein 
kinase 3.27 0.000020 
S. pombe 
SPAC13G7.02c ssa1 
Heat shock protein 
70 family -4.20 0.999980 
S. pombe 
SPBC1685.06  cid11  Cid1-related 4.42 0.000020 
S. pombe 
SPBC409.13   
6,7-dimethyl-8-
ribityllumazine 
synthase (predicted)
-3.76 0.999970 S. pombe SPCC663.12  cid12  Cid1-related 2.36 0.000020 
S. pombe 
SPBC2A9.02   
Dyhydroflavanol-4-
reductase 
(predicted) 
-3.94 0.999980 S. pombe SPAC821.04c cid13 
Poly(A) polymerase 
(PMID 12062100) 2.65 0.000020 
S. pombe 
SPBC32F12.03c  gpx1  
Glutathione 
peroxidase (PMID 
10455235) 
-3.59 0.999980 S. pombe SPAC1805.07c  
dad2 
/hos2  
DASH complex 
(predicted) 2.02 0.000020 
S. pombe 
SPBC17A3.07  pgr1  
Glutathione 
reductase (PMID 
9287302) 
-3.57 0.999448 S. pombe SPAC589.08c  dam1 
DASH complex 
(predicted) 2.17 0.000346 
S. pombe 
SPCC965.07c  gst2  
Glutathione S-
transferase (PMID 
11997110) 
-3.47 0.999833 S. pombe SPCC188.13c dcr1 Dicer 2.00 0.000078 
  
Stress response 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPBC215.05  gpd1  
Glycerol-3-
phosphate 
dehydrogenase 
-5.98 0.999980 S. pombe SPAC4C5.02c  ryh1  Small GTPase 3.36 0.000020 
S. pombe 
SPAC343.12  rds1   -4.97 0.999977 
S. pombe 
SPBC725.02  mpr1/spy1 Speedy. 2.22 0.000020 
S. pombe 
SPBC16H5.11c  skb1  
Methyltransferase 
(PMID 11278267) -4.06 0.999948 
S. pombe 
SPAPB17E12.04c  csn2  
COP9signalosome 
complex (subunit 2) 
(PMID 11854407) 
2.14 0.000040 
S. pombe 
SPBC16D10.09  pcn1  
PCNA (PMID 
1361173) -3.50 0.999693      
S. pombe 
SPAC2G11.07c  ptc3  
Serinethreonine 
protein phosphatase -4.93 0.999980      
S. pombe 
SPAC19G12.15c  tpp1  
Trehalose-6-
phosphate 
phosphatase (PMID 
11004189) 
-3.05 0.999727      
 
  
 
DNA repair 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPCC622.08c hta1 
Histone H2A (alpha) 
(PMID 3018512) -3.86 0.999980 
S. pombe 
SPBC119.14 rti1 DNA binding 4.96 0.000618 
S. pombe 
SPAC19G12.06c hta2 Histone H2A (beta) -3.88 0.999980 
S. pombe 
SPAC23C11.04c  pnk1  
DNA 
kinasephosphatase 
(PMID 11729194) 
3.19 0.000020 
S. pombe 
SPBC660.13c 
ssb1/ 
rpa1 
/rad11 
DNA replication 
factor A complex 
(subunit 1) (PMID 
9111307) (PMID 
8702843) 
-3.96 0.999811 S. pombe SPAC2F7.06c  pol4 
DNA polymerase X 
family 7.96 0.000088 
S. pombe 
SPBC16D10.09  pcn1  
PCNA (PMID 
1361173) -3.50 0.999693 
S. pombe 
SPCC23B6.05c  ssb3  
DNA replication 
factor A complex 
(subunit 3) 
3.11 0.000020 
S. pombe 
SPBC3H7.15  hhp1  
Serinethreonine 
protein kinase -3.54 0.998799 
S. pombe 
SPBC3D6.10  apn2  
DNA-(apurinic or 
apyrimidinic site) 
lyase activity 
(predicted) 
2.72 0.000052 
     S. pombe SPBC23G7.11   
DNA-3-
methyladenine 
glycosidase 
3.59 0.000023 
     S. pombe SPAPB1E7.06c  eme1  
Endodeoxy 
ribonuclease RUS 
activity (PMID 
11741546) 
3.27 0.000438 
  
DNA repair 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
     S. pombe SPAC30D11.10  rad22  
Involved in DNA 
repair (PMID 
8290356) 
4.19 0.000020 
     S. pombe SPBC1685.11  rlp1 
Involved in DNA 
repair (predicted) 2.03 0.000020 
     S. pombe SPAC13A11.03  mcp7 
Involved in 
homologous 
chromosome pairing 
at meiosis 
(predicted) (PMID 
11940665) 
4.19 0.000020 
     S. pombe SPAC13F5.01c  msh1  MutS family 2.08 0.000020 
     S. pombe SPAC25G10.02 cce1 
Cruciform cutting 
endonuclease 4.26 0.000020 
     S. pombe SPAC9.05 mph1 
DEADDEAH box 
helicase 2.24 0.000020 
     S. pombe SPAC22F3.03c  rdh54  
DEADDEAH box 
helicase (PMID 
14551247) 
2.32 0.000020 
     S. pombe SPBC1347.01c  rev1 
Deoxycytidyl 
transferase 
(predicted) 
2.93 0.000020 
     S. pombe SPCC550.05 nse1 
Smc5-6 complex 
(PMID 12966087) 2.02 0.000020 
  
DNA repair 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
     S. pombe SPCC970.01 rad16 
ssDNA 
endonuclease 2.13 0.000020 
     S. pombe SPAP27G11.15  slx1  
Stucture-specific 
endonuclease 
(catalytic subunit) 
(PMID 14528010) 
2.45 0.000020 
     S. pombe SPAC688.06c  slx4  
Stucture-specific 
endonuclease 
(contributes_to) 
(PMID 14528010) 
2.55 0.000020 
 
  
 
DNA replication 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPBC660.13c 
ssb1/ 
rpa1 
/rad11 
DNA replication 
factor A complex 
(subunit 1) (PMID 
9111307) (PMID 
8702843) 
-3.96 0.999811 S. pombe SPAC2F7.06c pol4 
DNA polymerase X 
family 7.96 0.000088 
S. pombe 
SPBC14C8.07c  cdc18  
Cell division control 
protein 18 -3.85 0.999886 
S. pombe 
SPCC23B6.05c  ssb3  
DNA replication 
factor A complex 
(subunit 3) 
3.11 0.000020 
S. pombe 
SPBC16D10.09  pcn1  
PCNA (PMID 
1361173) -3.50 0.999693 
S. pombe 
SPBC16G5.12c  top3  
DNA topoisomerase 
III 3.61 0.000020 
S. pombe 
SPAC1F7.05  cdc22  
Ribonucleoside 
reductase -5.24 0.999980 
S. pombe 
SPBC428.08c  clr4  
Histone H3 
methyltransferase 4.06 0.000020 
S. pombe 
SPBC25D12.04  suc22  
Ribonucleotide 
reductase -3.97 0.999973 
S. pombe 
SPAC8F11.07c  cdc24  
Involved in DNA 
replication (required) 2.05 0.000020 
     S. pombe SPBC14C8.01c  cut2  Securin 2.42 0.000241 
     S. pombe SPAC25G10.02  cce1  
Cruciform cutting 
endonuclease 4.26 0.000020 
     S. pombe SPBC3D6.11c slx8 Zinc finger protein 2.37 0.000020 
 
  
 
Cell cycle and cytoskeleton organization 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAP8A3.08  cdc4  
Myosin II light chain. 
EF hand -3.94 0.999932 
S. pombe 
SPBC20F10.10   Cyclin 2.73 0.000020 
S. pombe 
SPAC110.03  cdc42  GTPase -4.33 0.999980 
S. pombe 
SPAC8F11.07c  cdc24  
Involved in DNA 
replication (required) 2.05 0.000020 
S. pombe 
SPBC21B10.04c  nrf1  
Chaperone activity 
(predicted) -2.90 0.999980 
S. pombe 
SPBC1604.20c  tea2  Kinesin-like protein 2.37 0.000020 
S. pombe 
SPAC1F7.04  rho1  GTPase -4.51 0.999980 
S. pombe 
SPAC3A11.14c  pkl1  Kinesin-like protein 1.99 0.000020 
S. pombe 
SPBC1289.03c  spi1  GTPase -2.53 0.999135 
S. pombe 
SPAC29E6.04  nnf1 
Localization spindle 
pole body 2.39 0.000346 
S. pombe 
SPAC18G6.03  ypt3  GTPase -4.56 0.999980 
S. pombe 
SPAC27F1.04c  nuf2  
Localization spindle 
pole body 3.62 0.000020 
S. pombe 
SPBC582.03  cdc13  Cyclin -3.06 0.999973 
S. pombe 
SPBC12D12.01  sad1  
Localization spindle 
pole body (PMID 
7744953) 
2.12 0.000020 
S. pombe 
SPAPB2B4.03  cig2  Cyclin -4.09 0.999980 
S. pombe 
SPBC336.08  spc24 
Localization spindle 
pole body 
(predicted) 
3.13 0.000078 
S. pombe 
SPAC19E9.03  pas1  
Cyclin (PMID 
10982385) -4.16 0.999886 
S. pombe 
SPCC970.04c  mob2  
Phosphoprotein 
(predicted) 2.22 0.000020 
S. pombe 
SPCC1840.02c  bgs4  
1,3-beta-glucan 
synthase (subunit) 
(predicted) 
-3.89 0.999980 S. pombe SPCC18B5.03  wee1  
Serinethreonine 
protein kinase 3.27 0.000020 
  
Cell cycle and cytoskeleton organization 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC6F6.10c  arc2  
ARP23 actin-
organizing complex -3.90 0.999980 
S. pombe 
SPAC9G1.09  sid1  
Serinethreonine 
protein kinase 2.35 0.000020 
S. pombe 
SPBC1778.08c  arc2  
ARP23 actin-
organizing complex -3.42 0.999034 
S. pombe 
SPAC1805.07c  
dad2 
/hos2  
DASH complex 
(predicted) 2.02 0.000020 
S. pombe 
SPAC17G8.04c  arc5  
ARP23 actin-
organizing complex -2.71 0.999980 
S. pombe 
SPBC32F12.08c  duo1 
DASH complex 
(predicted) 4.83 0.000046 
S. pombe 
SPAC630.03  arp3  
ARP23 actin-
organizing complex -3.38 0.999886 
S. pombe 
SPAC589.08c  dam1 
DASH complex 
(predicted) 2.17 0.000346 
S. pombe 
SPAC1002.13c  psu1  
Beta-glucosidase 
(predicted) -4.17 0.999980 
S. pombe 
SPCC188.13c  dcr1  Dicer 2.00 0.000078 
S. pombe 
SPAC3A12.14  cam1  
Calmodulin (PMID 
3035538) -3.26 0.999970 
S. pombe 
SPAC4C5.02c  ryh1  Small GTPase 3.36 0.000020 
S. pombe 
SPBC646.13  
sds23/ 
psp1/ 
moc1 
CBS domain protein -3.63 0.999980 S. pombe SPBC725.02  
mpr1/ 
spy1 Speedy 2.22 0.000020 
S. pombe 
SPAC3H8.10  spo20  CRALTRIO domain -3.72 0.999980 
S. pombe 
SPBC2D10.06 rep1 Transcription factor 2.83 0.000020 
S. pombe 
SPBC1778.06c  fim1  Fimbrin -4.60 0.999980 
S. pombe 
SPAC22F3.09c mcs1 Transcription factor 2.65 0.000214 
S. pombe 
SPAC12B10.07  acp1 
F-actin capping 
protein (alpha 
subunit) 
-3.47 0.999508 S. pombe SPAC6F6.08c  cdc16/bub2
Two-component 
GAP for GTPase 
spg1 
2.45 0.000020 
S. pombe 
SPCC364.06  nap1 
Involved in 
nucleosome 
assembly (predicted)
-4.02 0.999562 S. pombe SPCC613.04c  rng3  
UCS-domain protein 
(PMID 1085282) 2.68 0.000020 
  
Cell cycle and cytoskeleton organization 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPBC146.13c  myo1  Myosin (type I) -4.12 0.999727 
S. pombe 
SPBPB8B6.04c grt1 Zinc finger protein 2.35 0.001077 
S. pombe 
SPAC9E9.13  wos2  
P23 homolog (PMID 
10581266) -3.64 0.999382 
S. pombe 
SPCC1672.06c  asp1  
Acid phosphatase 
activity (predicted) 2.08 0.000020 
S. pombe 
SPAPYUG7.03c  mid2  
Pleckstrin homology 
domain -3.97 0.999980 
S. pombe 
SPAC22F3.05c  alp41  
ADP-ribosylation 
factor 2.30 0.000020 
S. pombe 
SPACUNK4.07c  cta4  
P-type ATPase 
(PMID 12707717) -3.73 0.999954 
S. pombe 
SPAC890.02c  alp7  
Coiled-coil 
(predicted) 3.13 0.000046 
S. pombe 
SPAC1F7.05  cdc22  
Ribonucleoside 
reductase -5.24 0.999980      
S. pombe 
SPBC25D12.04  suc22  
Ribonucleotide 
reductase -3.97 0.999973      
S. pombe 
SPAC821.06  spn2  Septin (predicted) -3.03 0.998168      
S. pombe 
SPBC16H5.07c  ppa2  
Serinethreonine 
protein phosphatase 
(catalytic subunit) 
-2.78 0.998799      
S. pombe 
SPAC823.15  ppa1  
Serinethreonine 
protein phosphatase 
(minor) (catalytic 
subunit) 
-3.89 0.999870      
S. pombe 
SPBC1D7.04  mlo3  
TREX complex 
(predicted) -4.03 0.999973      
S. pombe 
SPAC27F1.02c  cdc8  Tropomyosin -4.62 0.999911      
  
Cell cycle and cytoskeleton organization 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPBC16A3.15c  nda2  Tubulin (alpha 1) -4.28 0.999980      
S. pombe 
SPBC800.05c  tub1  Tubulin (alpha 2) -4.94 0.999980      
S. pombe 
SPBC26H8.07c  nda3  
Tubulin (beta) (PMID 
6094012) -5.27 0.999654      
  
 
Meiosis 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
S. pombe 
SPAC31G5.11  pac2  
cAMP-independent 
regulatory protein 
(PMID 8536311) 
-3.52 0.999940 S. pombe SPBC16E9.17c  rem1  Cyclin 4.98 0.000020 
S. pombe 
SPBC646.13  
sds23/ 
psp1/ 
moc1 
CBS domain protein -3.63 0.999980 S. pombe SPBC2G2.09c  crs1 Cyclin (predicted) 3.03 0.000060 
S. pombe 
SPAC3H8.10  spo20  CRALTRIO domain -3.72 0.999980 
S. pombe 
SPAC21E11.05c  cyp8  Cyclophilin 3.63 0.000020 
S. pombe 
SPAC1805.08  dlc1  Dynein light chain -3.10 0.998168 
S. pombe 
SPBC1773.09c  mug184 
DNAJ domain 
protein 3.30 0.000020 
S. pombe 
SPAC18G6.07c  mra1  
Functions 
downstream of 
Ras1p 
-3.53 0.999382 S. pombe SPAC27D7.13c  ssm4  
Dynactin complex 
(predicted) 6.87 0.000020 
S. pombe 
SPBC1778.06c  fim1  Fimbrin -4.60 0.999980 
S. pombe 
SPAC20G4.02c  fus1  Formin 3.05 0.000020 
S. pombe 
SPBC146.13c  myo1  Myosin (type I) -4.12 0.999727 
S. pombe 
SPBC14C8.05c  meu17  Glucoamylase 4.84 0.000030 
S. pombe 
SPAC1F7.05  cdc22  
Ribonucleoside 
reductase -5.24 0.999980 
S. pombe 
SPBC428.08c  clr4  
Histone H3 
methyltransferase 4.06 0.000020 
     S. pombe SPCC1223.12c  meu10  
Involved in cell wall 
biosynthesis 
(predicted) 
4.69 0.000020 
  
Meiosis 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
     S. pombe SPAC1565.04c  ste4  
Involved in 
conjugation 3.76 0.000020 
     S. pombe SPAC30D11.10  rad22  
Involved in DNA 
repair (PMID 
8290356) 
4.19 0.000020 
     S. pombe SPBC1685.11  rlp1 
Involved in DNA 
repair (predicted) 2.03 0.000020 
     S. pombe SPAC13A11.03  mcp7 
Involved in 
homologous 
chromosome pairing 
at meiosis 
(predicted) (PMID 
11940665) 
4.19 0.000020 
     S. pombe SPBC31F10.08  mde2  
Involved in meiosis 
(implicated) 4.35 0.000020 
     S. pombe SPBC119.04  mei3  
Involved in meiosis 
(induction) (PMID 
3034608) 
9.17 0.000020 
     S. pombe SPBC1347.03  meu14  
Involved in meiosis 
(PMID 12759375) 4.51 0.000020 
     S. pombe SPBC29A10.14  rec8  
Involved in meiotic 
recombination 
(required) 
3.72 0.000692 
     S. pombe SPCC1753.03c  rec7  
Involved in meiotic 
recombination 
(required) (PMID 
1339382) 
5.98 0.000060 
  
Meiosis 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
     S. pombe SPAC25G10.04c  rec10  
Involved in meiotic 
recombination 
(required) (PMID 
7586030) 
3.09 0.000167 
     S. pombe SPBC21B10.12  rec6  
Involved in meiotic 
recombination 
(required) (PMID 
8005432) 
3.07 0.000020 
     S. pombe SPBC1711.14  rec15  
Involved in meiotic 
recombination 
(required) (PMID 
8559063) 
2.99 0.000020 
     S. pombe SPAC1F8.05  isp3  
Involved in sexual 
differentiation 3.58 0.000035 
     S. pombe SPAC1039.09  isp5  
Involved in sexual 
differentiation (PMID 
7954893) 
3.47 0.000020 
     S. pombe SPBC428.07  meu6  Lysine-rich protein 2.54 0.000020 
     S. pombe SPAC222.15  meu13  
Meiosis specific 
transcript (PMID 
11447128) 
2.38 0.000167 
     S. pombe SPAC1A6.06c  meu31  
Meiotic expression 
upregulated 3.74 0.000273 
     S. pombe SPBC19F8.06c  meu22  
Meiotic expression 
upregulated 3.94 0.000101 
  
Meiosis 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
     S. pombe SPBC27.03  meu25  
Meiotic expression 
upregulated 2.83 0.000020 
     S. pombe SPCPJ732.03  meu15  
Meiotic expression 
upregulated 4.60 0.000020 
     S. pombe SPCC1235.13  ght6  
Meiotic expression 
upregulated 5.55 0.000068 
     S. pombe SPAC1556.06  meu1  
Meiotic expression 
upregulated (PMID 
11376151) 
3.86 0.000020 
     S. pombe SPAC1556.06b  meu2  
Meiotic expression 
upregulated (PMID 
11376151) 
2.56 0.000020 
     S. pombe SPBC1711.01c  matmi  
Mating-type m-
specific polypeptide 
mi 
10.10 0.000020 
     S. pombe SPAPB8E5.05  mfm1  
M-factor precursor 
(PMID 8196631) 6.91 0.000346 
     S. pombe SPCC1795.06  map2  
P-factor (PMID 
8314086) 5.45 0.000020 
     S. pombe SPAC11H11.04  mam2  
Pheromone p-factor 
receptor (PMID 
1657593) 
2.74 0.000035 
     S. pombe SPAC8E11.03c  dmc1  RecA family 3.38 0.000346 
  
Meiosis 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
     S. pombe SPCC4E9.01c  rec11  
Region specific 
activator of 
recombination  
3.78 0.000020 
     S. pombe SPAC27D7.03c  mei2  RNA-binding protein 2.49 0.000241 
     S. pombe SPCC320.07c  mde7  RNA-binding protein 7.59 0.001832 
     S. pombe SPAC1610.03c  crp79  RNA-binding protein 6.94 0.000020 
     S. pombe SPBC19F8.01c  spn7  Septin 1.99 0.000023 
     S. pombe SPCC188.12  spn6  Septin 5.62 0.000035 
     S. pombe SPAC24C9.15c  spn5  Septin (predicted) 3.07 0.000492 
     S. pombe SPAC16E8.05c  mde1  Sequence orphan 3.67 0.000020 
     S. pombe SPAC1296.03c  sxa2  
Serine 
carboxypeptidase 2.30 0.000035 
     S. pombe SPBC8D2.19  mde3  
Serinethreonine 
protein kinase 3.72 0.000060 
     S. pombe SPBC21C3.18  spo4  
Serinethreonine 
protein kinase 5.92 0.000020 
     S. pombe SPAC14C4.03  mek1  
Serinethreonine 
protein kinase 
(predicted) 
3.79 0.000346 
  
Meiosis 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
     S. pombe SPCC417.06c  ppk35 
Serinethreonine 
protein kinase 
(predicted) 
6.87 0.000030 
     S. pombe SPBP35G2.03c  sgo1  Shugoshin 2.74 0.000020 
     S. pombe SPAC22F3.03c  rdh54  
DEADDEAH box 
helicase (PMID 
14551247) 
2.32 0.000020 
     S. pombe SPCC188.13c  dcr1  Dicer 2.00 0.000078 
     S. pombe SPBC29A10.02  spo5 
Single-strand 
polynucleotide 
binding protein 
(predicted) 
3.49 0.000346 
     S. pombe SPBC18H10.07   
Small nuclear 
ribonucleoprotein 
(snRNP) (predicted) 
(pers. comm. J.A. 
Potashkin) 
4.23 0.000027 
     S. pombe SPCC550.05  nse1  
Smc5-6 complex 
(PMID 12966087) 2.02 0.000020 
     S. pombe SPAC17A5.11  rec12  
Spo11Top6A 
topoisomerase 
family (PMID 
12437782) 
3.07 0.000346 
     S. pombe SPBC1778.04  spo6  
Spo4p regulatory 
subunit 2.18 0.000020 
  
Meiosis 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
     S. pombe SPCC1919.11   
Src (SH3) homology 
domain 8.61 0.000035 
     S. pombe SPCC970.01  rad16  
ssDNA 
endonuclease 2.13 0.000020 
     S. pombe SPBC32H8.06   TPR repeat protein 6.83 0.000020 
     S. pombe SPBC2D10.06  rep1  Transcription factor 2.83 0.000020 
     S. pombe SPAC22F3.09c mcs1 Transcription factor 2.65 0.000214 
     S. pombe SPAC22F3.02 atf31 Transcription factor 3.32 0.000035 
     S. pombe SPBC2F12.09c  atf21  Transcription factor 5.92 0.000020 
     S. pombe SPAC11E3.06  map1  Transcription factor 3.05 0.000020 
     S. pombe SPBC32H8.11  mei4  
Transcription factor 
(meiotic) (PMID 
9528784) 
3.64 0.000020 
     S. pombe SPBC1198.12  mfr1  WD repeat protein 3.60 0.000020 
     S. pombe SPBC646.17c  dic1 WD repeat protein 3.64 0.000020 
     S. pombe SPAC25H1.09  mde5  Alpha-amylase 3.77 0.000020 
  
Meiosis 
 REPRESSED   INDUCED 
Accesion Gene Protein type Index p value Accesion Gene Protein type Index p value 
Number encoded    Number encoded 
     S. pombe SPCC550.10 meu8 
Betaine aldehyde 
dehydrogenase 
(predicted) 
2.31 0.000020 
     S. pombe SPAC6G9.12   BRCT domain 2.97 0.000020 
     S. pombe SPAC2G11.05c   BRO1-like domain 2.43 0.000027 
     S. pombe SPBC947.12  kms2  
Coiled-coil 
(predicted) 3.33 0.000020 
     S. pombe SPBC216.02  mcp5 
Coiled-coil  
(predicted) 4.93 0.000020 
     S. pombe SPCC11E10.03  mug1 
Coiled-coil  
(predicted) 3.23 0.000020 
     S. pombe SPAC6B12.16 meu26 
Conserved fungal 
protein 4.74 0.000020 
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APPENDIX 2. Set of differential equations for the presented model 
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SOBRE ESTA TESIS 
El estudio presentado en esta Tesis Doctoral se centra en la investigación de la 
función de la fosfatasa Flp1p (también conocida como Clp1p) de la familia Cdc14 en 
los mecanismos de vigilancia celular, especialmente en la cascada de señalización en 
respuesta al estrés replicativo y al daño en el DNA. Para ello se llevaron a cabo 
análisis genéticos y bioquímicos comparados de las mencionadas respuestas en 
cepas silvestres y mutadas para flp1, así como estudios de la expresión génica en 
respuesta a estrés. En el marco de esta tesis se está desarrollando así mismo un 
modelo matemático del checkpoint de replicación en colaboración con el grupo de 
Biología Computacional de Sistemas del Instituto Max Planck de Genética Molecular 
de Berlín, Alemania. 
Este apéndice corresponde a un resumen en Español de la Tesis Doctoral “ANÁLISIS 
DE LA FUNCIÓN  DE CDC14/FLP1 EN LA RESPUESTA A ESTRÉS GENOTÓXICO 
EN Schizosaccharomyces pombe” cuya memoria ha sido escrita en Inglés. Dado que 
nuestros resultados apuntan claramente a una implicación de la fosfatasa Flp1p en la 
ruta de señalización en respuesta a estrés replicativo, en este resumen nos 
centraremos en los análisis bioquímicos y genéticos realizados a este respecto. Los 
datos correspondientes a la respuesta a daño en el DNA, así como los estudios 
realizados utilizando otro tipo de aproximaciones teóricas y experimentales se pueden 
encontrar en la versión íntegra de la Tesis, referenciada como texto principal.  
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INTRODUCCIÓN 
1. LOS MECANISMOS DE VIGILANCIA CELULARES ANTE 
ESTRÉS REPLICATIVO Y DAÑO AL DNA 
En cada ciclo celular la replicación del material genético y su segregación 
entre las células hijas se ven afectados por una serie de factores intra- y extra-
celulares que amenazan la estabilidad del genoma. Por ello en organismos eucariotas 
existen mecanismos moleculares conservados que preservan la integridad genética, 
denominados checkpoints (del inglés, puntos de control).  Los checkpoints de 
respuesta a alteraciones en el DNA son cascadas de señalización por medio de las 
cuales se detecta la presencia de DNA no replicado o DNA dañado mediante 
proteínas sensoras que inducen una serie de respuestas encaminadas a garantizar la 
estabilidad del genoma. Estas respuestas incluyen el retraso o parada del ciclo 
celular, la estabilización de horquillas de replicación, procesos de reparación del DNA, 
la alteración del programa transcripcional, la alteración del patrón de la cromatina y 
mecanismos de muerte celular o apoptosis. A su vez existen mecanismos que 
permiten la reanudación de los procesos celulares y ciclo celular cuando la fuente de 
estrés desaparece o cuando el estrés persiste indefinidamente. Estos mecanismos se 
conocen como recuperación y adaptación respectivamente.  
Los defectos en originar y transmitir las señales de vigilancia adecuadas pueden 
resultar en aneuploidía, acumulación de mutaciones y reordenamientos 
cromosómicos, procesos que se asocian a la muerte celular y el cáncer. 
Schizosaccharomyces pombe es un organismo modelo de gran utilidad para el 
estudio de los checkpoints, debido a su relativa simplicidad y paralelismo con las 
células humanas. Los mecanismos de vigilancia del DNA en la levadura de fisión 
incluyen el checkpoint en respuesta al DNA no replicado durante fase S y el 
checkpoint en respuesta a lesiones en el DNA durante G2. Además, existe un 
checkpoint de intra-fase S, responsable de la ralentización de la progresión a través 
de dicha fase en respuesta a daño en el DNA detectado durante la replicación. 
En S. pombe la proteína sensora principal de los checkpoints de DNA dañado o no 
adecuadamente replicado es Rad3p, una quinasa emparentada con ATM y ATR, las 
quinasas sensoras en mamíferos. El estrés replicativo y el daño al DNA producido en 
RESUMEN EN ESPAÑOL 
211 
fase S conlleva la activación mediante fosforilación por Rad3p de la quinasa efectora 
del checkpoint Cds1p (Murakami and Okayama, 1995; Lindsay et al., 1998; Brondello 
et al., 1999; Xu et al., 2006), mientras que el daño al DNA activa la quinasa efectora 
Chk1p durante G2, también a través de Rad3p (Walworth et al., 1993; Brondello et al., 
1999). 
La activación de Cds1p y/o Chk1p resulta en una parada en el ciclo celular que 
impide la entrada en mitosis si el DNA está dañado o no está replicado 
completamente. Esta parada se produce mediante inhibición de la fosfatasa Cdc25p y 
potenciación de la actividad de la quinasa Mik1p (Furnari et al., 1997; Rhind et al., 
1997; Furnari et al., 1999; Rhind and Russell, 2001). Estos procesos resultan a su vez 
en la potenciación de la fosforilación en tirosina 15 de Cdc2p y en la correspondiente 
inhibición su actividad, de modo que se asegura que no se alcancen niveles de 
actividad quinasa suficientes para la entrada en mitosis.  
Además de su función en ralentizar el ciclo celular en respuesta a alteraciones en el 
DNA, Cds1p desempeña un papel esencial en la protección y estabilización de 
horquillas de replicación conservando el ensamblaje del replisoma y manteniendo la 
estructura del DNA en un estado adecuado para la reanudación de la replicación 
(Lopes et al., 2001; Tercero and Diffley, 2001; Sogo et al., 2002; Noguchi et al., 2003; 
Tercero et al., 2003; Noguchi et al., 2004; Meister et al., 2005; Ansbach et al., 2007). 
Las células delecionadas para cds1 son capaces de frenar la progresión a través del 
ciclo celular gracias a la activación de Chk1p, pero rápidamente pierden viabilidad 
tras el estrés replicativo (Boddy et al., 1998; Lindsay et al., 1998), hecho que pone de 
manifiesto la importancia de la función estabilizadora específica de Cds1p.  
2. LA FOSFATASA Flp1p 
Flp1p y sus ortólogos 
La familia de fosfatasas Cdc14 desempeña una importante función en la regulación 
negativa de las quinasas dependientes de ciclina mitóticas, CDKs mitóticas (del 
inglés, Cyclin Dependent Kinases), mediante la desfosforilación específica de 
residuos fosforilados por dichas quinasas (Visintin et al., 1998; Kaiser et al., 2002; 
Gray et al., 2003). En Saccharomyces cerevisiae el gen CDC14 es esencial para la 
viabilidad celular y los mutantes termosensibles paran su progresión celular en 
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telofase con niveles altos de actividad quinasa asociada al complejo Cdc28p-Clb 
(Wan et al., 1992; Taylor et al., 1997; Visintin et al., 1998). Atendiendo a la similitud 
en la secuencia, se han encontrado miembros de la familia Cdc14 en varios 
organismos eucariotas, incluyendo S. pombe (Flp1p o Clp1p, del inglés cdc-fourteen-
like-protein), Caenorhabditis elegans (CeCDC-14), Xenopus laevis (XCdc14A and 
XCdc14B) y Homo sapiens (hCdc14A and hCdc14B) (Li et al., 1997; Cueille et al., 
2001; Trautmann et al., 2001; Gruneberg et al., 2002; Kaiser et al., 2002; Krasinska et 
al., 2007). 
Las Cdc14 son fosfatasas de doble especificidad que comparten un núcleo de 
aproximadamente 300 aminoácidos en la zona amino terminal que incluye un dominio 
proteína-fosfatasa bien conservado entre los miembros de la familia (Gray et al., 
2003). 
Las fosfatasas Cdc14 y el control de la salida de mitosis 
En S. cerevisiae Cdc14p regula la salida de mitosis mediante desfosforilación y 
activación de sustratos de la CDK mitótica como la proteína Hct1p/Cdh1p, un 
componente del complejo promotor de anafase/ciclosoma APC/C (del inglés 
anaphase promoting complex/cyclosome) responsable de la ubiquitinación de las 
ciclinas mitóticas, o el inhibidor de CDK Sic1p, en ambos casos para conseguir una 
bajada de la actividad quinasa (Walworth et al., 1993; Brondello et al., 1999; 
Jaspersen et al., 1999; Shou et al., 1999; Visintin et al., 1999). 
En S. pombe Flp1p también regula la salida de mitosis, pero lo hace a través de un 
mecanismo diferente. Flp1p no desfosforila a Rum1p ni Ste9p (los homólogos de 
Sic1p y Hct1p), si no que antagoniza la actividad CDK desfosforilando y marcando 
para degradación a la fosfatasa Cdc25p, lo que indirectamente conlleva un aumento 
en la fosforilación en tirosina 15 de Cdc2p bajando su actividad quinasa (Cueille et al., 
2001; Trautmann et al., 2001; Esteban et al., 2004; Wolfe and Gould, 2004).    
Los residuos fosforilados por CDK1 en la fosfatasa humana Cdc25A son sustratos in 
vitro de hCdc14A, y esta fosfatasa puede rescatar una deleción de flp1 en S. pombe 
desfosforilando Cdc25p, sugiriendo un paralelismo en el mecanismo de salida de 
mitosis entre la levadura de fisión y los humanos (Vazquez-Novelle et al., 2005; 
Esteban et al., 2006). Sin embargo Hct1p también ha sido identificado como un 
sustrato de hCdc14A (Bembenek and Yu, 2001; Kaiser et al., 2002). 
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La regulación de la actividad de las proteínas Cdc14 
La actividad de las proteínas Cdc14 está regulada al menos en parte por su secuestro 
en el nucleolo y posterior liberación (Shou et al., 1999; Visintin et al., 1999; Bembenek 
and Yu, 2001; Cueille et al., 2001; Trautmann et al., 2001; Kaiser et al., 2002).  
En S. cerevisiae Cdc14p se encuentra secuestrada en el nucleolo en forma inactiva 
desde G1 hasta metafase mediante su unión con el inhibidor nucleolar Net1p/Cfi1p, 
miembro del complejo RENT (del inglés regulator of nucleolar silencing and 
telophase) (Shou et al., 1999; Straight et al., 1999; Visintin et al., 1999; Traverso et 
al., 2001). En anafase temprana, ScCdc14p es liberado del nucleolo mediante la 
acción coordinada de una serie de proteínas englobadas en la red de señalización 
FEAR (del inglés cdc-fourteen early anaphase release) (Stegmeier et al., 2002; 
Azzam et al., 2004). La red FEAR induce la fosforilación de Net1p/Cfi1p por CDK 
(Azzam et al., 2004) y su disociación de Cdc14p (Queralt et al., 2006). La red MEN 
(del inglés mitotic exit network) mantiene a la fosfatasa fuera del nucleolo durante la 
progresión a través de anaphase (Jaspersen et al., 1998; Bardin et al., 2000). 
Recientemente se ha descubierto que la propia Cdc14p es responsable de su 
inactivación al final de mitosis, ya que promueve la degradación de la polo quinasa 
Cdc5p (componente de la red FEAR y regulador clave de la red MEN) mediante la 
activación de APC/C-Cdh1p. La degradación de Cdc5p mediada por Cdc14p provoca 
el silenciamiento de las redes FEAR y MEN y promueve el retorno de la fosfatasa al 
nucleolo (Visintin et al., 2008). 
Mientras que ScCdc14p está secuestrada en el nucleolo hasta anafase, otros 
miembros de la familia Cdc14 no están regulados de la misma manera. Los ortólogos 
de S. pombe Flp1p, las isoformas humanas Cdc14A y B y Cdc14A de Xenopus sufren 
un cambio en su localización celular ya en la entrada a mitosis (Cueille et al., 2001; 
Trautmann et al., 2001; Kaiser et al., 2002; Mailand et al., 2002; Kaiser et al., 2004). 
La localización y las funciones de Flp1p 
La serina/treonina fosfatasa Flp1p, al contrario que su ortóloga ScCdc14p, no es 
esencial y las células delecionadas para flp1 sobreviven con un fenotipo avanzado en 
mitosis (Cueille et al., 2001). 
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Flp1p controla la rápida degradación de Cdc25p al final de mitosis (Esteban et al., 
2004; Wolfe and Gould, 2004), lo que resulta en la potenciación de fosforilación 
inhibidora en tirosina 15 de Cdc2p y en la consiguiente bajada de actividad quinasa 
necesaria para la salida de mitosis. La acción de Flp1p es necesaria para la 
ubiquitinación de Cdc25p por APC/C en este punto del ciclo, de modo que las células 
delecionadas para flp1 presentan niveles basales altos de Cdc25p. Como se ha 
mencionado anteriormente esta función podría estar conservada en eucariotas 
multicelulares.  
En la levadura de fisión las células delecionadas para flp1 entran en mitosis con un 
tamaño reducido, es decir presentan un fenotipo wee (Cueille et al., 2001; Trautmann 
et al., 2001). La sobrexpresión de flp1 provoca una parada de las células en G2 con 
Cdc25p desfosforilado, en un proceso dependiente de la actividad de Wee1p (Cueille 
et al., 2001; Esteban et al., 2004). 
Además de su función durante la progresión celular, Flp1p es necesario para la 
efectividad del checkpoint de citoquinesis (Cueille et al., 2001; Trautmann et al., 2001; 
Trautmann and McCollum, 2005) y para una adecuada segregación cromosómica 
(Trautmann et al., 2004). 
Para desempeñar sus distintas funciones, Flp1p debe estar adecuadamente 
localizado en la célula. Durante un ciclo celular normal, Flp1p se localiza en el 
nucleolo y en el cuerpo polar del huso durante interfase, y en el núcleo, en el huso 
mitótico y en el anillo medial durante mitosis (Cueille et al., 2001; Trautmann et al., 
2001). 
Se desconocen los mecanismos por los cuales Flp1p permanece retenido en el 
nucleolo en interfase y es liberado a sus posiciones mitóticas en profase. 
Recientemente se ha identificado una proteína nucleolar, Dnt1p, que presenta 
homología de secuencia con ScNet1/Cfi1p, pero se ha demostrado que no es 
responsable del secuestro o inhibición de Flp1p (Jin et al., 2007). Por otra parte, 
aunque los componentes de la red FEAR (separasa Esp1p, polo quinasa Cdc5p, 
Slk19p y Spo12p) están conservados en S. pombe, éstos no median la salida de 
Flp1p del nucleolo (Chen et al., 2006). Una red de iniciación de septación, SIN (del 
inglés septation initiation network) se encarga de mantener a Flp1p en sus posiciones 
mitóticas hasta que se completa la citoquinesis. Esto es de especial importancia en 
caso de activación del checkpoint de citoquinesis (Cueille et al., 2001; Mishra et al., 
2005). Se ha demostrado que Flp1p permanece en el citoplasma unido a la proteína 
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14-3-3 Rad24p en respuesta a defectos en citoquinesis (Mishra et al 2005.; 
Trautmann et al., 2005). La atenuación del SIN es necesaria para la correcta 
relocalización de Flp1p en el nucleolo al final de mitosis (Cueille et al., 2001). 
Ya en el núcleo Flp1p es inhibido mediante hiperfosforilación  por CDK en los 
estadios tempranos de la mitosis. hCdc14A y XCdc14A también se encuentran 
hiperfosforiladas en mitosis temprana (Kaiser et al., 2002; Kaiser et al., 2004). 
Durante anafase Flp1p revierte la hiperfosforilación inhibidora mediante su 
autodesfosforilación. En esta fase alcanza la actividad catalítica necesaria para actuar 
sobre Cdc25p marcándola para degradación, de modo que se interrumpe el proceso 
de autoactivación de Cdc2p y se potencia la señalización de la red SIN (Esteban et 
al., 2004; Wolfe and Gould, 2004). 
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OBJETIVOS 
1. Dilucidar si la fosfatasa Flp1p de Schizosaccharomyces pombe está implicada 
en los mecanismos de respuesta a estrés genotóxico en dicho organismo. 
2. Estudiar la función de la fosfatasa en la respuesta a estrés genotóxico: análisis 
de los fenotipos asociados a la mutación de flp1 en el marco de la respuesta 
celular a alteraciones en el DNA. 
3. Estudiar el mecanismo de acción de la fosfatasa Flp1p dentro de la respuesta a 
estrés genotóxico: análisis de la relación funcional de la fosfatasa con 
diferentes proteínas implicadas en los checkpoints de respuesta a estrés 
genotóxico. 
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RESULTADOS 
En el ciclo celular vegetativo Flp1p regula la salida de mitosis provocando la 
inactivación de Cdc25p y su degradación rápida, promoviendo indirectamente la 
reducción de actividad quinasa necesaria en este punto del ciclo.  
Una de las respuestas activadas por los mecanismos de vigilancia ante estrés 
replicativo es precisamente la reducción de la actividad de Cdc2p, en este caso para 
impedir la entrada en mitosis si la replicación del DNA no ha sido completa. Esta 
reducción de actividad quinasa se consigue en parte debido a la acción inhibidora de 
las proteínas efectoras del checkpoint sobre Cdc25p.  
De este modo, las dianas de la cascada de señalización en respuesta a alteraciones 
en el DNA y las de la red que garantiza la salida de mitosis son similares. Este hecho 
nos llevó a investigar una posible implicación de Flp1p en la obtención de una 
respuesta celular adecuada en respuesta a estrés replicativo. 
1. ESTUDIO DE LA LOCALIZACIÓN DE Flp1p DURANTE 
ESTRÉS REPLICATIVO 
Flp1p se libera al núcleo en células que sufren estrés replicativo 
Durante un ciclo celular normal Flp1p cambia de localización subcelular para llevar a 
cabo sus diferentes funciones. Flp1p está en el nucleolo y en el cuerpo polar de uso 
en interfase. En profase es liberado del nucleolo mediante un mecanismo 
desconocido para ocupar sus posiciones mitóticas, en el núcleo, huso mitótico y anillo 
medial (Cueille et al., 2001; Trautmann et al., 2001). Como se ha resaltado en la 
introducción, la presencia de Flp1p en sus posiciones mitóticas es importante para la 
regulación de la salida de mitosis y para una correcta segregación cromosómica. Por 
otra parte la retención de Flp1p en el citoplasma asegura una respuesta celular 
adecuada a defectos en citoquinesis. 
Como primera aproximación a nuestro estudio, asumimos que si la fosfatasa estaba 
implicada en la respuesta a estrés replicativo probablemente se pudiera observar una 
salida de Flp1p del nucleolo en células sometidas a este tipo de estrés.  
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Con el fin de probar esta hipótesis, tratamos cultivos asíncronos en crecimiento 
exponencial de una cepa flp1-GFP con hidroxiurea (HU), sustancia inhibidora de la 
ribonucleótido reductasa que provoca estrés replicativo por depleción de nucleótidos. 
Después de dos horas de tratamiento con una concentración 12mM de la droga, la 
mayoría de las células de la población carecían de septo, tenían un solo núcleo y se 
habían alargado como consecuencia de la parada en fase S producida por el 
checkpoint ante el estrés replicativo. Para estudiar en detalle la localización de Flp1p-
GFP durante el estrés, utilizamos Gar2p-RFP como marcador nucleolar y tinción con 
Hoechst para distinguir la parte no nucleolar del núcleo. Como se puede observar en 
la Figura 2 del texto principal Flp1p es nuclear en células tratadas con HU. 
Observando la localización de la proteína nucleolar Gar2p-RFP podemos además 
concluir que el cambio de localización observado en Flp1p no es general para las 
proteínas nucleolares, y que la concentración de HU utilizada no produce una 
reestructuración del nucleolo.  
Mediante un estudio más detallado a los realizados anteriormente (Cueille et al., 
2001; Trautmann et al., 2001) probamos que Flp1p permanece localizado en el 
nucleolo y en el cuerpo polar del uso durante toda la fase S cuando el checkpoint de 
replicación no está activo (Figura 3). De este modo, el cambio de localización de 
Flp1p observado tras el tratamiento con HU se debe específicamente a la acción de la 
droga y no es inherente al punto del ciclo celular en el cual las células están 
bloqueadas. 
El mismo cambio de localización se observó en cultivos sincronizados de la cepa 
cdc10-129 flp1-GFP y tratados con HU en fase S (Figura 4).  
La acumulación nuclear de Flp1p durante estrés replicativo 
depende de un checkpoint activo y de Cds1p 
Por otra parte quisimos probar que el cambio de localización de Flp1p estaba 
asociado a la activación del checkpoint y no era un efecto colateral del tratamiento 
con HU. Para ello comprobamos la localización de Flp1p-GFP en un mutante rad3, 
incapaz de producir un bloqueo en la progresión celular durante el tratamiento con HU 
al carecer de la principal proteína detectora del estrés replicativo.  Tras dos horas de 
tratamiento la localización de Flp1p-GFP era indistinguible de la observada en células 
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sin tratar, probando que la liberación al núcleo de la fosfatasa tras el tratamiento con 
drogas dependía de un mecanismo de vigilancia activo (Figura 5). 
A la vista de este resultado, era de esperar que se produjera una relocalización de 
Flp1p a sus posiciones típicas de ciclo celular una vez que se retirara la fuente de 
estrés replicativo. En efecto, tratando las células durante tres horas con HU 12mM y 
liberando a las células del bloqueo mediante lavados y trasferencia a medio libre de 
droga, observamos Flp1p de vuelta en el nucleolo en un intervalo tan corto como 5 
minutos después de la liberación y más tarde, cuando las células entran en fase M, 
en sus localizaciones mitóticas (Figura 6). 
Como las dos ramas de respuesta ante alteraciones del DNA están íntimamente 
relacionadas y el cambio de localización de Flp1p se podía observar tanto en 
respuesta a estrés replicativo como a daño en el DNA (véase texto principal), 
quisimos comprobar si la liberación de Flp1p al nucleolo dependía específicamente de 
alguna de las dos proteínas efectoras del checkpoint, Cds1p y Chk1p. Para ello 
estudiamos la localización de Flp1p en cepas delecionadas para cds1 o chk1 
respectivamente. En cultivos sin tratar de Δcds1 flp1-GFP o Δchk1 flp1-GFP la 
localización de la fosfatasa era igual a la observada en un tipo silvestre (Figuras 7 y 
8). Sin embargo en cultivos tratados con HU 12mM durante 2 horas, Flp1p seguía 
localizado en el nucleolo y en el cuerpo polar del huso en el mutante cds1 
(localización correspondiente a fase S sin perturbar), mientras que en el mutante chk1 
si se observaba liberación al núcleo. Este resultado indica que la localización de 
Flp1p durante estrés replicativo dependía directa o indirectamente de Cds1p.  
2. Flp1p interacciona funcionalmente con la proteína 14-3-3 
Rad24p en respuesta a estrés replicativo 
Rad24p y Flp1p interaccionan en respuesta a defectos durante la citoquinesis (Mishra 
et al., 2005; Trautmann and McCollum, 2005). Rad24p y Rad25p están además 
implicados en la correcta localización y función de proteínas implicadas en la 
respuesta a alteraciones en el DNA. Daño en el DNA estimula la asociación de Chk1p 
con las proteínas 14-3-3 y esta interacción afecta tanto la localización como la función 
de Chk1p como efector del checkpoint (Chen et al., 1999a; Dunaway et al., 2005). 
Además Rad24p media la exclusión nuclear de Cdc25p asociada a la respuesta 
celular a alteraciones en el DNA (Lopez-Girona et al., 1999; Lopez-Girona et al., 
2001a). 
RESUMEN EN ESPAÑOL 
220 
Estas funciones descritas de las proteínas 14-3-3 asociadas al checkpoint nos 
impulsaron a estudiar si Rad24p estaba implicado en la acumulación nuclear de Flp1p 
en respuesta a estrés replicativo. La acumulación de Flp1p en el núcleo depende en 
efecto de un alelo funcional de rad24+, sugiriendo que Rad24p es necesario para la 
liberación de la fosfatasa del nucleolo asociada a la activación del checkpoint (Figura 
24A). 
Por otra parte, por medio de un ensayo de purificación por afinidad de la etiqueta 
GST, en el cual purificamos GST-Rad24p e inmunodetectamos Flp1p-Ha, probamos 
que Flp1p y Rad24p interaccionan físicamente en respuesta al checkpoint (Figura 
24B).  
Por otra parte también probamos que el doble mutante Δrad24 Δflp1 es más sensible 
a HU que el mutante simple Δrad24 (Figura 24C). Esta interacción genética indica que 
la deleción de flp1 agrava el defecto de la deleción de rad24 en respuesta a estrés 
replicativo, sugiriendo que Flp1p y Rad24 tendrían alguna función relacionada con 
vías del checkpoint independientes. 
3. ANÁLISIS DE LA RELACIÓN ENTRE Flp1p Y Cds1p EN LA 
RESPUESTA A ESTRÉS REPLICATIVO 
Flp1p y Cds1p interaccionan físicamente 
Como hemos mostrado anteriormente el cambio de localización de Flp1p durante la 
respuesta a estrés replicativo depende de Cds1p. Una posibilidad interesante era que 
la mediación de este cambio de localización se debiera a una interacción in vivo entre 
la quinasa y la fosfatasa. Para ello purificamos GST-Flp1p en una cepa cds1p-Ha en 
cultivos sin droga y tras el tratamiento con HU e inmunodetectamos Cds1p-Ha. 
También realizamos el ensayo purificando la forma catalíticamente inactiva de Flp1p 
(Flp1pCS), ya que habíamos demostrado anteriormente en nuestro grupo que GST-
Flp1pCS interacciona más eficientemente con Cdc25p in vivo que GST-Flp1p (Esteban 
et al., 2004; Vazquez-Novelle et al., 2005). 
Mientras que en células no tratadas no se detecta interacción, pudimos observar 
interacción entre Cds1p y Flp1p en células tratadas con agentes genotóxicos (Figura 
12A). Tal y como esperábamos el resultado es más evidente en cepas que expresan 
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la forma catalíticamente inactiva de Flp1p, en las cuales la interacción se puede 
detectar incluso en células sin tratar.  
Estos resultados indican que Cds1p y Flp1p pueden formar un complejo in vivo, 
sugiriendo la existencia de una interacción enzima/sustrato.  
Δflp1 presenta bajos niveles proteicos de Cds1p y actividad 
reducida de la quinasa en respuesta a estrés replicativo 
Flp1p como fosfatasa podría tener una función en la atenuación de la respuesta 
celular a estrés replicativo revertiendo fosforilaciones activadores sobre algún efector 
de la cascada de señalización correspondiente. Dadas nuestras observaciones que 
relacionan Flp1p y Cds1p, quisimos comprobar si Flp1p ejercía alguna acción sobre 
Cds1p en respuesta a estrés replicativo.  
Como primera aproximación, analizamos los niveles de Cds1p durante estrés 
replicativo en una cepa delecionada para flp1 mediante western blot. Mientras en una 
cepa silvestre los niveles de Cds1p aumentan significativamente en las primeras 2 
horas de tratamiento con HU, en Δflp1 este aumento en los niveles de la quinasa es 
mucho más moderado (Figura 12B).  
A continuación analizamos si la actividad de Cds1p en respuesta al checkpoint se 
veía afectada en una deleción de flp1. Para ello inmunoprecipitamos Cds1p-Ha de 
células sin tratar y de cultivos tratados con HU cada media hora durante 4 horas de 
exposición a la droga. La actividad de Cds1p-Ha se ensayó usando MBP (del inglés 
myelin basic protein) como sustrato. La actividad medida se normalizó teniendo en 
cuenta la cantidad de Cds1p-Ha presente en cada muestra. La actividad de la 
fosfatasa en un fondo Δflp1 resultó ser más baja que la detectada en la cepa silvestre 
durante el tratamiento completo (Figura 12C). La diferencia más significativa en 
activación de la quinasa entre las dos cepas se detectó a los 90 minutos de 
tratamiento, tiempo de máxima activación, momento en el cual Δflp1 presenta una 
actividad reducida en un 30% con respecto al tipo silvestre. 
Tomados en conjunto estos resultados desmienten nuestra hipótesis de partida, ya 
que al presentar Δflp1 niveles y actividad reducidos de la quinasa, la función de Flp1p 
en la respuesta a estrés replicativo parecería ser la de activar a Cds1p bien 
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directamente, bien a través de la regulación de algún inhibidor o activador de la 
quinasa.  
Cds1p fosforila a Flp1p in vitro y esta fosforilación potencia su 
actividad fosfatasa 
Anteriormente demostramos que el cambio de localización de Flp1p-GFP durante 
estrés replicativo depende de la presencia de Cds1p. Esto parecía indicar que la 
quinasa ejerce una acción sobre Flp1p en el marco de la respuesta celular a este tipo 
de estrés. Por ello decidimos estudiar si Flp1p podía ser fosforilado por Cds1p activo. 
Para ello inmunoprecipitamos Cds1p-Ha de cultivos en los que habíamos inducido 
estrés replicativo mediante la adición de HU 12mM o MMS 0.033% y ensayamos su 
actividad sobre MBP. Con ello comprobamos que la quinasa estaba activa en ambas 
condiciones, alcanzando un máximo de activación tras 2 horas de tratamiento. A 
continuación realizamos ensayos quinasa de Cds1p inmunoprecipitado en el punto de 
máxima activación sobre GST-Flp1p purificado por afinidad de células Δcds1. Como 
referencia también utilizamos GST como sustrato. El ensayo resultó en la fosforilación 
específica de Flp1p por Cds1p activado por la acción de ambas drogas (Figura 13A). 
También detectamos una banda inferior de fosforilación específica que corresponde a 
una proteína que inmunoprecipita con la quinasa. 
Este resultado tomado en conjunto con nuestras observaciones anteriores sugeriría 
que Flp1p es un sustrato de Cds1p en el marco de la respuesta celular a estrés 
replicativo o daño al DNA asociado a la replicación.  
A continuación probamos si la fosforilación de Flp1p por Cds1p alteraba su actividad 
fosfatasa in vitro. Para ello realizamos ensayos de fosforilación análogos a los 
descritos anteriormente (utilizando ATP no hidrolizable para evitar el posible efecto de 
la autofosforilación de Flp1p durante el posterior ensayo fosfatasa). Posteriormente la 
actividad de este GST-Flp1p fosforilado fue comparada con la de GST-Flp1p 
sometido al mismo proceso pero sin adición de la quinasa. Mediante ensayos 
fosfatasa sobre DiFMUP probamos que la fosforilación de Flp1p por Cds1p estimula 
su actividad fosfatasa (Figura 13B). 
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El mutante flp1-9A: obtención de una forma de Flp1p no 
fosforilable por Cds1p 
A continuación procedimos a la identificación de los residuos en los cuales ocurría la 
reacción de fosforilación de Flp1p por Cds1p con el objetivo de construir una forma de 
Flp1p no fosforilable por la quinasa. De este modo, la cepa modificada resultante 
sería una herramienta de gran utilidad para estudiar las consecuencias de abolir la 
propuesta modificación in vivo de Flp1p por Cds1p en condiciones de estrés 
replicativo. 
Mediante espectrometría de masas se identificó la fosforilación del residuo Serina 468 
en GST-Flp1p fosforilado por Cds1p activado tanto en HU como en MMS. Este 
residuo se encuentra en un sitio RXXS consenso para la fosforilación por la quinasa 
humana homóloga Chk2p en Cdc25A (O'Neill et al., 2002). 
Mutación de esta Serina al residuo no fosforilable Alanina no fue suficiente para abolir 
al fosforilación por Cds1p de la correspondiente proteína mutada (GST-Flp1pS468A).  
Existen otros 8 sitios RXXS en Flp1p situados respectivamente en las Serinas 160, 
396, 408, 467, 493, 499, 513 and 537. Mediante mutación de los 9 sitios RXXS a 
RXXA en el plásmido pREP-KZ-flp1+ nos permitió expresar una forma de la proteína 
(GST-Flp1p9A) no fosforilable por Cds1p in vitro (Figura 14). 
A la vista de nuestros resultados anteriores que relacionaban Cds1p con el cambio de 
localización de Flp1p y mostraban la capacidad de la quinasa de fosforilar a Flp1p in 
vitro, una posibilidad interesante era que la mutación de los sitios de fosforilación por 
Cds1p conllevase una anulación in vivo de la salida de Flp1p al núcleo en condiciones 
de estrés replicativo. 
Para probar esta hipótesis, construimos una versión integrada de la proteína mutada 
marcada con EGFP (en adelante flp1-9A), tal y como se describe en la sección 
MATERIALES Y MÉTODOS del texto principal.  
La proteína Flp1p-9A-EGFP presentaba localización silvestre de Flp1p durante el 
ciclo mitótico normal. Sin embargo mientras el tratamiento con HU 12mM causa una 
liberación de Flp1p en la cepa silvestre, la proteína mutante Flp1p-9A-EGFP 
permanece en sus localizaciones interfásicas en condiciones de estrés replicativo 
(Figura 15).  
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Este resultado es especialmente interesante ya que apunta la existencia de una 
modificación por fosforilación in vivo de Flp1p por Cds1p en respuesta a estrés 
replicativo que sería responsable del cambio de localización de la fosfatasa 
observado en estas condiciones. 
4. ANÁLISIS DE LA INFLUENCIA DE Flp1p EN LA RESPUESTA 
CELULAR EFICIENTE ANTE ESTRÉS REPLICATIVO 
Comportamiento de los mutantes de flp1 en respuesta a 
tratamientos prolongados con HU 
Para estudiar el efecto de Flp1p en respuesta al checkpoint estudiamos como primera 
aproximación si la deleción de flp1 producía sensibilidad a la exposición prolongada a 
HU o agravaba el fenotipo asociado a la deleción de cds1. Como se muestra en la 
figura 16, Δflp1 se comporta de manera silvestre en cuanto a supervivencia en HU y 
no añade ningún defecto observable al crecimiento impedido de los mutantes del 
checkpoint a las concentraciones estudiadas. El mutante flp1-9A presenta un 
comportamiento similar a Δflp1 en estas condiciones. Sin embargo, observamos que 
las células carentes de flp1 son sensibles a la exposición prolongada a estrés 
replicativo tras sincronización en G1. 
Comportamiento de los mutantes de flp1 la respuesta celular a 
corto plazo inducida por estrés replicativo  
Como acabamos de señalar, el mutante flp1-9A no presenta defectos observables en 
cuanto a supervivencia en tratamientos prolongados con HU. Sin embargo  después 
de dos horas de tratamiento con esta droga en medio líquido, pudimos detectar que 
mientras que una cepa silvestre sólo presentaba un 9% de células en mitosis, en el 
mutante el porcentaje de células que no estaban respondiendo adecuadamente al 
bloqueo ascendía al 24%. Mediante análisis del índice de septación en el tipo 
silvestre, flp1-9A y Δflp1 durante tratamiento con HU probamos que este defecto en el 
bloqueo se producía de forma similar para ambos mutantes de flp1 (Figura 17). 
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A continuación quisimos estudiar si este defecto en bloqueo en respuesta a estrés 
replicativo se traducía en una segregación aberrante del DNA durante mitosis. Para 
ello monitorizamos la presencia de células binucleadas (tanto normales como 
aberrantes o cut) durante el tratamiento con HU en cultivos control de cdc10-129 y 
cdc10-129 Δrad3  así como de cdc10-129 Δflp1 sincronizados en G1 y liberados en 
presencia de la droga. También analizamos el contenido en DNA y el tamaño de las 
células mediante citometría de flujo. El estudio se realizó en cultivos sincronizados 
para descartar que los defectos observados pudieran ser consecuencia de una 
dinámica de progresión celular alterada en el mutante.  En la Figura 18 se puede 
observar que efectivamente existe un defecto asociado a la deleción de flp1 
presentando más de un 15% de mitosis aberrantes a partir de las dos horas de 
tratamiento con HU. Esto se refleja en el análisis de citometría de flujo en el que se 
observan contenidos en DNA inferiores a 1C para el mutante. Este defecto es 
moderado en comparación con el observado para el mutante Δrad3. 
La acumulación de Cdc25p y el aumento de fosforilación en 
Tirosina 15 de Cdc2p no se ven afectadas por la deleción de Δflp1 
La respuesta celular a alteraciones en el DNA incluye la exclusión de Cdc25p del 
núcleo (Lopez-Girona et al., 1999; Lopez-Girona et al., 2001b). Dada la implicación de 
Flp1p durante el ciclo mitótico en la degradación de Cdc25p para garantizar la bajada 
en la actividad quinasa de Cdc2p necesaria para la salida de mitosis (Esteban et al., 
2004; Wolfe and Gould, 2004), decidimos analizar si la deleción de flp1 alteraba la 
cinética de acumulación de Cdc25p o el patrón de fosforilación en Tirosina 15p de 
Cdc2p durante estrés replicativo.  
Mediante detección de Cdc25p y Tyr15 de Cdc2p a diferentes tiempos del tratamiento 
observamos que no existía diferencia apreciable entre las correspondientes cinéticas 
para la cepa silvestre y Δflp1 (Figura 20).  
Estos resultados indican que Flp1p no desempeña un papel relevante en el control de 
los niveles de Cdc25p o en la regulación de la actividad de Cdc2p durante la acción 
del checkpoint. 
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Los mutantes de flp1 presentan focos de recombinación en 
respuesta a estrés replicativo 
Además de regular la actividad de Cdc2p en respuesta a estrés replicativo, Cds1p 
desempeña funciones en la protección del DNA que Chk1p no puede realizar. Como 
se ha detallado en la introducción, Cds1p juega un papel central en la estabilización 
de horquillas de replicación en situaciones de estrés y en la coordinación de los 
procesos de recuperación, garantizando el ensamblaje del replisoma durante el 
bloqueo y regulando los procesos de recombinación. Cds1p está implicada en la 
inhibición de la recombinación en las horquillas paradas mediante estabilización de 
sus componentes y a través de la regulación de la endonucleasa Mus81p, de la 
helicasa Rqh1p y de Rad60p. Así las cepas delecionadas para cds1 presentan 
múltiples focos de recombinación durante tratamiento con HU (Meister et al., 2005), 
no observados en una cepa silvestre. La concentración de Rad22p (homólogo a 
ScRad52p) en focos nucleares es indicativo de la inducción de recombinación 
homóloga (Lisby et al., 2001; Du et al., 2003; Meister et al., 2003; Noguchi et al., 
2003).  
Dadas las evidencias que relacionan Flp1p con Cds1p durante estrés replicativo y a la 
vista de que la ausencia de Flp1p no parece alterar significativamente el patrón de 
fosforilación en Tirosina 15 de Cdc2p, decidimos estudiar si la interacción de Flp1p y 
Cds1p podía estar relacionada con las funciones de la quinasa en la inhibición de 
recombinación en horquillas pausadas. 
Para ello analizamos la presencia de focos de recombinación en cultivos sin tratar y 
sometidos a estrés replicativo del tipo silvestre, ∆cds1, ∆flp1 y flp1-9A detectando 
Rad22p-YFP (Figura 21). Mediante clasificación de los núcleos dependiendo del 
número de focos observados en ellos (sin focos, un foco, múltiples focos), 
observamos que mientras que la cepa silvestre presentaba un número similar de 
focos en células tratadas y sin tratar, los mutantes de flp1 sufrían una acumulación 
considerable de focos múltiples como consecuencia del tratamiento con HU. El 
número de focos observado en los mutantes de flp1 es moderado en comparación 
con la acumulación detectada en Δcds1. Estos resultados apuntan una vez más a una 
pérdida de función de la repuesta celular a alteraciones en el DNA en mutantes de 
flp1 y son coherentes con nuestra anterior observación correlacionando la presencia 
de Flp1p con una activación completa de Cds1p. 
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DISCUSIÓN 
El mantenimiento de la estabilidad del genoma a través de generaciones de 
células hijas asegura una transmisión fiel de la información genética que la célula 
contiene. Toda célula asegura dicha estabilidad durante la replicación del genoma en 
fase S y también tiene que hacerlo cuando eventualmente se expone a daños en el 
DNA o a paradas o pausas circunstanciales en la replicación. Para ello las células 
eucariotas tienen mecanismos de control que protegen activamente la integridad del 
genoma. Estos mecanismos están conservados en todos los sistemas modelo 
estudiados hasta el momento. 
El trabajo presentado se centra en el estudio de la fosfatasa Flp1p (cdc fourteen-like 
phosphatase, también llamada Clp1p) en el organismo modelo S. pombe y en papel 
que desempeña en los checkpoints frente a alteraciones en el DNA. 
La serina/treonina fosfatasa Flp1p de S. pombe desempeña funciones descritas en 
ciclo celular, controlando la degradación rápida de la proteína Cdc25p al final de 
mitosis (Esteban et al., 2004; Wolfe and Gould, 2004), necesaria para la bajada de 
actividad quinasa de Cdc2p correspondiente a este punto del ciclo.     
En la levadura de fisión al igual que en eucariotas superiores, la entrada a mitosis se 
retrasa en células que tienen su integridad genómica comprometida, bien por daño al 
DNA o por estrés replicativo. Este retraso se regula por medio de cascadas de 
señalización o checkpoints que inhiben de Cdc25p y estimulan la actividad de Mik1p 
mediante las quinasas Cds1p y Chk1p (Furnari et al., 1999), que se traduce en 
inhibición de Cdc2p (Rhind et al., 1997).  
Nuestra hipótesis inicial de trabajo para investigar la implicación de la fosfatasa Flp1 
en las cascadas de respuesta a daño genotóxico se basó en la similitud existente 
entre las dianas reguladoras de la salida mitosis, proceso en el cual Flp1p participa 
activamente, y las que en última instancia son responsables de la ralentización del 
ciclo celular en caso de amenaza a la integridad genómica.  
Nuestra investigación nos ha llevado a plantear, en efecto, una función para Flp1p 
dentro de la respuesta a estrés replicativo. Sorprendentemente, esta función es 
independiente de la que la fosfatasa desempeña durante el ciclo vegetativo, ya que la 
deleción de flp1 no conlleva una alteración significativa de la dinámica de 
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acumulación de Cdc25p ni de la inhibición por fosforilación de Cdc2p características 
de la respuesta celular a estrés genotóxico. 
Los resultados de nuestro estudio indican que la respuesta celular a estrés replicativo 
produce una alteración en la situación sub-celular de Flp1p y claramente relacionan a 
Flp1p con la principal quinasa efectora del checkpoint, Cds1p. Hemos probado que la 
interacción entre Flp1p y Cds1p es importante para la consecución de una completa 
activación de la quinasa durante la respuesta a estrés replicativo. También hemos 
demostrado que Flp1p interacciona físicamente y/o genéticamente con otras 
proteínas implicadas en la correcta señalización celular en condiciones de estrés, 
como Rad24p (véase texto principal). Además la alteración de los niveles proteicos de 
Flp1p o su localización resulta en la desregulación de la respuesta a estrés, 
produciéndose efectos como pérdida de eficiencia en el bloqueo de la progresión 
celular o la aparición de focos de recombinación. 
1. LA LOCALIZACIÓN DE Flp1p EN RESPUESTA A ESTRÉS 
GENOTÓXICO 
Durante un ciclo normal Flp1p se localiza en el nucleolo y en el cuerpo polar del huso 
durante la replicación del DNA en fase S (Cueille et al., 2001; Trautmann et al., 2001) 
y este trabajo). Sin embargo cuando se activa la respuesta celular por la detección de 
estrés replicativo, Flp1p se libera del nucleolo para ocupar todo el núcleo. Este 
cambio de localización no ocurre en una cepa delecionada para rad3 indicando que 
es un efecto específico de la activación del checkpoint. Flp1p permanece también en 
su localización nucleolar durante estrés replicativo en un mutante Δrad24, indicando 
que la proteína 14-3-3 estaría implicada en el transporte de la fosfatasa. Sin embargo, 
se debe tener en cuenta que la deleción de rad24 afecta a numerosos procesos 
celulares (las células Δrad24 presentan una morfología tipo orb además de 
localización alterada de proteínas implicadas en el ciclo celular y los mecanismos de 
vigilancia), así que la deslocalización de Flp1p en este mutante podría ser la 
consecuencia de un entorno celular alterado. 
Mientras que se desconoce el mecanismo por el cual durante el ciclo mitótico Flp1p 
se libera al núcleo en mitosis temprana, los datos que presentamos en este trabajo 
demuestran que es la acción de Cds1p, la que libera a Flp1p al núcleo en condiciones 
de estrés replicativo: Flp1p no sale del nucleolo durante el tratamiento con HU en una 
cepa Δcds1 y por otra parte, la mutación de los sitios de fosforilación in vitro de Cds1p 
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en Flp1p anula la liberación de la fosfatasa al núcleo específicamente durante 
situaciones de estrés. En concordancia con este argumento también pudimos 
detectar interacción física entre Flp1p y Cds1p en respuesta a estrés replicativo. 
De acuerdo con nuestros resultados y ya que Cds1p parece estar localizada en 
mayor o menor medida en toda la célula (Brondello et al., 1999; Matsuyama et al., 
2006), la fosforilación de Flp1p por la fosfatasa podría tener lugar en el nucleolo. En 
futuros estudios se analizará detalladamente la regulación espacio-temporal de la 
acción de Cds1p sobre Flp1p. 
Flp1p en el núcleo en situaciones de estrés replicativo 
En S. cerevisiae, la respuesta a daño al DNA conlleva la activación de las dos rutas 
de respuesta, asociadas a Chk1p y Rad53 respectivamente, lo que resulta en la 
inhibición de las redes FEAR y MEN. Esto produce la retención de ScCdc14p en el 
nucleolo durante la activación del checkpoint (Liang and Wang, 2007).  
En nuestro estudio hemos probado que en S. pombe la respuesta celular a 
alteraciones en el DNA provoca la liberación de Flp1p al núcleo (véase también texto 
principal). Dado que ambas fosfatasas ortólogas están implicadas en la regulación de 
la actividad mitótica de CDK durante la progresión celular, el hecho de que la 
activación del checkpoint provoque reacciones opuestas en el control de la 
localización de Flp1p y ScCdc14p es en principio desconcertante. Por otra parte, la 
predominante localización nucleolar de Flp1p durante tratamiento con MMS, así como 
la degradación de la fosfatasa en estas condiciones (véase texto principal), podría 
indicar que la respuesta celular en S. pombe provoca la inhibición de la actividad de 
Flp1p específicamente ante daño en el DNA, de forma similar a lo que ocurre en S. 
cerevisiae, pero a través de otro mecanismo. 
Estudios en S. cerevisiae han planteado, por otra parte, que el secuestro de 
ScCdc14p en el nucleolo durante la fase S podría ser necesario para que se 
produzcan adecuadamente las modificaciones mediadas por CDK necesarias para la 
replicación del DNA. Si se fuerza una localización de ScCdc14p al núcleo, ésta es 
capaz de desfosforilar los factores de replicación Sld2p y Dpb2p, que se fosforilan por 
Clb5-CDK durante fase S para garantizar la asociación de polimerasas a los orígenes 
de replicación. De este modo la presencia forzada de Cdc14p en el núcleo en 
ausencia de ciclina Clb5p dificulta la compleción de la replicación del DNA (Bloom 
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and Cross, 2007). En este estudio hemos probado que la respuesta del checkpoint a 
DNA no replicado causa una acumulación de Flp1p en el núcleo. En vista de las 
observaciones mencionadas para S. cerevisiae, se podría especular que la liberación 
de Flp1p al núcleo durante estrés replicativo puede producirse para inhibir de alguna 
manera la maquinaria de replicación revirtiendo los efectos de los complejos mitóticos 
de fase S.  
Nuestros resultados relativos a la mutación de flp1 durante estrés replicativo 
muestran que Δflp1 y flp1-9A presentan fenotipos similares de recombinación, defecto 
en el bloqueo asociado al checkpoint y activación reducida de Cds1p. Esto indicaría 
que estos defectos se derivan de la ausencia de Flp1p en el núcleo en respuesta al 
checkpoint. El hecho de que flp1-9A  presente actividad reducida de Cds1p como 
Δflp1 prueba que la salida de Flp1p al núcleo es un suceso clave en el control de la 
actividad de la quinasa efectora del checkpoint durante estrés replicativo. Los 
defectos en el bloqueo mediado por el checkpoint y la aparición de focos de 
recombinación en los mutantes de flp1 se pueden justificar apelando a la reducción 
en la actividad de Cds1p. Sin embargo, hemos probado por otra parte que la 
expresión de genes implicados en recombinación y en otros aspectos de la respuesta 
a estrés replicativo se ve alterada en una deleción de flp1 (véase texto principal), por 
lo que no se puede descartar una función directa de la forma nuclear de Flp1p en la 
regulación transcripcional asociada al checkpoint. 
2. La relación funcional entre Cds1p y Flp1p: un mecanismo 
para la adecuada activación de la respuesta celular a estrés 
replicativo 
Los resultados presentados en este estudio relacionan a Flp1p con el principal efector 
de la cascada de señalización en respuesta a estrés replicativo, Cds1p. 
Sorprendentemente, nuestras evidencias experimentales indican que existe tanto una 
acción de Cds1p sobre Flp1p como de la fosfatasa sobre la quinasa en el marco de la 
respuesta celular a estrés replicativo. 
De acuerdo con nuestras observaciones Cds1p tendría una acción sobre Flp1p para 
regular su localización, su estabilidad y su actividad ya que: (1) Flp1p no se libera al 
núcleo en un fondo Δcds1. (2) La quinasa activada por el checkpoint es capaz de 
fosforilar Flp1p in vitro. Esta fosforilación tendría lugar muy probablemente también in 
vivo con el fin de liberar Flp1p al núcleo en respuesta a estrés replicativo, ya que la 
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mutación de todos los sitios putativos de fosforilación por Cds1p en Flp1p (lo que 
anula la fosforilación de la fosfatasa por la quinasa in vitro) conlleva una abolición 
específica del cambio de localización de Flp1p en respuesta al checkpoint. (3) La 
fosforilación de Flp1p por Cds1p in vitro produce una potenciación de su actividad 
fosfatasa. Nuestros resultados preliminares in vivo muestran que la actividad de la 
fosfatasa aumenta tras dos horas de tratamiento, observación que refuerza la relación 
propuesta entre fosforilación, localización y aumento de la actividad fosfatasa.  
Por otra parte Flp1p regula directa o indirectamente los niveles y la actividad de 
Cds1p: (1) Δflp1 presenta niveles reducidos de Cds1p en respuesta a estrés 
replicativo en comparación con el tipo silvestre. (2) En un fondo Δflp1 Cds1p es 
menos activa que en células silvestres en respuesta a HU y MMS. 
En lo que respecta a la sucesión temporal de las distintas interacciones funcionales 
entre Cds1p y Flp1p, el hecho de que la disrupción de la acción de Cds1p sobre 
Flp1p en el mutante flp1-9A produzca el mismo tipo de defectos en respuesta al 
checkpoint que la deleción de flp1 parece indicar que la acción de Flp1p sobre Cds1p 
(regulando su actividad y niveles) sería dependiente de un paso previo en el cual la 
quinasa activa la fosfatasa. 
Hemos probado que la deleción de flp1 causa dos defectos diferentes en la respuesta 
celular a estrés replicativo. Por una parte pudimos observar la aparición de focos de 
recombinación durante la activación del checkpoint en Δflp1 y además observamos 
que un porcentaje moderado de células de esta cepa escapa al bloqueo producido 
por el checkpoint en estas condiciones, y progresan en el ciclo dando lugar a mitosis 
aberrantes. Estos dos defectos se pueden explicar por la bajada en la actividad 
quinasa de Cds1p observada en Δflp1. 
Todas estas observaciones nos llevan a plantear un modelo para el mecanismo de la 
implicación de Flp1p en la respuesta celular a estrés replicativo (Figura D1): en 
respuesta a estrés replicativo Cds1p es activada mediante fosforilación por Rad3p. 
Una vez activado Cds1p fosforilaría a Flp1p para regular su salida del nucleolo y su 
actividad. Rad24p podría estar implicado en este mecanismo de localización. 
Finalmente la forma nuclear de Flp1p activaría directa o indirectamente la activación 
completa de Cds1p. 
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¿Una acción directa de Flp1p sobre Cds1p?  
Una importante pregunta abierta en nuestro trabajo es si el control de Flp1p sobre 
Cds1p se debe a una acción directa. Un control directo sería una posibilidad 
interesante, ya que, de acuerdo con nuestros resultados esto implicaría que la 
desfosforilación de la quinasa produciría su activación. En futuros estudios se 
analizará si la fosfatasa puede potenciar la activación de Cds1p favoreciendo la 
dimerización o autofosforilación de la quinasa, pasos descritos de su activación. 
Apuntando a una acción directa de la fosfatasa sobre la quinasa, pudimos detectar 
interacción física entre Cds1p y Flp1p durante estrés genotóxico. La interacción se 
detecta mejor cuando utilizamos una forma catalíticamente inactiva de Flp1p, lo que 
indicaría que la interacción podría ocurrir para desfosforilar Cds1p. Sin embargo, 
estos datos no deberían considerarse concluyentes ya que hay que tener en cuenta 
que la interacción se ha detectado en condiciones de sobre-expresión de Flp1p y que 
la señal que observamos es débil incluso cuando utilizamos la forma catalíticamente 
inactiva de la fosfatasa.  
Por otra parte, considerando una regulación indirecta de Cds1p por la fosfatasa, 
Flp1p podría estar actuando sobre proteínas implicadas en la regulación de los 
niveles y actividad de Cds1p. Así, posibles dianas de Flp1p serían las proteínas 
implicadas en replicación y estabilización de horquillas, ya que muchas de ellas 
median la activación de Cds1p en condiciones de estrés replicativo. Entre las posibles 
dianas sería interesante considerar las chaperonas Ssa1p y Ssa2p, no caracterizadas 
en S. pombe, que podrían tener una función en la estabilización de Cds1p. El estudio 
de la posible función de estas chaperonas en la activación de Cds1p durante estrés 
genotóxico nos parece de especial interés en el marco de nuestra investigación ya 
que hemos comprobado que Ssa2p co-purifica con GST-Flp1p. 
3. CONSTRUCCIÓN DE UN MODELO MATEMÁTICO PARA LA 
RESPUESTA CELULAR A ESTRÉS REPLICATIVO EN S. 
pombe 
Como se ha indicado anteriormente, en el marco de esta Tesis se está desarrollando 
un modelo matemático del checkpoint de replicación en colaboración con el grupo de 
Biología Computacional de Sistemas del Instituto Max Planck de Genética Molecular 
de Berlín, Alemania. Los detalles de la construcción de este modelo así como los 
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resultados obtenidos y nuestros planes para mejora del mismo se pueden encontrar 
en el texto principal. 
Nuestro modelo está formado por dos módulos: uno mediante el cual reproducimos el 
ciclo celular mitótico y un submódulo para la acción del checkpoint en condiciones de 
estrés replicativo. Una de las principales novedades que aporta nuestro modelo, es 
que el módulo para el ciclo celular es autónomo y autoregulado, es decir, es capaz de 
reproducir la naturaleza oscilatoria de la progresión celular sin la necesidad de 
introducir ninguna orden matemática ajena al esquema biológico empleado.  
Otra característica destacable de nuestro modelo global es que ha sido ajustado a 
datos experimentales, es decir, el conjunto de parámetros del sistema ha sido 
seleccionado de manera que no sólo se reproduce el comportamiento biológico 
cuantitativo, si no que responde a perfiles dinámicos específicos representados por 
cinéticas experimentales.  
También se han empleado cinéticas experimentales en el estadio de validación del 
modelo.  
Como se detalla en el texto principal, se está trabajando en la construcción de un 
modelo mejorado principalmente en lo que respecta a la regulación de Cdc25p.  
Una vez que obtengamos un modelo ajustado y validado capaz de reproducir, de 
acuerdo con nuestras exigencias, el comportamiento dinámico de todas las especies 
implicadas, someteremos al sistema a diferentes análisis. Con ellos pretendemos 
obtener información que nos ayude a comprender algunos aspectos de nuestra 
investigación (el mecanismo que subyace al defecto observado en repuesta al 
checkpoint tanto de Δflp1 como de opflp1; una descripción matemática de los 
umbrales de actividad de Cds1p asociados a estabilidad de horquillas y al bloqueo de 
la progresión celular, y de la función de Flp1p en alcanzarlos, etc).  
Por otra parte, tanto el módulo para el ciclo celular como el submódulo para la 
respuesta celular a estrés replicativo, pueden ser usados como base para modelos 
más descriptivos y/o exhaustivos. Esto será de especial interés cuando se disponga 
de un mayor número de datos experimentales de concentraciones proteicas y 
velocidades de reacción en S. pombe. 
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CONCLUSIONES 
1. La fosfatasa Flp1p está implicada en la respuesta celular a estrés genotóxico: 
a. Los mutantes estudiados de flp1 presentan defectos moderados en la 
respuesta celular a estrés replicativo.  
b. La fosfatasa cambia de localización en respuesta a estrés genotóxico de 
manera dependiente de la activación del checkpoint.  
i. La liberación de Flp1p al núcleo en condiciones de estrés replicativo 
ocurre dependientemente de Cds1p y ocurre con gran probabilidad 
por fosforilación de la fosfatasa.  
ii. La liberación de Flp1p al núcleo es decisiva para sus funciones ya 
que la retención de Flp1p en el nucleolo en condiciones de estrés 
provoca fenotipos análogos a la deleción de flp1. 
c. En respuesta a estrés genotóxico Flp1p no actúa sobre Cdc25p ni afecta 
indirectamente de forma significativa los niveles de fosforilación en 
Tirosina 15 de Cdc2p, en contraste con su función durante ciclo celular y 
a pesar de que la respuesta celular a estrés replicativo conlleva la 
regulación de Cdc25p y Cdc2p. 
d. Existe una estrecha relación funcional entre Flp1p y Cds1p, que resulta 
en la correcta activación de la quinasa en respuesta a estrés replicativo. 
Los fenotipos asociados a una respuesta celular parcialmente deficiente 
en respuesta a estrés replicativo en los mutantes de flp1 se pueden 
explicar en su mayoría por la actividad atenuada de Cds1p que 
presentan.  
e. No podemos descartar que Flp1p desempeñe un papel activo en la 
regulación transcripcional en respuesta al checkpoint. 
2. Se ha construido un modelo matemático capaz de simular el ciclo celular 
mitótico y la respuesta celular a estrés replicativo en S. pombe. Un modelo 
mejorado está en proceso, el cual una vez validado, pretendemos emplear 
como herramienta para esclarecer algunos aspectos de nuestra investigación 
relativos al mecanismo de acción de Flp1p en la respuesta a estrés replicativo. 
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